NCT ID;Title;Status;Phase;Study Type;Enrollment;Conditions
NCT01746238;Bevacizumab/Doxorubicin/Radiation for Sarcoma;ACTIVE_NOT_RECRUITING;['PHASE1'];INTERVENTIONAL;14.0;['Sarcoma']
NCT02354131;Niraparib Versus Niraparib-bevacizumab Combination in Women With Platinum-sensitive Epithelial Ovarian Cancer;COMPLETED;['PHASE1', 'PHASE2'];INTERVENTIONAL;108.0;['Ovarian Cancer']
NCT00932438;Drug-Eluting Bead, Irinotecan (DEBIRI) Therapy of Liver Metastasis From Colon Cancer With Systemic Fluorouracil, Oxaliplatin, Leucovorin and Bevacizumab;COMPLETED;['PHASE1', 'PHASE2'];INTERVENTIONAL;70.0;['Colon Cancer With Metastases to the Liver']
NCT00608972;Phase II Trial of Doxil, Carboplatin, Bevacizumab in Triple Negative Untreated Metastatic Breast Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;31.0;['Metastatic Breast Cancer']
NCT00217672;Docetaxel With Bevacizumab as First-Line Therapy in Treating Women With Stage IV Breast Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;76.0;['Breast Cancer']
NCT00702572;Carboplatin, Paclitaxel, Bevacizumab and Vorinostat for Patients With Advanced Non-Small Cell Lung Cancer;TERMINATED;['PHASE1'];INTERVENTIONAL;25.0;['Non-small Cell Lung Cancer']
NCT00120172;Study of Oxaliplatin, Capecitabine, and Bevacizumab to Treat Older Patients With Colorectal Cancer;TERMINATED;['PHASE2'];INTERVENTIONAL;40.0;['Colorectal Cancer', 'Neoplasm Metastasis']
NCT04356729;A Phase II Trial of PD-L1 Therapy Combined With Anti-VEGF Therapy in Unresectable or Metastatic Melanoma;RECRUITING;['PHASE2'];INTERVENTIONAL;30.0;['Clinical Stage III Cutaneous Melanoma AJCC v8', 'Stage IV Melanoma', 'Unresectable Stage III Cutaneous Melanoma', 'Unresectable Stage IV Cutaneous Melanoma']
NCT00662129;Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;50.0;['Breast Cancer']
NCT02664961;Study of TRC105 and Bevacizumab in Patients With Refractory Gestational Trophoblastic Neoplasia (GTN);TERMINATED;['PHASE2'];INTERVENTIONAL;3.0;['Gestational Trophoblastic Neoplasia', 'Choriocarcinoma', 'Placental Site Trophoblastic Tumor', 'Epithelioid Trophoblastic Tumor']
NCT00604461;Carboplatin, Bevacizumab and Pemetrexed in the First-Line Treatment of Patients With Malignant Pleural Mesothelioma (MPM);TERMINATED;['PHASE1', 'PHASE2'];INTERVENTIONAL;13.0;['Mesothelioma']
NCT00360360;Paclitaxel/Carboplatin Plus Bevacizumab/Erlotinib in the First Line Treatment of Carcinoma of Unknown Primary Site;COMPLETED;['PHASE2'];INTERVENTIONAL;60.0;['Neoplasm, Unknown Primary']
NCT00602329;MRI in Predicting Response in Patients Receiving Combination Chemotherapy and Bevacizumab For Advanced or Metastatic Colorectal Cancer;TERMINATED;['PHASE2'];INTERVENTIONAL;5.0;['Colorectal Cancer']
NCT00533429;Study of Pemetrexed + Carboplatin + Bevacizumab + Enzastaurin Versus Pemetrexed + Carboplatin + Bevacizumab + Placebo in Participants With Non-Small Cell Lung Cancer Who Have Not Been Previously Treated With Chemotherapy;COMPLETED;['PHASE2'];INTERVENTIONAL;40.0;['Non-small Cell Lung Cancer']
NCT00960960;A Study of PI3-Kinase Inhibitor GDC-0941 in Combination With Paclitaxel, With and Without Bevacizumab or Trastuzumab, and With Letrozole, in Participants With Locally Recurrent or Metastatic Breast Cancer;COMPLETED;['PHASE1'];INTERVENTIONAL;71.0;['Breast Cancer']
NCT02313272;Hypofractionated Stereotactic Irradiation (HFSRT) With Pembrolizumab and Bevacizumab for Recurrent High Grade Gliomas;COMPLETED;['PHASE1'];INTERVENTIONAL;32.0;['Malignant Glioma']
NCT00600210;Neoadjuvant Bevacizumab and Carboplatin Followed by Concurrent Bevacizumab, Carboplatin and Radiotherapy in the Primary Treatment of Cervix Cancer;WITHDRAWN;['PHASE2'];INTERVENTIONAL;0.0;['Cervical Cancer']
NCT00203372;Neoadjuvant TAC Plus or Minus Bevacizumab(AVF3299);COMPLETED;['PHASE2'];INTERVENTIONAL;6.0;['Breast Cancer']
NCT01386710;Repeated Super-selective Intraarterial Cerebral Infusion Of Bevacizumab Plus Carboplatin For Treatment Of Relapsed/Refractory GBM And Anaplastic Astrocytoma;SUSPENDED;['PHASE1', 'PHASE2'];INTERVENTIONAL;54.0;['Glioblastoma Multiforme', 'Anaplastic Astrocytoma']
NCT05200364;A Study of STRO-002, an Anti-Folate Receptor Alpha Antibody Drug Conjugate, in Combination With Bevacizumab in Epithelial Ovarian Cancer;RECRUITING;['PHASE1'];INTERVENTIONAL;58.0;['Ovarian Cancer', 'Ovarian Carcinoma', 'Ovary Cancer', 'Fallopian Tube Cancer', 'Primary Peritoneal Carcinoma']
NCT02478164;Trial of Ponatinib in Patients With Bevacizumab-Refractory Glioblastoma;COMPLETED;['PHASE2'];INTERVENTIONAL;17.0;['Glioblastoma']
NCT00805961;RT, Temozolomide, and Bevacizumab Followed by Bevacizumab/Everolimus in First-line Treatment of GBM;COMPLETED;['PHASE2'];INTERVENTIONAL;68.0;['Glioblastoma Multiforme']
NCT00047710;Study of Combined RHUMAB VEGF and Capecitabine-based Chemoradiation for Patients With Locally Advanced Pancreatic Cancer;COMPLETED;['PHASE1'];INTERVENTIONAL;48.0;['Pancreatic Cancer']
NCT00464646;Therapy With Bevacizumab (BEV), Epirubicin, and Cyclophosphamide Followed by Docetaxel Plus Trastuzumab and BEV Given as Neoadjuvant or Adjuvant Therapy for Women With Locally Advanced HER2 Positive Invasive Breast Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;105.0;['Breast Cancer']
NCT00222729;Study of Pemetrexed and Bevacizumab in Patients With Head and Neck Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;42.0;['Cancer']
NCT01946529;Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumors;ACTIVE_NOT_RECRUITING;['PHASE2'];INTERVENTIONAL;24.0;['Desmoplastic Small Round Cell Tumor', 'Ewing Sarcoma of Bone or Soft Tissue', 'Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor', 'Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor']
NCT00308529;Irinotecan, Carboplatin, Bevacizumab, and Radiation Therapy in the Treatment of Limited Stage Small Cell Lung Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;55.0;['Carcinoma, Small Cell Lung', 'Lung Cancer']
NCT05751629;Study to Evaluate the Safety and Efficacy of TSR-042, Bevacizumab, and Niraparib in Participants With Recurrent Ovarian Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;41.0;['Ovarian Neoplasm']
NCT01005329;Intensity-Modulated Radiation Therapy, Cisplatin, and Bevacizumab Followed by Carboplatin and Paclitaxel in Treating Patients Who Have Undergone Surgery for Endometrial Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;34.0;['Endometrial Adenocarcinoma', 'Endometrial Adenosquamous Carcinoma', 'Endometrial Clear Cell Adenocarcinoma', 'Endometrial Serous Adenocarcinoma', 'Stage IA Uterine Corpus Cancer AJCC v7', 'Stage IB Uterine Corpus Cancer AJCC v7', 'Stage II Uterine Corpus Cancer AJCC v7', 'Stage IIIA Uterine Corpus Cancer AJCC v7', 'Stage IIIB Uterine Corpus Cancer AJCC v7', 'Stage IIIC Uterine Corpus Cancer AJCC v7', 'Stage IVA Uterine Corpus Cancer AJCC v7', 'Stage IVB Uterine Corpus Cancer AJCC v7']
NCT00426829;Proton Therapy and Bevacizumab for Primary Liver Tumors;TERMINATED;['PHASE1'];INTERVENTIONAL;3.0;['Liver Cancer', 'Hepatocellular Carcinoma', 'Cholangiocarcinoma']
NCT01894451;Pilot Study of Zirconium-89 Bevacizumab Positron Emission Tomography for Imaging Angiogenesis in Patients With Inflammatory Breast Carcinoma Receiving Preoperative Chemotherapy;COMPLETED;['EARLY_PHASE1'];INTERVENTIONAL;2.0;['Inflammatory Breast Carcinoma']
NCT01295112;Effect of OzurdexÂ® 0.7 mg on Improvement of Efficacy of Bevacizumab for Central Retinal Vein Occlusion;COMPLETED;['PHASE2', 'PHASE3'];INTERVENTIONAL;68.0;['Non-Ischemic Central Retinal Vein Occlusion']
NCT03387085;QUILT-3.067: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With TNBC Who Have Progressed on or After Standard-of-care Therapy.;ACTIVE_NOT_RECRUITING;['PHASE1', 'PHASE2'];INTERVENTIONAL;79.0;['Triple Negative Breast Cancer']
NCT01473251;Analysis of Growth Factors in Patients Undergoing Lucentis or Avastin Injections for Diabetic Macular Edema and Exudative Macular Degeneration;COMPLETED;['NA'];INTERVENTIONAL;16.0;['Exudative Macular Degeneration', 'Diabetic Macular Edema']
NCT00846612;Pharmacokinetic Study of Avastin and Doxil in Ovarian Cancer;COMPLETED;['PHASE1'];INTERVENTIONAL;15.0;['Ovarian Cancer']
NCT00421512;A Phase I Study of Bevacizumab and Sunitinib in Metastatic Renal Cell Carcinoma Patients;COMPLETED;['PHASE1'];INTERVENTIONAL;28.0;['Metastatic Renal Cell Carcinoma', 'Kidney Cancer']
NCT01198548;High-Dose Cholecalciferol in Treating Patients Receiving Combination Chemotherapy and Bevacizumab as First-Line Therapy For Metastatic Colorectal Cancer;TERMINATED;['PHASE2'];INTERVENTIONAL;10.0;['Stage IV Colon Cancer', 'Stage IV Rectal Cancer']
NCT01578551;Study of Metformin Plus Paclitaxel/Carboplatin/Bevacizumab in Patients With Adenocarcinoma.;TERMINATED;['PHASE2'];INTERVENTIONAL;25.0;['Carcinoma, Non-Small-Cell Lung', 'Lung Adenocarcinoma']
NCT00320255;A Phase 2 Pilot Study of Apixaban for the Prevention of Thromboembolic Events in Patients With Advanced (Metastatic) Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;130.0;['Thrombosis', 'Cancer', 'Pulmonary Embolism']
NCT01057212;Trial of Bevacizumab and Ixabepilone for Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC);TERMINATED;['PHASE2'];INTERVENTIONAL;6.0;['Non-squamous Non-small Cell Lung Cancer']
NCT00276055;Phase IB Study of Gemcitabine, Docetaxel and Bevacizumab in Patients With Soft Tissue Sarcoma;COMPLETED;['PHASE1'];INTERVENTIONAL;38.0;['Sarcoma']
NCT02471651;Dexamethasone Intravitreal Implant for the Treatment of Persistent Diabetic Macular Edema;COMPLETED;['PHASE4'];INTERVENTIONAL;40.0;['Diabetic Macular Edema']
NCT00565851;Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer;ACTIVE_NOT_RECRUITING;['PHASE3'];INTERVENTIONAL;1052.0;['Clear Cell Adenocarcinoma', 'Fallopian Tube Clear Cell Adenocarcinoma', 'Fallopian Tube Endometrioid Adenocarcinoma', 'Fallopian Tube Mucinous Adenocarcinoma', 'Fallopian Tube Serous Adenocarcinoma', 'Fallopian Tube Transitional Cell Carcinoma', 'Fallopian Tube Undifferentiated Carcinoma', 'Mucinous Adenocarcinoma', 'Ovarian Brenner Tumor', 'Ovarian Clear Cell Adenocarcinofibroma', 'Ovarian Clear Cell Adenocarcinoma', 'Ovarian Endometrioid Adenocarcinoma', 'Ovarian Seromucinous Carcinoma', 'Ovarian Serous Adenocarcinoma', 'Ovarian Transitional Cell Carcinoma', 'Ovarian Undifferentiated Carcinoma', 'Primary Peritoneal Clear Cell Adenocarcinoma', 'Primary Peritoneal Endometrioid Adenocarcinoma', 'Primary Peritoneal Serous Adenocarcinoma', 'Primary Peritoneal Transitional Cell Carcinoma', 'Primary Peritoneal Undifferentiated Carcinoma', 'Recurrent Fallopian Tube Carcinoma', 'Recurrent Ovarian Carcinoma', 'Recurrent Primary Peritoneal Carcinoma', 'Undifferentiated Carcinoma']
NCT00881751;Bevacizumab and Erlotinib or Sorafenib as First-Line Therapy in Treating Patients With Advanced Liver Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;95.0;['Liver Cancer']
NCT00369551;Bevacizumab, Paclitaxel, Carboplatin, and Radiation Therapy to the Chest in Treating Patients With Locally Advanced Non-Small Cell Lung Cancer;TERMINATED;['PHASE1'];INTERVENTIONAL;36.0;['Adenocarcinoma of the Lung', 'Bronchoalveolar Cell Lung Cancer', 'Large Cell Lung Cancer', 'Stage II Non-small Cell Lung Cancer', 'Stage IIIA Non-small Cell Lung Cancer', 'Stage IIIB Non-small Cell Lung Cancer']
NCT00387751;Bevacizumab and Sorafenib in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma;COMPLETED;['PHASE2'];INTERVENTIONAL;14.0;['Recurrent Melanoma', 'Stage III Skin Melanoma', 'Stage IV Skin Melanoma']
NCT01984242;A Study of Atezolizumab (an Engineered Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) as Monotherapy or in Combination With Bevacizumab (AvastinÂ®) Compared to Sunitinib (SutentÂ®) in Participants With Untreated Advanced Renal Cell Carcinoma;COMPLETED;['PHASE2'];INTERVENTIONAL;305.0;['Renal Cell Carcinoma']
NCT00025389;Bevacizumab, Paclitaxel, and Carboplatin Before Surgery in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;8.0;['Lung Cancer']
NCT00369889;A Study to Test the Safety and Efficacy of Erlotinib Plus Bevacizumab to Treat Advanced Thymoma and Thymic Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;18.0;['Thymic Cancer', 'Thymoma']
NCT04094688;Vitamin D3 With Chemotherapy and Bevacizumab in Treating Patients With Advanced or Metastatic Colorectal Cancer;ACTIVE_NOT_RECRUITING;['PHASE3'];INTERVENTIONAL;455.0;['Colorectal Adenocarcinoma']
NCT00356889;Bevacizumab and Erlotinib Hydrochloride in Treating Patients With Metastatic or Unresectable Biliary Tumors;COMPLETED;['PHASE2'];INTERVENTIONAL;56.0;['Cholangiocarcinoma of the Extrahepatic Bile Duct', 'Cholangiocarcinoma of the Gallbladder', 'Gastrointestinal Cancer', 'Recurrent Extrahepatic Bile Duct Cancer', 'Recurrent Gallbladder Cancer', 'Unresectable Extrahepatic Bile Duct Cancer', 'Unresectable Gallbladder Cancer']
NCT01495988;Trial of Vemurafenib/Cobimetinib With or Without Bevacizumab in Patients With Stage IV BRAFV600 Mutant Melanoma;TERMINATED;['PHASE2'];INTERVENTIONAL;10.0;['Melanoma', 'Metastatic Melanoma']
NCT00883688;Bevacizumab and Lapatinib in Children With Recurrent or Refractory Ependymoma;COMPLETED;['PHASE2'];INTERVENTIONAL;24.0;['Brain Cancer', 'Pediatric Cancers']
NCT03425292;A Longitudinal Assessment of Tumor Evolution in Patients With Brain Cancer;COMPLETED;['PHASE1'];INTERVENTIONAL;49.0;['Newly Diagnosed High Grade Glioma']
NCT00586092;A Phase I Study of ABT-510 in Combination With Bevacizumab in Advanced Solid Tumors;COMPLETED;['PHASE1'];INTERVENTIONAL;45.0;['Solid Tumors']
NCT00511992;Study of Bevacizumab Followed by Bevacizumab Consolidation for Ovarian Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;20.0;['Advanced Ovarian Carcinoma', 'Primary Peritoneal Carcinoma', 'Ovarian Carcinosarcoma']
NCT00423930;Cisplatin, Bevacizumab, and Intensity-Modulated Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;44.0;['Head and Neck Cancer']
NCT01206530;FOLFOX/Bevacizumab/Hydroxychloroquine (HCQ) in Colorectal Cancer;COMPLETED;['PHASE1', 'PHASE2'];INTERVENTIONAL;50.0;['Rectal Cancer', 'Colon Cancer', 'Metastasis', 'Adenocarcinoma']
NCT00953121;Bevacizumab Plus Irinotecan Plus Carboplatin for Recurrent Malignant Glioma (MG);COMPLETED;['PHASE2'];INTERVENTIONAL;104.0;['Malignant Glioma']
NCT02420821;A Study of Atezolizumab in Combination With Bevacizumab Versus Sunitinib in Participants With Untreated Advanced Renal Cell Carcinoma (RCC);COMPLETED;['PHASE3'];INTERVENTIONAL;915.0;['Renal Cell Carcinoma']
NCT02336165;Phase 2 Study of Durvalumab (MEDI4736) in Patients With Glioblastoma;COMPLETED;['PHASE2'];INTERVENTIONAL;159.0;['Glioblastoma']
NCT00462865;Trial of Chemotherapy and Avastin as Treatment for Women With Breast Cancer at High Risk for Relapse;TERMINATED;['PHASE2'];INTERVENTIONAL;18.0;['Breast Cancer']
NCT00492089;Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;11.0;['Adult Anaplastic Astrocytoma', 'Adult Anaplastic Ependymoma', 'Adult Anaplastic Meningioma', 'Adult Anaplastic Oligodendroglioma', 'Adult Brain Stem Glioma', 'Adult Central Nervous System Germ Cell Tumor', 'Adult Choroid Plexus Tumor', 'Adult Diffuse Astrocytoma', 'Adult Ependymoma', 'Adult Grade II Meningioma', 'Adult Grade III Meningioma', 'Adult Malignant Hemangiopericytoma', 'Adult Mixed Glioma', 'Adult Oligodendroglioma', 'Adult Papillary Meningioma', 'Adult Pineocytoma', 'Malignant Neoplasm', 'Meningeal Melanocytoma', 'Radiation Toxicity', 'Recurrent Adenoid Cystic Carcinoma of the Oral Cavity', 'Recurrent Adult Brain Tumor', 'Recurrent Basal Cell Carcinoma of the Lip', 'Recurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity', 'Recurrent Inverted Papilloma of the Paranasal Sinus and Nasal Cavity', 'Recurrent Lymphoepithelioma of the Nasopharynx', 'Recurrent Lymphoepithelioma of the Oropharynx', 'Recurrent Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity', 'Recurrent Mucoepidermoid Carcinoma of the Oral Cavity', 'Recurrent Salivary Gland Cancer', 'Recurrent Squamous Cell Carcinoma of the Hypopharynx', 'Recurrent Squamous Cell Carcinoma of the Larynx', 'Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity', 'Recurrent Squamous Cell Carcinoma of the Nasopharynx', 'Recurrent Squamous Cell Carcinoma of the Oropharynx', 'Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity', 'Recurrent Verrucous Carcinoma of the Larynx', 'Recurrent Verrucous Carcinoma of the Oral Cavity', 'Stage I Adenoid Cystic Carcinoma of the Oral Cavity', 'Stage I Basal Cell Carcinoma of the Lip', 'Stage I Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity', 'Stage I Inverted Papilloma of the Paranasal Sinus and Nasal Cavity', 'Stage I Lymphoepithelioma of the Nasopharynx', 'Stage I Lymphoepithelioma of the Oropharynx', 'Stage I Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity', 'Stage I Mucoepidermoid Carcinoma of the Oral Cavity', 'Stage I Salivary Gland Cancer', 'Stage I Squamous Cell Carcinoma of the Hypopharynx', 'Stage I Squamous Cell Carcinoma of the Larynx', 'Stage I Squamous Cell Carcinoma of the Lip and Oral Cavity', 'Stage I Squamous Cell Carcinoma of the Nasopharynx', 'Stage I Squamous Cell Carcinoma of the Oropharynx', 'Stage I Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity', 'Stage I Verrucous Carcinoma of the Larynx', 'Stage I Verrucous Carcinoma of the Oral Cavity', 'Stage III Adenoid Cystic Carcinoma of the Oral Cavity', 'Stage III Basal Cell Carcinoma of the Lip', 'Stage III Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity', 'Stage III Inverted Papilloma of the Paranasal Sinus and Nasal Cavity', 'Stage III Lymphoepithelioma of the Nasopharynx', 'Stage III Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity', 'Stage III Mucoepidermoid Carcinoma of the Oral Cavity', 'Stage III Salivary Gland Cancer', 'Stage III Squamous Cell Carcinoma of the Hypopharynx', 'Stage III Squamous Cell Carcinoma of the Larynx', 'Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity', 'Stage III Squamous Cell Carcinoma of the Nasopharynx', 'Stage III Squamous Cell Carcinoma of the Oropharynx', 'Stage III Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity', 'Stage III Verrucous Carcinoma of the Larynx', 'Stage III Verrucous Carcinoma of the Oral Cavity', 'Stage IV Adenoid Cystic Carcinoma of the Oral Cavity', 'Stage IV Basal Cell Carcinoma of the Lip', 'Stage IV Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity', 'Stage IV Inverted Papilloma of the Paranasal Sinus and Nasal Cavity', 'Stage IV Lymphoepithelioma of the Nasopharynx', 'Stage IV Lymphoepithelioma of the Oropharynx', 'Stage IV Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity', 'Stage IV Mucoepidermoid Carcinoma of the Oral Cavity', 'Stage IV Salivary Gland Cancer', 'Stage IV Squamous Cell Carcinoma of the Hypopharynx', 'Stage IV Squamous Cell Carcinoma of the Larynx', 'Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity', 'Stage IV Squamous Cell Carcinoma of the Nasopharynx', 'Stage IV Squamous Cell Carcinoma of the Oropharynx', 'Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity', 'Stage IV Verrucous Carcinoma of the Larynx', 'Stage IV Verrucous Carcinoma of the Oral Cavity']
NCT01831089;Phase I Study of Lurbinectedin (PM01183) in Combination With Paclitaxel, With or Without Bevacizumab, in Selected Advanced Solid Tumors;COMPLETED;['PHASE1'];INTERVENTIONAL;69.0;['Breast Cancer', 'Ovarian Cancer', 'Gynecological Cancer', 'Head and Neck Carcinoma', 'Non-small Cell Lung Cancer', 'Small Cell Lung Cancer', 'Non-squamous Cell Lung Cancer']
NCT01090830;Safety and Efficacy of Belinostat When Used With Standard of Care Chemotherapy for Untreated Non-small Cell Lung Cancer;TERMINATED;['PHASE1', 'PHASE2'];INTERVENTIONAL;7.0;['Non-Small-Cell Lung Carcinoma']
NCT02715531;A Study of the Safety and Efficacy of Atezolizumab Administered in Combination With Bevacizumab and/or Other Treatments in Participants With Solid Tumors;COMPLETED;['PHASE1'];INTERVENTIONAL;243.0;['Solid Tumor']
NCT00600821;A Study Of AG-013736 (Axitinib) Or Bevacizumab (Avastin) In Combination With Paclitaxel And Carboplatin In Patients With Advanced Lung Cancer.;COMPLETED;['PHASE2'];INTERVENTIONAL;118.0;['Non-Small-Cell Lung Carcinoma', 'Adenocarcinoma']
NCT01478321;Efficacy of Hypofractionated XRT w/Bev. + Temozolomide for Recurrent Gliomas;TERMINATED;['PHASE2'];INTERVENTIONAL;54.0;['Adult Anaplastic Astrocytoma', 'Adult Anaplastic Ependymoma', 'Adult Anaplastic Oligodendroglioma', 'Adult Giant Cell Glioblastoma', 'Adult Glioblastoma']
NCT00026221;Bevacizumab With or Without Interferon Alfa in Treating Patients With Metastatic Malignant Melanoma;COMPLETED;['PHASE2'];INTERVENTIONAL;57.0;['Recurrent Melanoma', 'Stage IV Skin Melanoma']
NCT00660621;A Phase II Study Of Gliadel, Concomitant Temozolomide And Radiation, Followed By Dose Dense Therapy With Temozolomide Plus Bevacizumab For Newly Diagnosed Malignant High Grade Glioma;UNKNOWN;['PHASE2'];INTERVENTIONAL;40.0;['Glioma']
NCT00707889;Phase 2 Study of ABT-869 in Combination With mFOLFOX6 Versus Bevacizumab in Combination With mFOLFOX6 to Treat Advanced Colorectal Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;159.0;['Advanced Colorectal Cancer', 'Adenocarcinoma of the Colon', 'Adenocarcinoma of the Rectum']
NCT05116189;Pembrolizumab/Placebo Plus Paclitaxel With or Without Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer (MK-3475-B96/KEYNOTE-B96/ENGOT-ov65);ACTIVE_NOT_RECRUITING;['PHASE3'];INTERVENTIONAL;616.0;['Ovarian Cancer', 'Carcinoma, Ovarian Epithelial', 'Fallopian Tube Neoplasms']
NCT01532089;Erlotinib Hydrochloride With or Without Bevacizumab in Treating Patients With Stage IV Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutations;COMPLETED;['PHASE2'];INTERVENTIONAL;88.0;['EGFR Exon 19 Deletion Mutation', 'EGFR NP_005219.2:p.L858R', 'Lung Non-Squamous Non-Small Cell Carcinoma', 'Stage IV Lung Non-Small Cell Cancer AJCC v7']
NCT00409565;A Phase II Trial of Cetuximab and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;48.0;['Head and Neck Cancer', 'Squamous Cell Carcinoma']
NCT03128047;HUMC 1612: Optune NovoTTF-200A System;ACTIVE_NOT_RECRUITING;['PHASE1'];INTERVENTIONAL;6.0;['High Grade Glioma', 'Ependymoma']
NCT02120287;Border Zone Stereotactic Radiosurgery With Bevacizumab in Patients With Glioblastoma Multiforme;COMPLETED;['PHASE2'];INTERVENTIONAL;16.0;['Glioblastoma Multiforme', 'Glioblastoma - Category']
NCT01015222;Dasatinib, Bevacizumab, Paclitaxel in Patients With Advanced Malignancies;COMPLETED;['PHASE1'];INTERVENTIONAL;122.0;['Advanced Cancer']
NCT00959647;A Study of Vismodegib (GDC-0449) in Patients Treated With Vismodegib in a Previous Genentech-sponsored Phase I or II Cancer Study;COMPLETED;['PHASE2'];INTERVENTIONAL;19.0;['Ovarian Cancer', 'Basal Cell Carcinoma', 'Metastatic Colorectal Cancer']
NCT01207687;Bevacizumab for Symptomatic Vestibular Schwannoma in Neurofibromatosis Type 2 (NF2);COMPLETED;['PHASE2'];INTERVENTIONAL;14.0;['Vestibular Schwannoma', 'Neurofibromatosis Type 2']
NCT05231122;Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer;RECRUITING;['PHASE2'];INTERVENTIONAL;80.0;['Ovarian Clear Cell Adenocarcinoma', 'Platinum-Sensitive Ovarian Carcinoma', 'Recurrent Endometrial Serous Adenocarcinoma', 'Recurrent Fallopian Tube Carcinoma', 'Recurrent Fallopian Tube Endometrioid Adenocarcinoma', 'Recurrent Fallopian Tube Serous Adenocarcinoma', 'Recurrent Ovarian Carcinoma', 'Recurrent Ovarian Clear Cell Adenocarcinoma', 'Recurrent Ovarian Endometrioid Adenocarcinoma', 'Recurrent Ovarian Serous Adenocarcinoma', 'Recurrent Platinum-Resistant Ovarian Carcinoma', 'Recurrent Primary Peritoneal Carcinoma', 'Recurrent Primary Peritoneal Clear Cell Adenocarcinoma', 'Recurrent Primary Peritoneal Endometrioid Adenocarcinoma', 'Recurrent Primary Peritoneal Serous Adenocarcinoma']
NCT00466687;Erlotinib and Bevacizumab in Treating Patients With Stage IV Melanoma;COMPLETED;['PHASE2'];INTERVENTIONAL;34.0;['Melanoma']
NCT01916447;A Phase I Study of TAS-102 in Patients With Advanced Gastrointestinal Tumors.;COMPLETED;['PHASE1'];INTERVENTIONAL;65.0;['Advanced Gastrointestinal Tumors']
NCT00098787;Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;247.0;['Colorectal Cancer']
NCT00762255;A Phase I Trial of Vorinostat in Combination With Bevacizumab & Irinotecan in Recurrent Glioblastoma;COMPLETED;['PHASE1'];INTERVENTIONAL;19.0;['Glioblastoma']
NCT01327612;Open Label Extension Study of Conatumumab and Ganitumab (AMG 479);COMPLETED;['PHASE2'];INTERVENTIONAL;12.0;['Advanced Solid Tumors', 'Carcinoid', 'Colorectal Cancer', 'Locally Advanced', 'Lymphoma', 'Metastatic Cancer', 'Non-Small Cell Lung Cancer', 'Sarcoma', 'Solid Tumors']
NCT00625651;Phase 1b/2 Study of AMG 655 With mFOLFOX6 and Bevacizumab for First-Line Metastatic Colorectal Cancer;COMPLETED;['PHASE1', 'PHASE2'];INTERVENTIONAL;202.0;['Metastatic Colorectal Cancer', 'Colon Cancer', 'Colorectal Cancer', 'Rectal Cancer']
NCT01617148;Wet Macular Degeneration Study to Compare Ranibizumab or Bevacizumab to Aflibercept;COMPLETED;['PHASE4'];INTERVENTIONAL;26.0;['Exudative Macular Degeneration']
NCT00946712;S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer;TERMINATED;['PHASE3'];INTERVENTIONAL;1333.0;['Recurrent Large Cell Lung Carcinoma', 'Recurrent Lung Adenocarcinoma', 'Recurrent Squamous Cell Lung Carcinoma', 'Stage IV Large Cell Lung Carcinoma', 'Stage IV Lung Adenocarcinoma', 'Stage IV Squamous Cell Lung Carcinoma']
NCT02521051;Phase I/II Trial of Alectinib and Bevacizumab in Patients With Advanced, Anaplastic Lymphoma Kinase (ALK)-Positive, Non-Small Cell Lung Cancer;UNKNOWN;['PHASE1', 'PHASE2'];INTERVENTIONAL;43.0;['Non-Small Cell Lung Cancer (NSCLC)']
NCT03329248;QUILT-3.060: NANT Pancreatic Cancer Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy;UNKNOWN;['PHASE1', 'PHASE2'];INTERVENTIONAL;80.0;['Pancreatic Cancer']
NCT00548548;A Study of Bevacizumab in Combination With Capecitabine and Cisplatin as First-line Therapy in Patients With Advanced Gastric Cancer;COMPLETED;['PHASE3'];INTERVENTIONAL;774.0;['Adenocarcinoma']
NCT00049088;Bortezomib and Docetaxel in Treating Patients With Advanced Solid Tumors;TERMINATED;['PHASE1'];INTERVENTIONAL;24.0;['Unspecified Adult Solid Tumor, Protocol Specific']
NCT01727089;Bevacizumab With or Without TRC105 in Treating Patients With Metastatic Kidney Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;59.0;['Clear Cell Renal Cell Carcinoma', 'Recurrent Renal Cell Carcinoma', 'Stage IV Renal Cell Cancer', 'Type 1 Papillary Renal Cell Carcinoma', 'Type 2 Papillary Renal Cell Carcinoma']
NCT00556088;LBH589, Paclitaxel, Carboplatin +/- Bevacizumab for Solid Tumors;COMPLETED;['PHASE1'];INTERVENTIONAL;40.0;['Solid Tumors']
NCT00741988;Ixabepilone and Carboplatin +/- Bevacizumab in Advanced Non-Small-Cell Lung Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;82.0;['Non-Small Cell Lung Cancer']
NCT00984438;Surgery With Implantable Biodegradable Carmustine (BCNU) Wafer Followed by Chemo for Patients With Recurrent Glioblastoma Multiforme;WITHDRAWN;['PHASE1', 'PHASE2'];INTERVENTIONAL;0.0;['Glioblastoma Multiforme']
NCT00737438;Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinoma;COMPLETED;['PHASE2'];INTERVENTIONAL;22.0;['Esophageal Cancer', 'Gastric Cancer']
NCT00795665;Bevacizumab and Carmustine in Treating Patients With Relapsed or Progressive High-Grade Glioma;COMPLETED;['PHASE2'];INTERVENTIONAL;7.0;['Glioma']
NCT00378638;Dose-Dense Chemotherapy Plus Bevacizumab in High Risk Lymph Node Positive Breast Cancer: A Pilot Study;UNKNOWN;['PHASE2'];INTERVENTIONAL;30.0;['Breast Cancer']
NCT02032238;Clinical Efficacy of Bevacizumab Combined With Navigated Laser in Patients With Clinically Significant Macula Edema;TERMINATED;['NA'];INTERVENTIONAL;12.0;['Clinically Significant Macular Edema']
NCT04607421;A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer;RECRUITING;['PHASE3'];INTERVENTIONAL;815.0;['Neoplasms']
NCT01898130;Bevacizumab in Pats w/ Recurrent ST Brain Metas Who Have Failed Whole Brain Radiation Therapy;COMPLETED;['PHASE2'];INTERVENTIONAL;27.0;['Metastatic Cancer', 'Unspecified Adult Solid Tumor, Protocol Specific']
NCT00557492;Efficacy of Neoadjuvant Chemoradiation for Potentially Resectable Pancreas Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;59.0;['Pancreatic Cancer']
NCT00368992;S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;110.0;['Adenocarcinoma of the Lung', 'Adenosquamous Cell Lung Cancer', 'Bronchoalveolar Cell Lung Cancer', 'Large Cell Lung Cancer', 'Recurrent Non-small Cell Lung Cancer', 'Squamous Cell Lung Cancer', 'Stage IIIB Non-small Cell Lung Cancer', 'Stage IV Non-small Cell Lung Cancer']
NCT03937830;Combined Treatment of Durvalumab, Bevacizumab, Tremelimumab and Transarterial Chemoembolization (TACE) in Subjects With Hepatocellular Carcinoma or Biliary Tract Carcinoma;RECRUITING;['PHASE2'];INTERVENTIONAL;72.0;['Hepatocellular Cancer', 'Hepatocellular Carcinoma', 'Metastatic Hepatocellular Carcinoma']
NCT01332721;Study of TRC105 Combined With Standard-Dose Bevacizumab for Advanced Solid Tumors for Which Bevacizumab is Indicated;COMPLETED;['PHASE1'];INTERVENTIONAL;38.0;['Adult Solid Tumor']
NCT00193492;A Study of Rituximab and Bevacizumab in Patients With Follicular Non-Hodgkin's Lymphoma;COMPLETED;['PHASE2'];INTERVENTIONAL;60.0;['Lymphoma, Follicular']
NCT05087992;A Study to Find the Best Dose of BI 905711 in Combination With Chemotherapy and to Test Whether This Dose Helps People With Advanced Gastrointestinal Cancers;COMPLETED;['PHASE1'];INTERVENTIONAL;13.0;['Gastrointestinal Cancer, Metastatic']
NCT00392392;Preoperative Bevacizumab and Trastuzumab With ABI-007 and Carboplatin in HER2+ Breast Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;29.0;['Breast Cancer']
NCT00079430;Paclitaxel, Bevacizumab And Adjuvant Intraperitoneal Carboplatin in Treating Patients Who Had Initial Debulking Surgery for Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer;COMPLETED;['PHASE1'];INTERVENTIONAL;113.0;['Brenner Tumor', 'Fallopian Tube Cancer', 'Ovarian Clear Cell Cystadenocarcinoma', 'Ovarian Endometrioid Adenocarcinoma', 'Ovarian Mixed Epithelial Carcinoma', 'Ovarian Mucinous Cystadenocarcinoma', 'Ovarian Serous Cystadenocarcinoma', 'Ovarian Undifferentiated Adenocarcinoma', 'Primary Peritoneal Cavity Cancer', 'Stage II Ovarian Epithelial Cancer', 'Stage III Ovarian Epithelial Cancer', 'Stage IV Ovarian Epithelial Cancer']
NCT00868192;Trial of Pemetrexed and Bevacizumab for Recurrent Ovarian Primary Peritoneal Carcinoma;COMPLETED;['PHASE2'];INTERVENTIONAL;38.0;['Ovarian Carcinoma', 'Primary Peritoneal Carcinoma']
NCT01954030;Phase 1/2 CTO + Bevacizumab for Recurrent Glioma Post-Bevacizumab Failure;TERMINATED;['PHASE1'];INTERVENTIONAL;17.0;['Malignant Glioma (WHO Grade III or IV)']
NCT05141721;A Study of a Patient-Specific Neoantigen Vaccine in Combination With Immune Checkpoint Blockade for Patients With Metastatic Colorectal Cancer;ACTIVE_NOT_RECRUITING;['PHASE2', 'PHASE3'];INTERVENTIONAL;700.0;['Colorectal Neoplasms']
NCT00867321;Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer;COMPLETED;['PHASE1', 'PHASE2'];INTERVENTIONAL;24.0;['Liver Cancer']
NCT00385021;ChronoFOLFOX Plus Avastin for Patients With Metastatic Colorectal Cancer;TERMINATED;['PHASE2'];INTERVENTIONAL;20.0;['Colorectal Neoplasms']
NCT00853021;Bevacizumab and Aldesleukin in Treating Patients With Metastatic Clear Cell Carcinoma of the Kidney;COMPLETED;['PHASE2'];INTERVENTIONAL;26.0;['Kidney Cancer']
NCT00612430;Ph II Bevacizumab + Etoposide for Pts w Recurrent MG;COMPLETED;['PHASE2'];INTERVENTIONAL;59.0;['Glioblastoma', 'Gliosarcoma']
NCT02829931;Hypofractionated Stereotactic Irradiation With Nivolumab, Ipilimumab and Bevacizumab in Patients With Recurrent High Grade Gliomas;COMPLETED;['PHASE1'];INTERVENTIONAL;33.0;['Malignant Glioma']
NCT01987830;Bevacizumab w / Temozolomide PET & Vascular MRI For GBM;COMPLETED;['NA'];INTERVENTIONAL;13.0;['Recurrent Glioblastoma']
NCT04008030;A Study of Nivolumab, Nivolumab Plus Ipilimumab, or Investigator's Choice Chemotherapy for the Treatment of Participants With Deficient Mismatch Repair (dMMR)/Microsatellite Instability High (MSI-H) Metastatic Colorectal Cancer (mCRC);RECRUITING;['PHASE3'];INTERVENTIONAL;831.0;['Metastatic Colorectal Cancer']
NCT00352521;Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) With Bevacizumab and Irinotecan for Malignant Glioma;COMPLETED;['PHASE2'];INTERVENTIONAL;20.0;['Brain and Central Nervous System Tumors']
NCT00446030;Pilot Study of the Safety & Efficacy of Two Docetaxel-Based Regimens Plus Bevacizumab for the Adjuvant Treatment of Subjects With Node Positive or High Risk Node Negative Breast Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;127.0;['Breast Neoplasms']
NCT00361231;Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Biliary Tract and Gallbladder Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;35.0;['Biliary Tract Cancer', 'Gallbladder Adenocarcinoma']
NCT01091792;Exploratory Study of the Modulation of the Immune System by VEGF Blockade in Patients With Glioblastoma Multiforme (GBM);COMPLETED;['EARLY_PHASE1'];INTERVENTIONAL;13.0;['Glioblastoma Multiforme']
NCT05956821;Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age;NOT_YET_RECRUITING;['PHASE1', 'PHASE2'];INTERVENTIONAL;20.0;['Glioblastoma Multiforme', 'Anaplastic Astrocytoma', 'Fibrillary Astrocytomas', 'Oligodendroglioma', 'Diffuse Intrinsic Brainstem Glioma']
NCT00545792;Safety Study Of Avastin And Pelvic Radiation In Women With Recurrent Gynecological Cancers;COMPLETED;['PHASE2'];INTERVENTIONAL;21.0;['Cervical Cancer', 'Endometrial Cancer', 'Ovarian Cancer', 'Vaginal Cancer', 'Carcinoma of the Vulva']
NCT00856492;S0800, Nab-Paclitaxel, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;215.0;['Breast Cancer']
NCT00254592;Neoadjuvant Treatment of Breast Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;43.0;['Breast Cancer']
NCT02843230;Monitoring Anti-angiogenic Therapy in Brain Tumors by Advanced MRI;COMPLETED;;OBSERVATIONAL;30.0;['Glioblastoma']
NCT00447330;Oxaliplatin, Capecitabine and Avastin for Metastatic Esophagogastric Adenocarcinoma;COMPLETED;['PHASE2'];INTERVENTIONAL;60.0;['Esophageal Neoplasms', 'Stomach Neoplasms', 'Neoplasm Metastasis']
NCT04931342;A Study Evaluating the Efficacy and Safety of Biomarker-Driven Therapies in Patients With Persistent or Recurrent Rare Epithelial Ovarian Tumors;RECRUITING;['PHASE2'];INTERVENTIONAL;550.0;['Ovarian Cancer']
NCT00609765;Avastin, Fluorouracil, Doxorubicin and Streptozocin in Locally Advanced and Metastatic Pancreatic Endocrine Tumors;TERMINATED;['PHASE2'];INTERVENTIONAL;1.0;['Pancreatic Cancer']
NCT00722865;Avastin (Bevacizumab) Plus Adriamycin, Bleomycin, Vinblastine and Dacarbazine (ABVD) for Advanced Stage Hodgkin Lymphoma;TERMINATED;['PHASE2'];INTERVENTIONAL;25.0;['Hodgkin Lymphoma']
NCT03740165;Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK-001/ENGOT-ov43/GOG-3036);ACTIVE_NOT_RECRUITING;['PHASE3'];INTERVENTIONAL;1367.0;['Ovarian Cancer', 'Fallopian Tube Cancer', 'Peritoneal Neoplasms']
NCT02414165;The Toca 5 Trial: Toca 511 & Toca FC Versus Standard of Care in Patients With Recurrent High Grade Glioma;TERMINATED;['PHASE2', 'PHASE3'];INTERVENTIONAL;403.0;['Glioblastoma Multiforme', 'Anaplastic Astrocytoma']
NCT00126542;Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;35.0;['Fallopian Tube Cancer', 'Primary Peritoneal Cavity Cancer', 'Recurrent Ovarian Epithelial Cancer', 'Stage IV Ovarian Epithelial Cancer']
NCT00392665;Bevacizumab/Tarceva and Tarceva/Sulindac in Squamous Cell Carcinoma of the Head and Neck;TERMINATED;['PHASE2'];INTERVENTIONAL;36.0;['Squamous Cell Carcinoma of the Head and Neck (SCCHN)']
NCT01167712;Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer;ACTIVE_NOT_RECRUITING;['PHASE3'];INTERVENTIONAL;692.0;['Fallopian Tube Endometrioid Adenocarcinoma', 'Fallopian Tube Mucinous Adenocarcinoma', 'Fallopian Tube Transitional Cell Carcinoma', 'Ovarian Brenner Tumor', 'Ovarian Clear Cell Adenocarcinofibroma', 'Ovarian Endometrioid Adenocarcinoma', 'Ovarian Mucinous Adenocarcinoma', 'Ovarian Seromucinous Carcinoma', 'Ovarian Serous Adenocarcinoma', 'Ovarian Transitional Cell Carcinoma', 'Ovarian Undifferentiated Carcinoma', 'Primary Peritoneal Serous Adenocarcinoma', 'Stage IIA Fallopian Tube Cancer AJCC v6 and v7', 'Stage IIA Ovarian Cancer AJCC V6 and v7', 'Stage IIB Fallopian Tube Cancer AJCC v6 and v7', 'Stage IIB Ovarian Cancer AJCC v6 and v7', 'Stage IIC Fallopian Tube Cancer AJCC v6 and v7', 'Stage IIC Ovarian Cancer AJCC v6 and v7', 'Stage IIIA Fallopian Tube Cancer AJCC v7', 'Stage IIIA Ovarian Cancer AJCC v6 and v7', 'Stage IIIA Primary Peritoneal Cancer AJCC v7', 'Stage IIIB Fallopian Tube Cancer AJCC v7', 'Stage IIIB Ovarian Cancer AJCC v6 and v7', 'Stage IIIB Primary Peritoneal Cancer AJCC v7', 'Stage IIIC Fallopian Tube Cancer AJCC v7', 'Stage IIIC Ovarian Cancer AJCC v6 and v7', 'Stage IIIC Primary Peritoneal Cancer AJCC v7', 'Stage IV Fallopian Tube Cancer AJCC v6 and v7', 'Stage IV Ovarian Cancer AJCC v6 and v7', 'Stage IV Primary Peritoneal Cancer AJCC v7']
NCT01114555;Bevacizumab, Irinotecan and Temozolomide for Relapsed or Refractory Neuroblastoma;COMPLETED;['PHASE2'];INTERVENTIONAL;34.0;['Neuroblastoma']
NCT02974621;Cediranib Maleate and Olaparib Compared to Bevacizumab in Treating Patients With Recurrent Glioblastoma;ACTIVE_NOT_RECRUITING;['PHASE2'];INTERVENTIONAL;70.0;['Recurrent Glioblastoma']
NCT04553692;Phase 1a/1b Study of Aplitibart (IGM-8444) Alone or in Combination in Participants With Relapsed, Refractory, or Newly Diagnosed Cancers;RECRUITING;['PHASE1'];INTERVENTIONAL;430.0;['Solid Tumor', 'Colorectal Cancer', 'Non Hodgkin Lymphoma', 'Sarcoma', 'Chondrosarcoma', 'Small Lymphocytic Lymphoma', 'Chronic Lymphocytic Leukemia', 'Acute Myeloid Leukemia']
NCT00403130;Phase 2 Study of Gemzar, Taxol & Avastin Combination as 1st Line Treatment for Metastatic Breast Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;31.0;['Breast Cancer', 'Metastatic Breast Cancer']
NCT03412630;Perfusion CT in Predicting Outcomes in Ovarian, Fallopian, or Peritoneal Cancer With Bevacizumab;TERMINATED;['NA'];INTERVENTIONAL;1.0;['Recurrent Fallopian Tube Carcinoma', 'Recurrent Ovarian Carcinoma', 'Recurrent Primary Peritoneal Carcinoma']
NCT00507585;Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, Leucovorin, and Avastin;COMPLETED;['PHASE1'];INTERVENTIONAL;63.0;['Liver Cancer', 'Advanced Solid Tumors']
NCT00533585;BAY 43-9006 in Previously Untreated Patients With Non-Small Cell Lung Cancer (NSCLC);COMPLETED;['PHASE1'];INTERVENTIONAL;23.0;['Lung Cancer']
NCT01013285;Bevacizumab, Temozolomide, and External Beam Radiation Therapy as First-Line Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma;COMPLETED;['PHASE2'];INTERVENTIONAL;70.0;['Brain and Central Nervous System Tumors']
NCT00027885;Phase II Bevacizumab + Tax In Advanced Breast Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;49.0;['Breast Cancer']
NCT01940887;A Phase 3 Safety and Efficacy Study of FovistaÂ® (E10030) Intravitreous Administration in Combination With Either AvastinÂ® or EyleaÂ® Compared to AvastinÂ® or EyleaÂ® Monotherapy;TERMINATED;['PHASE3'];INTERVENTIONAL;645.0;['Age-Related Macular Degeneration']
NCT04737187;Phase III Study of Trifluridine/Tipiracil With and Without Bevacizumab in Refractory Metastatic Colorectal Cancer Patients;COMPLETED;['PHASE3'];INTERVENTIONAL;492.0;['Refractory Metastatic Colorectal Cancer']
NCT02446431;Metronomic Therapy for Pediatric Patients With Solid Tumors at High Risk of Recurrence;RECRUITING;['EARLY_PHASE1'];INTERVENTIONAL;20.0;['Solid Tumor']
NCT01588431;Bevacizumab/Ph 2 for Locally Advanced Head and Neck Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;3.0;['Carcinoma, Squamous Cell of Head and Neck']
NCT00458731;Bevacizumab and Cediranib Maleate in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic Astrocytoma;COMPLETED;['PHASE1'];INTERVENTIONAL;57.0;['Adult Grade III Lymphomatoid Granulomatosis', 'Adult Nasal Type Extranodal NK/T-cell Lymphoma', 'Anaplastic Large Cell Lymphoma', 'Angioimmunoblastic T-cell Lymphoma', 'Childhood Burkitt Lymphoma', 'Childhood Diffuse Large Cell Lymphoma', 'Childhood Grade III Lymphomatoid Granulomatosis', 'Childhood Immunoblastic Large Cell Lymphoma', 'Childhood Nasal Type Extranodal NK/T-cell Lymphoma', 'Cutaneous B-cell Non-Hodgkin Lymphoma', 'Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue', 'Hepatosplenic T-cell Lymphoma', 'Intraocular Lymphoma', 'Nodal Marginal Zone B-cell Lymphoma', 'Noncutaneous Extranodal Lymphoma', 'Peripheral T-cell Lymphoma', 'Progressive Hairy Cell Leukemia, Initial Treatment', 'Recurrent Adult Burkitt Lymphoma', 'Recurrent Adult Diffuse Large Cell Lymphoma', 'Recurrent Adult Diffuse Mixed Cell Lymphoma', 'Recurrent Adult Diffuse Small Cleaved Cell Lymphoma', 'Recurrent Adult Hodgkin Lymphoma', 'Recurrent Adult Immunoblastic Large Cell Lymphoma', 'Recurrent Adult Lymphoblastic Lymphoma', 'Recurrent Adult T-cell Leukemia/Lymphoma', 'Recurrent Childhood Anaplastic Large Cell Lymphoma', 'Recurrent Childhood Large Cell Lymphoma', 'Recurrent Childhood Lymphoblastic Lymphoma', 'Recurrent Childhood Small Noncleaved Cell Lymphoma', 'Recurrent Grade 1 Follicular Lymphoma', 'Recurrent Grade 2 Follicular Lymphoma', 'Recurrent Grade 3 Follicular Lymphoma', 'Recurrent Mantle Cell Lymphoma', 'Recurrent Mycosis Fungoides/Sezary Syndrome', 'Recurrent/Refractory Childhood Hodgkin Lymphoma', 'Refractory Hairy Cell Leukemia', 'Small Intestine Lymphoma', 'Splenic Marginal Zone Lymphoma', 'Stage IV Adult Burkitt Lymphoma', 'Stage IV Adult Diffuse Large Cell Lymphoma', 'Stage IV Adult Diffuse Mixed Cell Lymphoma', 'Stage IV Adult Diffuse Small Cleaved Cell Lymphoma', 'Stage IV Adult Hodgkin Lymphoma', 'Stage IV Adult Immunoblastic Large Cell Lymphoma', 'Stage IV Adult Lymphoblastic Lymphoma', 'Stage IV Adult T-cell Leukemia/Lymphoma', 'Stage IV Childhood Anaplastic Large Cell Lymphoma', 'Stage IV Childhood Hodgkin Lymphoma', 'Stage IV Childhood Large Cell Lymphoma', 'Stage IV Childhood Lymphoblastic Lymphoma', 'Stage IV Childhood Small Noncleaved Cell Lymphoma', 'Stage IV Grade 1 Follicular Lymphoma', 'Stage IV Grade 2 Follicular Lymphoma', 'Stage IV Grade 3 Follicular Lymphoma', 'Stage IV Mantle Cell Lymphoma', 'Stage IVA Mycosis Fungoides/Sezary Syndrome', 'Stage IVB Mycosis Fungoides/Sezary Syndrome', 'T-cell Large Granular Lymphocyte Leukemia', 'Testicular Lymphoma', 'Unspecified Adult Solid Tumor, Protocol Specific', 'Unspecified Childhood Solid Tumor, Protocol Specific', 'WaldenstrÃ¶m Macroglobulinemia']
NCT01468831;Minocycline to Treat Branch Retinal Vein Occlusion;COMPLETED;['PHASE1', 'PHASE2'];INTERVENTIONAL;9.0;['Retinal Vein Occlusion']
NCT01366131;Study Evaluating the Safety and Efficacy of MEGF0444A in Combination With Carboplatin, Paclitaxel and Bevacizumab in Patients With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer Who Have Not Received Prior Chemotherapy for Advanced Disease (NILE);COMPLETED;['PHASE2'];INTERVENTIONAL;104.0;['Non-Squamous Non-Small Cell Lung Cancer']
NCT01402531;Submucosal Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT);COMPLETED;['PHASE2'];INTERVENTIONAL;10.0;['Hereditary Hemorrhagic Telangiectasia (HHT)']
NCT00356031;Bevacizumab and Radiation Therapy for Sarcomas;COMPLETED;['PHASE2'];INTERVENTIONAL;20.0;['Soft Tissue Sarcoma', 'Fibrous Histiocytoma', 'Liposarcoma', 'Leiomyosarcoma', 'Fibrosarcoma', 'Synovial Sarcoma']
NCT02390531;Phase 1 Trial of Bevacizumab Treatment for Severe Retinopathy of Prematurity;COMPLETED;['PHASE1'];INTERVENTIONAL;120.0;['Retinopathy of Prematurity']
NCT00305825;Bevacizumab and Letrozole in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer That Cannot Be Removed By Surgery;COMPLETED;['PHASE2'];INTERVENTIONAL;43.0;['Breast Cancer']
NCT01374425;Study of Bevacizumab + mFOLFOX6 Versus Bevacizumab + FOLFIRI With Biomarker Stratification in Participants With Previously Untreated Metastatic Colorectal Cancer (mCRC);COMPLETED;['PHASE2'];INTERVENTIONAL;376.0;['Colorectal Cancer']
NCT01167725;Standard Therapy With or Without Surgery and Mitomycin C in Treating Patients With Advanced Limited Peritoneal Dissemination of Colon Cancer;UNKNOWN;['PHASE3'];INTERVENTIONAL;340.0;['Colorectal Cancer']
NCT00055692;Bevacizumab in Treating Patients With Unresectable Nonmetastatic Liver Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;46.0;['Adult Primary Hepatocellular Carcinoma', 'Localized Unresectable Adult Primary Liver Cancer', 'Recurrent Adult Primary Liver Cancer']
NCT02884648;Bevacizumab in Ovarian Cancer Patients With Disease at Second-Look Surgery;RECRUITING;['PHASE2'];INTERVENTIONAL;35.0;['Malignant Neoplasms of Female Genital Organs', 'Ovarian Cancer', 'Fallopian Tube Cancer', 'Primary Peritoneal Cancer']
NCT01083966;Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Vestibular Schwannoma;SUSPENDED;['PHASE1'];INTERVENTIONAL;30.0;['Vestibular Schwannoma']
NCT00072566;Bevacizumab and Low-Dose Cyclophosphamide in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;70.0;['Primary Peritoneal Carcinoma', 'Recurrent Ovarian Carcinoma', 'Stage IV Ovarian Cancer']
NCT00101348;Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer;COMPLETED;['PHASE1', 'PHASE2'];INTERVENTIONAL;66.0;['Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma', 'Recurrent Adenoid Cystic Carcinoma of the Oral Cavity', 'Recurrent Basal Cell Carcinoma of the Lip', 'Recurrent Colon Cancer', 'Recurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity', 'Recurrent Inverted Papilloma of the Paranasal Sinus and Nasal Cavity', 'Recurrent Lymphoepithelioma of the Nasopharynx', 'Recurrent Lymphoepithelioma of the Oropharynx', 'Recurrent Metastatic Squamous Neck Cancer With Occult Primary', 'Recurrent Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity', 'Recurrent Mucoepidermoid Carcinoma of the Oral Cavity', 'Recurrent Non-small Cell Lung Cancer', 'Recurrent Pancreatic Cancer', 'Recurrent Rectal Cancer', 'Recurrent Salivary Gland Cancer', 'Recurrent Squamous Cell Carcinoma of the Hypopharynx', 'Recurrent Squamous Cell Carcinoma of the Larynx', 'Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity', 'Recurrent Squamous Cell Carcinoma of the Nasopharynx', 'Recurrent Squamous Cell Carcinoma of the Oropharynx', 'Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity', 'Recurrent Verrucous Carcinoma of the Larynx', 'Recurrent Verrucous Carcinoma of the Oral Cavity', 'Stage III Adenoid Cystic Carcinoma of the Oral Cavity', 'Stage III Basal Cell Carcinoma of the Lip', 'Stage III Colon Cancer', 'Stage III Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity', 'Stage III Inverted Papilloma of the Paranasal Sinus and Nasal Cavity', 'Stage III Lymphoepithelioma of the Nasopharynx', 'Stage III Lymphoepithelioma of the Oropharynx', 'Stage III Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity', 'Stage III Mucoepidermoid Carcinoma of the Oral Cavity', 'Stage III Pancreatic Cancer', 'Stage III Rectal Cancer', 'Stage III Salivary Gland Cancer', 'Stage III Squamous Cell Carcinoma of the Hypopharynx', 'Stage III Squamous Cell Carcinoma of the Larynx', 'Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity', 'Stage III Squamous Cell Carcinoma of the Nasopharynx', 'Stage III Squamous Cell Carcinoma of the Oropharynx', 'Stage III Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity', 'Stage III Verrucous Carcinoma of the Larynx', 'Stage III Verrucous Carcinoma of the Oral Cavity', 'Stage IIIB Non-small Cell Lung Cancer', 'Stage IV Adenoid Cystic Carcinoma of the Oral Cavity', 'Stage IV Basal Cell Carcinoma of the Lip', 'Stage IV Colon Cancer', 'Stage IV Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity', 'Stage IV Inverted Papilloma of the Paranasal Sinus and Nasal Cavity', 'Stage IV Lymphoepithelioma of the Nasopharynx', 'Stage IV Lymphoepithelioma of the Oropharynx', 'Stage IV Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity', 'Stage IV Mucoepidermoid Carcinoma of the Oral Cavity', 'Stage IV Non-small Cell Lung Cancer', 'Stage IV Pancreatic Cancer', 'Stage IV Rectal Cancer', 'Stage IV Renal Cell Cancer', 'Stage IV Salivary Gland Cancer', 'Stage IV Squamous Cell Carcinoma of the Hypopharynx', 'Stage IV Squamous Cell Carcinoma of the Larynx', 'Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity', 'Stage IV Squamous Cell Carcinoma of the Nasopharynx', 'Stage IV Squamous Cell Carcinoma of the Oropharynx', 'Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity', 'Stage IV Verrucous Carcinoma of the Larynx', 'Stage IV Verrucous Carcinoma of the Oral Cavity', 'Untreated Metastatic Squamous Neck Cancer With Occult Primary']
NCT01490866;A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC);COMPLETED;['PHASE2'];INTERVENTIONAL;70.0;['Colorectal Cancer']
NCT02052648;Study of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain Tumors;COMPLETED;['PHASE1', 'PHASE2'];INTERVENTIONAL;160.0;['Glioblastoma Multiforme', 'Glioma', 'Gliosarcoma', 'Malignant Brain Tumor']
NCT00667485;Rapamycin Plus Bevacizumab in Advanced Cancers;COMPLETED;['PHASE1'];INTERVENTIONAL;28.0;['Advanced Cancer', 'Metastatic Cancer']
NCT00321685;Bevacizumab, Radiation Therapy, and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Nonmetastatic Rectal Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;57.0;['Rectal Adenocarcinoma', 'Stage II Rectal Cancer AJCC v7', 'Stage III Rectal Cancer AJCC v7']
NCT05199285;A Phase II Study of Nivolumab + Ipilimumab in Advanced HCC Patients Who Have Progressed on First Line Atezolizumab + Bevacizumab;RECRUITING;['PHASE2'];INTERVENTIONAL;40.0;['BCLC Stage B Hepatocellular Carcinoma', 'BCLC Stage C Hepatocellular Carcinoma', 'Locally Advanced Hepatocellular Carcinoma', 'Metastatic Hepatocellular Carcinoma', 'Stage III Hepatocellular Carcinoma AJCC v8', 'Stage IIIA Hepatocellular Carcinoma AJCC v8', 'Stage IIIB Hepatocellular Carcinoma AJCC v8', 'Stage IV Hepatocellular Carcinoma AJCC v8', 'Stage IVA Hepatocellular Carcinoma AJCC v8', 'Stage IVB Hepatocellular Carcinoma AJCC v8', 'Unresectable Hepatocellular Carcinoma']
NCT04074785;Abemaciclib w/Bevacizumab in Recurrent GBM Pts w/Loss of CDKN2A/B or Gain or Amplification of CDK4/6;ACTIVE_NOT_RECRUITING;['EARLY_PHASE1'];INTERVENTIONAL;10.0;['GBM', 'Glioblastoma', 'Brain Tumor', 'Brain Tumor, Recurrent']
NCT00723125;Carboplatin, Abraxane, Avastin as Neoadjuvant Therapy for Her2-Negative Breast Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;60.0;['Breast Cancer']
NCT00217425;Bevacizumab and Combination Chemotherapy in Treating Patients With Peripheral T-Cell Lymphoma or Natural Killer Cell Neoplasms;COMPLETED;['PHASE2'];INTERVENTIONAL;46.0;['Lymphoma']
NCT00095225;A Study to Evaluate Bevacizumab and Chemotherapy or Tarceva in Treating Recurrent or Refractory NSCLC (Non-Small Cell Lung Cancer);COMPLETED;['PHASE2'];INTERVENTIONAL;122.0;['Non-Small-Cell Lung Carcinoma', 'Neoplasm Recurrence, Local']
NCT05806931;Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal Cancer;RECRUITING;['PHASE2'];INTERVENTIONAL;55.0;['Colon Cancer', 'Rectal Cancer']
NCT00525525;Study of Bevacizumab Plus Temodar and Tarceva in Patients With Glioblastoma or Gliosarcoma;COMPLETED;['PHASE2'];INTERVENTIONAL;74.0;['Glioblastoma', 'Gliosarcoma']
NCT01217931;Sequential Two-agent Assessment in Renal Cell Carcinoma Therapy: The START Trial;ACTIVE_NOT_RECRUITING;['PHASE2'];INTERVENTIONAL;180.0;['Kidney Cancer']
NCT00666692;A Phase 1b Study With Volociximab in Combination With Carboplatin, Paclitaxel, and Bevacizumab in First-line, Advanced Non-small Cell Lung Cancer (NSCLC);COMPLETED;['PHASE1'];INTERVENTIONAL;7.0;['Non-small Cell Lung Cancer']
NCT02669173;Capecitabine + Bevacizumab in Patients With Recurrent Glioblastoma;ACTIVE_NOT_RECRUITING;['PHASE1'];INTERVENTIONAL;12.0;['Glioblastoma']
NCT00673673;FOLFOX With Bevacizumab in Metastatic or Unresectable Gastroesophageal and Gastric Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;39.0;['Gastroesophageal Cancer', 'Gastric Cancer']
NCT01492673;Cyclophosphamide, Topotecan, and Bevacizumab (CTB) in Patients With Relapsed/Refractory Ewing's Sarcoma and Neuroblastoma;COMPLETED;['PHASE2'];INTERVENTIONAL;9.0;['Neuroblastoma', 'Sarcoma']
NCT00072046;Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer);COMPLETED;['PHASE3'];INTERVENTIONAL;732.0;['Kidney Cancer']
NCT00626561;Bevacizumab and Paclitaxel for Neuroendocrine Tumors of the Cervix;TERMINATED;['PHASE2'];INTERVENTIONAL;4.0;['Cervical Cancer', 'Uterine Cancer']
NCT00425646;Imatinib Mesylate and Bevacizumab After First-Line Chemotherapy and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;50.0;['Lung Cancer']
NCT00807573;Paclitaxel, Bevacizumab and Pemetrexed in Patients With Untreated, Advanced Non-Small Cell Lung Cancer Using Web-Based Data Collection, Patient Self-Reporting of Adverse Effects and Automated Response Assessment;COMPLETED;['PHASE2'];INTERVENTIONAL;44.0;['Lung Cancer']
NCT00252564;Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal Cancer;COMPLETED;['PHASE3'];INTERVENTIONAL;247.0;['Metastatic Colorectal Cancer']
NCT00268489;Pemetrexed Disodium and Bevacizumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;48.0;['Lung Cancer']
NCT02759588;GL-ONC1 Oncolytic Immunotherapy in Patients With Recurrent or Refractory Ovarian Cancer;COMPLETED;['PHASE1', 'PHASE2'];INTERVENTIONAL;46.0;['Ovarian Cancer', 'Peritoneal Carcinomatosis', 'Fallopian Tube Cancer']
NCT00633529;Safety of Adding IMO-2055 to Erlotinib + Bevacizumab in 2nd Line Treatment for Patients With NSCLC;COMPLETED;['PHASE1'];INTERVENTIONAL;36.0;['Non-Small Cell Lung Cancer']
NCT01349660;Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme;COMPLETED;['PHASE1', 'PHASE2'];INTERVENTIONAL;88.0;['Glioblastoma Multiforme']
NCT00088894;Gemcitabine With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer;COMPLETED;['PHASE3'];INTERVENTIONAL;590.0;['Adenocarcinoma of the Pancreas', 'Recurrent Pancreatic Cancer', 'Stage II Pancreatic Cancer', 'Stage III Pancreatic Cancer', 'Stage IV Pancreatic Cancer']
NCT00436332;S0635: Erlotinib and Bevacizumab in Stage IIIB and IV Bronchioloalveolar Carcinoma;COMPLETED;['PHASE2'];INTERVENTIONAL;84.0;['Lung Cancer']
NCT00667394;Tandutinib Plus Bevacizumab to Treat Recurrent Brain Tumors;COMPLETED;['PHASE2'];INTERVENTIONAL;42.0;['Glioblastoma', 'Gliosarcoma', 'Anaplastic Astrocytoma', 'Anaplastic Oligodendroglioma', 'Anaplastic Mixed Oligoastrocytoma']
NCT00976677;Carboplatin, Paclitaxel, and Bevacizumab With or Without Erlotinib Hydrochloride in Treating Non-Smokers With Advanced Non-Small Cell Lung Cancer;TERMINATED;['PHASE2'];INTERVENTIONAL;10.0;['Recurrent Non-small Cell Lung Cancer', 'Stage IIIB Non-small Cell Lung Cancer', 'Stage IV Non-small Cell Lung Cancer']
NCT04681677;Recurrent GBM Treated With Neurosurgical Resection and IORT Using the Xoft Axxent eBx System and Bevacizumab;RECRUITING;['PHASE2'];INTERVENTIONAL;100.0;['Glioblastoma', 'Recurrent Glioblastoma', 'GBM', 'Recurrent GBM']
NCT00393094;Bevacizumab and Irinotecan to Treat Brain Tumors;TERMINATED;['PHASE2'];INTERVENTIONAL;31.0;['High-Grade Gliomas']
NCT01183494;A Genotype-guided Study of Irinotecan Administered in Combination With 5-fluorouracil/Leucovorin (FOLFIRI) and Bevacizumab in Advanced Colorectal Cancer Patients;COMPLETED;['PHASE1'];INTERVENTIONAL;17.0;['Metastatic Colorectal Cancer']
NCT00780494;Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric Carcinoma;COMPLETED;['PHASE2'];INTERVENTIONAL;35.0;['Stomach Cancer', 'Gastric (Stomach) Cancer', 'Neoplasm of Cardioesophageal Junction', 'Gastrointestinal Stromal Tumor (GIST)']
NCT01478594;A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line Therapy;COMPLETED;['PHASE2'];INTERVENTIONAL;265.0;['Colorectal Cancer']
NCT00408694;Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;46.0;['Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7', 'Stage III Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7', 'Stage III Nasopharyngeal Undifferentiated Carcinoma AJCC v7', 'Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7', 'Stage IV Nasopharyngeal Undifferentiated Carcinoma AJCC v7']
NCT00850577;Ph II of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Treatment of Non-Small Cell Lung Cancer;TERMINATED;['PHASE2'];INTERVENTIONAL;255.0;['Non-small Cell Lung Cancer (NSCLC)']
NCT00585377;Bevacizumab (AvastinÂ®) + Erlotinib as First-line Therapy for Stage IIIB/IV or Recurrent, Non-squamous Cell Lung Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;50.0;['Cancer']
NCT04721132;Atezolizumab and Bevacizumab Before Surgery for the Treatment of Resectable Liver Cancer;RECRUITING;['PHASE2'];INTERVENTIONAL;30.0;['Resectable Hepatocellular Carcinoma', 'Stage I Hepatocellular Carcinoma AJCC v8', 'Stage IA Hepatocellular Carcinoma AJCC v8', 'Stage IB Hepatocellular Carcinoma AJCC v8', 'Stage II Hepatocellular Carcinoma AJCC v8']
NCT02314377;Bevacizumab Therapy for Brain Arteriovenous Malformation;COMPLETED;['PHASE1'];INTERVENTIONAL;2.0;['Brain Arteriovenous Malformation']
NCT01327794;Relationship Between Vitamin D Biomarkers and Survival in Blood Samples From Patients With Advanced Pancreatic Cancer;COMPLETED;;OBSERVATIONAL;265.0;['Pancreatic Cancer']
NCT00305877;Bevacizumab or Cetuximab And Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Pacreatic Cancer That Has Been Completely Removed By Surgery;COMPLETED;['PHASE2'];INTERVENTIONAL;137.0;['Stage IA Pancreatic Cancer', 'Stage IB Pancreatic Cancer', 'Stage IIA Pancreatic Cancer', 'Stage IIB Pancreatic Cancer']
NCT00234494;Cisplatin, Gemcitabine and Bevacizumab in Combination for Metastatic Transitional Cell Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;45.0;['Bladder Cancer']
NCT03250832;Study of TSR-033 With an Anti-programmed Cell Death-1 Receptor (PD-1) in Participants With Advanced Solid Tumors;COMPLETED;['PHASE1'];INTERVENTIONAL;111.0;['Neoplasms']
NCT00892177;Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme;COMPLETED;['PHASE2'];INTERVENTIONAL;144.0;['Glioblastoma Multiforme']
NCT01219777;Neoadjuvant Chemotherapy IV Carboplatin With Weekly Paclitaxel \Bevacizumab for Primary Ovarian;COMPLETED;['PHASE1'];INTERVENTIONAL;9.0;['Ovarian Cancer', 'Primary Peritoneal Cancer', 'Fallopian Tube Cancer']
NCT01253694;Ranibizumab as a Rescue Therapy for Diabetic Macular Edema;WITHDRAWN;['PHASE2'];INTERVENTIONAL;0.0;['Diabetic Macular Edema']
NCT00679029;Chemotherapy & Bevacizumab for Human Epidermal Growth Factor Receptor 2 (HER2)/Neu-Negative Stage II/III Breast Cancer;TERMINATED;['PHASE2'];INTERVENTIONAL;15.0;['HER2-negative Breast Cancer', 'Stage II Breast Cancer', 'Stage IIIA Breast Cancer', 'Stage IIIB Breast Cancer', 'Stage IIIC Breast Cancer']
NCT00517361;Phase II Study of Carboplatin and Bevacizumab (Avastin) for ER Neg, PR Neg, and HER2/Neu Neg Metastatic Breast Cancer;TERMINATED;['PHASE2'];INTERVENTIONAL;11.0;['Metastatic Breast Cancer']
NCT00614653;Bevacizumab, Erlotinib and Capecitabine for Advanced Pancreatic Cancer;COMPLETED;['PHASE1'];INTERVENTIONAL;17.0;['Pancreatic Cancer']
NCT03834753;A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD);COMPLETED;['PHASE3'];INTERVENTIONAL;228.0;['Age-related Macular Degeneration', 'Neovascular Age-related Macular Degeneration', 'Wet Macular Degeneration']
NCT01408953;Therapeutic Study of Bevacizumab Injection Directly Inside the Keloid Tissue;TERMINATED;['PHASE2'];INTERVENTIONAL;2.0;['Keloid']
NCT00066677;Bevacizumab With or Without Docetaxel in Treating Patients With Previously Treated Metastatic Pancreatic Cancer;TERMINATED;['PHASE2'];INTERVENTIONAL;32.0;['Pancreatic Cancer']
NCT00081861;Avastin Plus Rituximab for Patients With B-Cell Non-Hodgkin's Lymphoma;COMPLETED;['PHASE2'];INTERVENTIONAL;13.0;['Lymphoma']
NCT01269853;Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA;RECRUITING;['PHASE1', 'PHASE2'];INTERVENTIONAL;54.0;['Glioblastoma Multiforme', 'Anaplastic Astrocytoma']
NCT00755261;Phase II Study of Doxorubicin and AvastinÂ® in Sarcoma.;TERMINATED;['PHASE2'];INTERVENTIONAL;4.0;['Sarcoma', 'Soft Tissue Sarcoma']
NCT00456261;First-Line Treatment of A Comparison of 2 Treatments in Elderly Patients With Advanced NSCLC;COMPLETED;['PHASE2'];INTERVENTIONAL;110.0;['Lung Cancer']
NCT00055861;Bevacizumab and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;27.0;['Recurrent Breast Cancer', 'Stage IV Breast Cancer']
NCT04952753;Study of NIS793 and Other Novel Investigational Combinations With SOC Anti-cancer Therapy for the 2L Treatment of mCRC;ACTIVE_NOT_RECRUITING;['PHASE2'];INTERVENTIONAL;205.0;['Metastatic Colorectal Cancer']
NCT02413853;Combination Chemotherapy and Bevacizumab With or Without PRI-724 in Treating Patients With Newly Diagnosed Metastatic Colorectal Cancer;WITHDRAWN;['PHASE2'];INTERVENTIONAL;0.0;['Colorectal Adenocarcinoma', 'Stage IVA Colorectal Cancer', 'Stage IVB Colorectal Cancer']
NCT00021060;Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer;COMPLETED;['PHASE2', 'PHASE3'];INTERVENTIONAL;842.0;['Adenocarcinoma of the Lung', 'Bronchoalveolar Cell Lung Cancer', 'Large Cell Lung Cancer', 'Recurrent Non-small Cell Lung Cancer', 'Stage IIIB Non-small Cell Lung Cancer', 'Stage IV Non-small Cell Lung Cancer']
NCT01236560;Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade Glioma;COMPLETED;['PHASE2', 'PHASE3'];INTERVENTIONAL;101.0;['Brain Stem Glioma', 'Cerebral Astrocytoma', 'Childhood Cerebellar Anaplastic Astrocytoma', 'Childhood Cerebral Anaplastic Astrocytoma', 'Childhood Spinal Cord Neoplasm']
NCT00499694;Satraplatin and Bevacizumab in Treating Patients With Metastatic Prostate Cancer Previously Treated With Docetaxel;COMPLETED;['NA'];INTERVENTIONAL;31.0;['Prostate Cancer']
NCT01232777;Pan-VEGF Blockade for the Treatment of Retinopathy of Prematurity (BLOCK-ROP);WITHDRAWN;['PHASE2'];INTERVENTIONAL;0.0;['Retinopathy of Prematurity']
NCT00776594;Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy;COMPLETED;['PHASE2'];INTERVENTIONAL;102.0;['Prostate Cancer']
NCT00016094;S0108 Bevacizumab in Treating Patients With Non-Hodgkin's Lymphoma;COMPLETED;['PHASE2'];INTERVENTIONAL;60.0;['Anaplastic Large Cell Lymphoma', 'Recurrent Adult Burkitt Lymphoma', 'Recurrent Adult Diffuse Large Cell Lymphoma', 'Recurrent Mantle Cell Lymphoma']
NCT00667277;Phase II Study of Bevacizumab (AvastinÂ®) in Myelofibrosis;TERMINATED;['PHASE2'];INTERVENTIONAL;13.0;['Myelofibrosis']
NCT00849394;Evaluation of Protein in the Urine in Patients Receiving Bevacizumab;COMPLETED;;OBSERVATIONAL;106.0;['Colon Cancer', 'Rectal Cancer']
NCT04919629;APL-2 and Pembrolizumab Versus APL-2, Pembrolizumab and Bevacizumab Versus Bevacizumab Alone for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer and Malignant Effusion;RECRUITING;['PHASE2'];INTERVENTIONAL;40.0;['Fallopian Tube Carcinosarcoma', 'Fallopian Tube Adenocarcinoma', 'Fallopian Tube Serous Adenocarcinoma', 'Ovarian Carcinosarcoma', 'Ovarian Clear Cell Adenocarcinoma', 'Ovarian Endometrioid Adenocarcinoma', 'Ovarian Serous Adenocarcinoma', 'Primary Peritoneal Adenocarcinoma', 'Recurrent Fallopian Tube Carcinoma', 'Recurrent Ovarian Carcinoma', 'Recurrent Primary Peritoneal Carcinoma']
NCT01414153;Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD;COMPLETED;['PHASE2'];INTERVENTIONAL;158.0;['Exudative Age-related Macular Degeneration']
NCT04181060;Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer;RECRUITING;['PHASE3'];INTERVENTIONAL;300.0;['Advanced Lung Non-Squamous Non-Small Cell Carcinoma', 'Metastatic Lung Non-Squamous Non-Small Cell Carcinoma', 'Recurrent Lung Non-Squamous Non-Small Cell Carcinoma', 'Stage IIIB Lung Cancer AJCC v8', 'Stage IV Lung Cancer AJCC v8']
NCT00314353;Study of Bevacizumab Combined With Capecitabine and Either Oxaliplatin or Irinotecan as First Course of Treatment for Patients With Colorectal Cancer That Has Spread Beyond the Colon;TERMINATED;['PHASE2'];INTERVENTIONAL;7.0;['Colorectal Neoplasms']
NCT05359861;Trial of Atezolizumab and Bevacizumab With SRF388 or Placebo in Patients With Hepatocellular Carcinoma;ACTIVE_NOT_RECRUITING;['PHASE2'];INTERVENTIONAL;134.0;['Hepatocellular Carcinoma']
NCT05537402;LOcoregional vs Systemic Therapy in Patients With BCLC Stage B HCC;RECRUITING;['PHASE2'];INTERVENTIONAL;204.0;['Hepatocellular Carcinoma']
NCT01105702;Temodar (Temozolomide), Bevacizumab, Lithium and Radiation for High Grade Glioma;TERMINATED;['PHASE2'];INTERVENTIONAL;28.0;['Brain Cancer']
NCT03148418;A Study in Participants Previously Enrolled in a Genentech- and/or F. Hoffmann-La Roche Ltd-Sponsored Atezolizumab Study (IMbrella A);ACTIVE_NOT_RECRUITING;['PHASE3'];INTERVENTIONAL;382.0;['Cancer']
NCT00602602;Bevacizumab, Combination Chemotherapy, and Radiation Therapy in Treating Patients Undergoing Surgery For Locally Advanced Pancreatic Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;19.0;['Pancreatic Cancer']
NCT03020602;BPM31510 in Treating Patients With Recurrent High-Grade Glioma Previously Treated With Bevacizumab;COMPLETED;['PHASE1'];INTERVENTIONAL;12.0;['Gliosarcoma', 'Recurrent Glioblastoma', 'Astrocytoma of Brain', 'Glioblastoma']
NCT00112918;Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for High Risk Stage II or Stage III Colon Cancer;COMPLETED;['PHASE3'];INTERVENTIONAL;3451.0;['Colorectal Cancer']
NCT01266031;Phase I/II Adaptive Randomized Trial of Bevacizumab Versus Bevacizumab Plus Vorinostat in Adults With Recurrent Glioblastoma;COMPLETED;['PHASE1', 'PHASE2'];INTERVENTIONAL;96.0;['Malignant Glioma', 'Recurrent Glioblastoma']
NCT00294931;Irinotecan, Carboplatin, Bevacizumab in the Treatment of Patients With Extensive Stage Small Cell Lung Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;50.0;['Carcinoma, Small Cell Lung']
NCT00083031;Metronomic Low-Dose Cyclophosphamide and Methotrexate With or Without Bevacizumab in Treating Women With Metastatic Breast Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;57.0;['Breast Cancer']
NCT01057017;First-Line FOLFOX-Bevacizumab for Advanced Colorectal Cancer With Wild-Type Ras;TERMINATED;['PHASE2'];INTERVENTIONAL;5.0;['Colorectal Cancer']
NCT01251926;EZN-2208 (Pegylated SN-38) in Combination With Bevacizumab in Refractory Solid Tumors;COMPLETED;['PHASE1'];INTERVENTIONAL;12.0;['Neoplasms']
NCT03396926;Pembrolizumab, Capecitabine, and Bevacizumab in Treating Patients With Microsatellite Stable Colorectal Cancer That Is Locally Advanced, Metastatic, or Cannot Be Removed by Surgery;ACTIVE_NOT_RECRUITING;['PHASE2'];INTERVENTIONAL;44.0;['Microsatellite Stable', 'Mismatch Repair Protein Proficient', 'Stage III Colorectal Cancer AJCC v7', 'Stage IIIB Colorectal Cancer AJCC v7', 'Stage IIIC Colorectal Cancer AJCC v7', 'Stage IV Colorectal Cancer AJCC v7', 'Stage IVA Colorectal Cancer AJCC v7', 'Stage IVB Colorectal Cancer AJCC v7']
NCT00137826;Bevacizumab (Avastin) and Erlotinib (Tarceva) in Previously Treated Mesothelioma;COMPLETED;['PHASE2'];INTERVENTIONAL;37.0;['Mesothelioma']
NCT01996826;A Multi-Center Study of the Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival;COMPLETED;['PHASE1', 'PHASE2'];INTERVENTIONAL;75.0;['Corneal Neovascularization', 'Corneal Graft Failure']
NCT00622726;Bevacizumab Eliminates the Angiogenic Threat for Retinopathy of Prematurity;UNKNOWN;['PHASE2'];INTERVENTIONAL;150.0;['Retinopathy of Prematurity']
NCT03175432;Bevacizumab and Atezolizumab With or Without Cobimetinib in Treating Patients With Untreated Melanoma Brain Metastases;ACTIVE_NOT_RECRUITING;['PHASE2'];INTERVENTIONAL;29.0;['BRAF V600 Wild Type', 'Clinical Stage IV Cutaneous Melanoma AJCC v8', 'Intracranial Melanoma', 'Metastatic Malignant Neoplasm in the Brain', 'Metastatic Melanoma', 'Pathologic Stage IV Cutaneous Melanoma AJCC v8', 'Refractory Melanoma']
NCT00293332;Docetaxel, Carboplatin, and Bevacizumab in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed By Surgery;TERMINATED;['PHASE2'];INTERVENTIONAL;1.0;['Lung Cancer']
NCT01399918;Everolimus and Bevacizumab in Advanced Non-Clear Cell Renal Cell Carcinoma (RCC);COMPLETED;['PHASE2'];INTERVENTIONAL;57.0;['Renal Cell Carcinoma']
NCT01571232;Ozurdex for Treatment of Recalcitrant Diabetic Macular Edema;COMPLETED;['PHASE2'];INTERVENTIONAL;20.0;['Diabetic Macular Edema', 'Non-proliferative Diabetic Retinopathy', 'Proliferative Diabetic Retinopathy']
NCT00054132;Erlotinib Hydrochloride and Bevacizumab in Treating Patients With Stage IV Breast Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;38.0;['Recurrent Breast Carcinoma', 'Stage IV Breast Cancer']
NCT03526432;Phase II Study of Atezolizumab + Bevacizumab in Endometrial Cancer;RECRUITING;['PHASE2'];INTERVENTIONAL;110.0;['Endometrial Cancer']
NCT03642132;Avelumab and Talazoparib in Untreated Advanced Ovarian Cancer (JAVELIN OVARIAN PARP 100);TERMINATED;['PHASE3'];INTERVENTIONAL;79.0;['Ovarian Cancer']
NCT00159432;Study of Oxaliplatin, Capecitabine and Bevacizumab as First Line Treatment for Patients With Advanced Colorectal Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;63.0;['Colorectal Cancer']
NCT00017394;Bevacizumab Plus Vinorelbine in Treating Patients With Stage IV Breast Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;56.0;['Male Breast Cancer', 'Recurrent Breast Cancer', 'Stage IV Breast Cancer']
NCT00303628;Postoperative Chemotherapy With or Without Bevacizumab for Patients With Stage II or III Rectal Cancer;TERMINATED;['PHASE3'];INTERVENTIONAL;355.0;['Adenocarcinoma of the Rectum', 'Stage II Rectal Cancer', 'Stage III Rectal Cancer']
NCT04227028;Brigatinib and Bevacizumab for the Treatment of ALK-Rearranged Locally Advanced, Metastatic, or Recurrent NSCLC;RECRUITING;['PHASE1'];INTERVENTIONAL;31.0;['Locally Advanced Lung Non-Small Cell Carcinoma', 'Metastatic Lung Non-Small Cell Carcinoma', 'Recurrent Lung Non-Small Cell Carcinoma', 'Stage III Lung Cancer AJCC v8', 'Stage IIIA Lung Cancer AJCC v8', 'Stage IIIB Lung Cancer AJCC v8', 'Stage IIIC Lung Cancer AJCC v8', 'Stage IV Lung Cancer AJCC v8', 'Stage IVA Lung Cancer AJCC v8', 'Stage IVB Lung Cancer AJCC v8']
NCT01069328;Dose Escalating Study With BAY43-9006 With Carboplatin, Paclitaxel and Bevacizumab in Untreated Stage IIIb Non-small Cell Lung Cancer (NSCLC);COMPLETED;['PHASE1'];INTERVENTIONAL;33.0;['Carcinoma, Non-Small-Cell Lung', 'Lung Cancer']
NCT01632228;A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab Compared to Bevacizumab Alone or Onartuzumab Monotherapy in Participants With Recurrent Glioblastoma;COMPLETED;['PHASE2'];INTERVENTIONAL;135.0;['Glioblastoma']
NCT05593328;Study of Onvansertib in Combination With FOLFIRI and Bevacizumab Versus FOLFIRI and Bevacizumab for Second Line Treatment of Metastatic Colorectal Cancer in Participants With a Kirsten Rat Sarcoma Virus Gene (KRAS) or Neuroblastoma-RAS (NRAS) Mutation;ACTIVE_NOT_RECRUITING;['PHASE2'];INTERVENTIONAL;23.0;['Colorectal Cancer', 'Metastatic Colorectal Cancer']
NCT04634578;Bevacizumab Treatment For Type 1 ROP;RECRUITING;['PHASE2'];INTERVENTIONAL;80.0;['Retinopathy of Prematurity']
NCT02574078;A Study of Nivolumab in Advanced Non-Small Cell Lung Cancer (NSCLC);COMPLETED;['PHASE1', 'PHASE2'];INTERVENTIONAL;341.0;['Non-Small Cell Lung Cancer']
NCT00112528;Bevacizumab, Gemcitabine, and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;53.0;['Pancreatic Cancer']
NCT03847428;Assess Efficacy and Safety of Durvalumab Alone or Combined With Bevacizumab in High Risk of Recurrence HCC Patients After Curative Treatment;ACTIVE_NOT_RECRUITING;['PHASE3'];INTERVENTIONAL;908.0;['Hepatocellular Carcinoma']
NCT04116658;First-in-Human, Phase 1b/2a Trial of a Multipeptide Therapeutic Vaccine in Patients With Progressive Glioblastoma;ACTIVE_NOT_RECRUITING;['PHASE1', 'PHASE2'];INTERVENTIONAL;100.0;['Glioblastoma, Adult']
NCT00085358;Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer);COMPLETED;['PHASE1'];INTERVENTIONAL;40.0;['Brenner Tumor', 'Fallopian Tube Cancer', 'Ovarian Carcinosarcoma', 'Ovarian Clear Cell Cystadenocarcinoma', 'Ovarian Endometrioid Adenocarcinoma', 'Ovarian Mixed Epithelial Carcinoma', 'Ovarian Mucinous Cystadenocarcinoma', 'Ovarian Serous Cystadenocarcinoma', 'Ovarian Undifferentiated Adenocarcinoma', 'Primary Peritoneal Cavity Cancer', 'Stage II Ovarian Epithelial Cancer', 'Stage III Ovarian Epithelial Cancer', 'Stage IV Ovarian Epithelial Cancer']
NCT03428958;A Safety, Pharmacokinetic and Efficacy Study of NUC-3373 in Combination With Standard Agents Used in Colorectal Cancer Treatment;RECRUITING;['PHASE1', 'PHASE2'];INTERVENTIONAL;225.0;['Colorectal Cancer', 'Colorectal Neoplasms', 'Colorectal Carcinoma', 'Colorectal Tumors', 'Neoplasms, Colorectal']
NCT05251727;Assess Safety and Tolerability of ART-123 + FOLFOX + Bevacizumab in Metastatic Colorectal Cancer Patients;RECRUITING;['PHASE1'];INTERVENTIONAL;80.0;['Chemotherapy-induced Peripheral Neuropathy']
NCT00476827;A Phase II Safety and Tolerability Study of Bevacizumab When Added to Single-agent Chemotherapy to Treat Patient With Breast Cancer Metastatic to Brain;TERMINATED;['PHASE2'];INTERVENTIONAL;16.0;['Breast Cancer']
NCT00503906;Abraxane, Avastin, and Gemcitabine as First-Line Therapy for Patients With Metastatic Breast Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;30.0;['Breast Cancer']
NCT00550927;Enzastaurin and Bevacizumab in Treating Patients With Locally Advanced or Metastatic Cancer;COMPLETED;['PHASE1'];INTERVENTIONAL;42.0;['Unspecified Adult Solid Tumor, Protocol Specific']
NCT04051606;Regorafenib in Bevacizumab Refractory Recurrent Glioblastoma;ACTIVE_NOT_RECRUITING;['PHASE2'];INTERVENTIONAL;14.0;['Recurrent Glioblastoma']
NCT00543504;Bevacizumab in Multiple Phase I Combinations;COMPLETED;['PHASE1'];INTERVENTIONAL;343.0;['Advanced Cancer']
NCT05062317;ctDNA-Directed Post-Hepatectomy Chemotherapy for Patients With Resectable Colorectal Liver Metastases;RECRUITING;['PHASE2'];INTERVENTIONAL;120.0;['Liver Metastases']
NCT01656304;Bevacizumab in Treating Patients With Relapsed Prostate Cancer That Did Not Respond to Hormone Therapy;COMPLETED;['PHASE2'];INTERVENTIONAL;16.0;['Adenocarcinoma of the Prostate', 'Recurrent Prostate Cancer', 'Stage I Prostate Cancer', 'Stage IIA Prostate Cancer', 'Stage IIB Prostate Cancer', 'Stage III Prostate Cancer']
NCT03475004;Study of Pembrolizumab, Binimetinib, and Bevacizumab in Patients With Refractory Colorectal Cancer;ACTIVE_NOT_RECRUITING;['PHASE2'];INTERVENTIONAL;53.0;['Colorectal Cancer', 'Metastatic Cancer']
NCT01260506;Single-Arm Open-Label Multicenter Study of VB-111 in Patients With Recurrent Glioblastoma Multiforme;COMPLETED;['PHASE1', 'PHASE2'];INTERVENTIONAL;75.0;['Glioblastoma Multiforme']
NCT02734004;A Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors.;ACTIVE_NOT_RECRUITING;['PHASE1', 'PHASE2'];INTERVENTIONAL;264.0;['Ovarian', 'Breast', 'SCLC', 'Gastric Cancers']
NCT00735306;Phase I/II Trial of Radiation, Avastin and Tarceva for Pancreatic Adenocarcinoma;COMPLETED;['PHASE1'];INTERVENTIONAL;12.0;['Pancreatic Cancer']
NCT00392704;Treatment of Head & Neck Cancer With Chemotherapy and Radiation;COMPLETED;['PHASE2'];INTERVENTIONAL;60.0;['Head and Neck Cancer']
NCT05189171;MicroOrganoSphere (MOS) Drug Screen Pilot Trial in Colorectal Cancer;ACTIVE_NOT_RECRUITING;;OBSERVATIONAL;46.0;['Colorectal Neoplasms']
NCT00631371;Study Comparing Bevacizumab + Temsirolimus vs. Bevacizumab + Interferon-Alfa In Advanced Renal Cell Carcinoma Subjects;COMPLETED;['PHASE3'];INTERVENTIONAL;791.0;['Renal Cell Carcinoma']
NCT03556839;Platinum Chemotherapy Plus Paclitaxel With Bevacizumab and Atezolizumab in Metastatic Carcinoma of the Cervix;ACTIVE_NOT_RECRUITING;['PHASE3'];INTERVENTIONAL;404.0;['Carcinoma of the Cervix, Stage IVB']
NCT02654639;Ph 2 Study of TAS-102 / Bevacizumab Maintenance Therapy Post Induction Chemotherapy in Metastatic Colorectal Cancer;TERMINATED;['PHASE2'];INTERVENTIONAL;4.0;['Metastatic Colorectal Cancer']
NCT00240071;Study of Avastin (Bevacizumab) to Reverse Acquired Estrogen Independence in Previously Hormone Responsive Metastatic Breast Ca.;COMPLETED;['PHASE2'];INTERVENTIONAL;30.0;['Metastatic Breast Cancer']
NCT03832179;Steroid vs. Anti-vascular Endothelial Growth Factor for Diabetic Macular Edema Prior to Phacoemulsification;RECRUITING;['PHASE4'];INTERVENTIONAL;32.0;['Diabetic Macular Edema', 'Cataract']
NCT06047379;Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis;RECRUITING;['PHASE1', 'PHASE2'];INTERVENTIONAL;134.0;['Diffuse Astrocytoma, IDH-Mutant', 'Glioblastoma, IDH-wildtype', 'Brain Metastases, Adult', 'Cervical Cancer', 'Colorectal Cancer', 'Esophageal Cancer', 'Esophageal Squamous Cell Carcinoma', 'Gastric Cancer', 'Gastroesophageal Junction Adenocarcinoma', 'Head and Neck Squamous Cell Carcinoma', 'Melanoma', 'Merkel Cell Carcinoma', 'Microsatellite Instability-High Solid Malignant Tumor', 'Mismatch Repair Deficient Solid Malignant Tumor', 'Microsatellite Instability-High Colorectal Cancer', 'Mismatch Repair Deficient Colorectal Cancer', 'Non-small Cell Lung Cancer', 'Renal Cell Carcinoma', 'Small Cell Lung Cancer', 'Squamous Cell Carcinoma', 'Urothelial Carcinoma']
NCT01471691;Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving Bevacizumab;COMPLETED;['PHASE1', 'PHASE2'];INTERVENTIONAL;14.0;['Branch Retinal Vein Occlusion', 'Central Retinal Vein Occlusion', 'Macular Edema']
NCT00351039;Phase I/II Trial of Bevacizumab, Pemetrexed and Erlotinib in Elderly Patients With Non-Small Cell Lung Cancer;TERMINATED;['PHASE1', 'PHASE2'];INTERVENTIONAL;8.0;['Non-Small Cell Lung Cancer']
NCT00343291;A Study of Cetuximab and Bevacizumab in Combination With Paclitaxel and Carboplatin in Stage IIIb/IV NSCLC;COMPLETED;['PHASE2'];INTERVENTIONAL;121.0;['Non-Small Cell Lung Cancer']
NCT02031991;A Pharmacokinetic Study Comparing PF-06439535 And Bevacizumab In Healthy Male Volunteers (REFLECTIONS B739-01);COMPLETED;['PHASE1'];INTERVENTIONAL;102.0;['Healthy']
NCT00089609;Docetaxel, Thalidomide, Prednisone, and Bevacizumab to Treat Metastatic Prostate Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;73.0;['Prostatic Neoplasms']
NCT01186991;Study Evaluating the Safety and Efficacy of Onartuzumab And/or Bevacizumab in Combination With Paclitaxel in Participants With Metastatic, Triple Negative Breast Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;185.0;['Breast Cancer']
NCT00886691;Bevacizumab With or Without Everolimus in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;150.0;['Recurrent Fallopian Tube Carcinoma', 'Recurrent Ovarian Carcinoma', 'Recurrent Primary Peritoneal Carcinoma']
NCT02337491;Pembrolizumab +/- Bevacizumab for Recurrent GBM;COMPLETED;['PHASE2'];INTERVENTIONAL;80.0;['Glioblastoma']
NCT02840409;Vinblastine +/- Bevacizumab in Children With Unresectable or Progressive Low Grade Glioma (LGG);ACTIVE_NOT_RECRUITING;['PHASE2'];INTERVENTIONAL;109.0;['Low Grade Glioma']
NCT02420509;Postoperative Chemotherapy in High-Grade Appendiceal Adenocarcinoma With Peritoneal Carcinomatosis;TERMINATED;;OBSERVATIONAL;2.0;['Cancer']
NCT00924209;A Phase II Study of Neo-Adjuvant Gemcitabine, Cisplatin and Bevacizumab in Stage IIIA (N2) Non-Squamous Cell Non-Small Cell Lung Cancer;TERMINATED;['PHASE2'];INTERVENTIONAL;7.0;['NSCLC', 'Stage IIIA (N2)']
NCT02819479;Low-dose Intra-arterial Bevacizumab for Edema and Radiation Necrosis Therapeutic Intervention (LIBERTI);COMPLETED;['PHASE2'];INTERVENTIONAL;10.0;['Radiation Necrosis']
NCT01652079;CRLX101 in Combination With Bevacizumab for Recurrent Ovarian/Tubal/Peritoneal Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;63.0;['Ovarian Cancer', 'Fallopian Tube Cancer', 'Primary Peritoneal Cancer']
NCT02342379;TH-302 in Combination With Bevacizumab for Glioblastoma;COMPLETED;['PHASE2'];INTERVENTIONAL;35.0;['Glioblastoma']
NCT03452579;Nivolumab Plus Standard Dose Bevacizumab Versus Nivolumab Plus Low Dose Bevacizumab in GBM;ACTIVE_NOT_RECRUITING;['PHASE2'];INTERVENTIONAL;90.0;['Glioblastoma']
NCT06117891;An Observational Study to Learn More About How Well a Treatment Works When Given After Treatment With Atezolizumab and Bevacizumab or Another Similar Combination of Drugs in Adults With Liver Cancer That Cannot be Treated With Surgery;RECRUITING;;OBSERVATIONAL;300.0;['Unresectable Hepatocellular Carcinoma']
NCT00939991;Suberoylanilide Hydroxamic Acid (SAHA), Bevacizumab, Daily Temozolomide for Recurrent Malignant Gliomas;COMPLETED;['PHASE1', 'PHASE2'];INTERVENTIONAL;48.0;['Brain Tumor', 'Glioblastoma']
NCT06096779;A Study Evaluating Atezolizumab, With or Without Bevacizumab, in Patients With Unresectable Hepatocellular Carcinoma and Child-Pugh B7 and B8 Cirrhosis;RECRUITING;['PHASE2'];INTERVENTIONAL;120.0;['Hepatocellular Carcinoma']
NCT00074308;Imatinib Mesylate and Bevacizumab in Treating Patients With Advanced Melanoma or Other Advanced Cancers;COMPLETED;['PHASE1', 'PHASE2'];INTERVENTIONAL;40.0;['Recurrent Melanoma', 'Stage III Melanoma', 'Stage IV Melanoma', 'Unspecified Adult Solid Tumor, Protocol Specific']
NCT01969708;Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2);COMPLETED;['PHASE3'];INTERVENTIONAL;362.0;['Central Retinal Vein Occlusion']
NCT04054908;Gut Microbiome in Colorectal Cancer;COMPLETED;;OBSERVATIONAL;50.0;['Gastrointestinal Microbiome', 'Neoplasm, Colorectal']
NCT00323739;Bevacizumab (Avastin) and RAD001(Everolimus)in the Treatment of Advanced Clear Cell Renal Carcinoma;COMPLETED;['PHASE2'];INTERVENTIONAL;80.0;['Kidney Cancer']
NCT00365391;Bevacizumab and Erlotinib in Treating Patients With Advanced Liver Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;27.0;['Adult Primary Hepatocellular Carcinoma', 'Advanced Adult Primary Liver Cancer', 'Localized Unresectable Adult Primary Liver Cancer', 'Recurrent Adult Primary Liver Cancer']
NCT05440708;A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma;RECRUITING;['PHASE1', 'PHASE2'];INTERVENTIONAL;154.0;['Hepatocellular Carcinoma']
NCT00408408;Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery;UNKNOWN;['PHASE3'];INTERVENTIONAL;1206.0;['Breast Cancer']
NCT00114179;Capecitabine, Bevacizumab, and Radiation Therapy Followed By Gemcitabine and Bevacizumab in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery;COMPLETED;['PHASE2'];INTERVENTIONAL;82.0;['Adenocarcinoma of the Pancreas', 'Stage II Pancreatic Cancer', 'Stage III Pancreatic Cancer']
NCT00161291;Open Label Trial for Post-Menopausal Women With Newly Diagnosed Operable Breast Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;28.0;['Breast Cancer']
NCT01918371;A Retrospective Study of Anti-Vascular Endothelial Growth Factor (VEGF) Injections for Retinal Vein Occlusion or Diabetic Macular Edema;COMPLETED;;OBSERVATIONAL;323.0;['Retinal Vein Occlusion', 'Macular Edema']
NCT06011109;Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab;RECRUITING;['PHASE1', 'PHASE2'];INTERVENTIONAL;30.0;['Glioma', 'Glioblastoma Multiforme']
NCT03434379;A Study of Atezolizumab in Combination With Bevacizumab Compared With Sorafenib in Patients With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma;COMPLETED;['PHASE3'];INTERVENTIONAL;558.0;['Carcinoma, Hepatocellular']
NCT00523809;Allogeneic Hematopoietic Stem Cell Transplantation With Bevacizumab for Advanced Solid Tumor;TERMINATED;['PHASE2'];INTERVENTIONAL;5.0;['Breast Cancer', 'Ovarian Cancer']
NCT00271609;Bevacizumab for Recurrent Malignant Glioma;COMPLETED;['PHASE2'];INTERVENTIONAL;88.0;['Recurrent High-Grade Gliomas', 'Malignant Gliomas']
NCT05093608;SELINEXOR in Combination w/Bevacizumab and Atezolizumab in Newly Diagnosed Advanced Hepatocellular Carcinoma;TERMINATED;['PHASE1'];INTERVENTIONAL;2.0;['Hepatocellular Carcinoma']
NCT00887809;Gemcitabine and Docetaxel With Bevacizumab in Selected Sarcoma Subtypes;COMPLETED;['PHASE2'];INTERVENTIONAL;47.0;['Sarcoma', 'Leiomyosarcoma', 'Malignant Fibrous', 'Histiocytoma', 'Angiosarcoma']
NCT00501891;Bevacizumab in Combination With Metronomic Temozolomide for Recurrent Malignant Glioma;COMPLETED;['PHASE2'];INTERVENTIONAL;32.0;['Glioblastoma Multiforme']
NCT00785291;Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer;COMPLETED;['PHASE3'];INTERVENTIONAL;799.0;['Estrogen Receptor Negative', 'Estrogen Receptor Positive', 'HER2/Neu Negative', 'HER2/Neu Positive', 'Progesterone Receptor Negative', 'Progesterone Receptor Positive', 'Recurrent Breast Carcinoma', 'Stage IIIC Breast Cancer AJCC v6', 'Stage IV Breast Cancer AJCC v6 and v7']
NCT00436709;Bevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast Cancer;UNKNOWN;['NA'];INTERVENTIONAL;75.0;['Breast Cancer']
NCT01445509;Dasatinib in Combination With Bevacizumab to Treat Advanced Solid Tumors;COMPLETED;['PHASE1'];INTERVENTIONAL;50.0;['Solid Tumors']
NCT01870427;NEWTON: Aflibercept Injection for Previously Treated Macular Edema Associated With Central Retinal Vein Occlusions;COMPLETED;['PHASE4'];INTERVENTIONAL;20.0;['Macular Edema With Central Retinal Vein Occlusions']
NCT00881504;A Study of FOLFOX6 With Bevacizumab for Biliary System Carcinoma;TERMINATED;['PHASE2'];INTERVENTIONAL;9.0;['Biliary Tract Cancer']
NCT01663727;Study To Evaluate the Efficacy and Safety Of Bevacizumab, and Associated Biomarkers, In Combination With Paclitaxel Compared With Paclitaxel Plus Placebo as First-line Treatment Of Patients With Her2-Negative Metastatic Breast Cancer;COMPLETED;['PHASE3'];INTERVENTIONAL;481.0;['Metastatic Breast Cancer']
NCT01332604;GDC-0980 in Combination With a Fluoropyrimidine, Oxaliplatin, and Bevacizumab in Patients With Advanced Solid Tumors;COMPLETED;['PHASE1'];INTERVENTIONAL;41.0;['Solid Cancers']
NCT04677504;A Study of Atezolizumab With or Without Bevacizumab in Combination With Cisplatin Plus Gemcitabine in Patients With Untreated, Advanced Biliary Tract Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;162.0;['Biliary Tract Cancer']
NCT04634604;A Randomized Trial of Low-Dose Bevacizumab vs Laser for Type 1 ROP;TERMINATED;['PHASE3'];INTERVENTIONAL;16.0;['Retinopathy of Prematurity']
NCT00438204;Pemetrexed Disodium, Gemcitabine, and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer;TERMINATED;['PHASE2'];INTERVENTIONAL;39.0;['Lung Cancer']
NCT02923739;Paclitaxel and Bevacizumab With or Without Emactuzumab in Treating Patients With Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer;TERMINATED;['PHASE2'];INTERVENTIONAL;9.0;['Fallopian Tube Adenocarcinoma', 'Fallopian Tube Clear Cell Adenocarcinoma', 'Fallopian Tube Endometrioid Adenocarcinoma', 'Fallopian Tube Mucinous Adenocarcinoma', 'Fallopian Tube Serous Adenocarcinoma', 'Fallopian Tube Transitional Cell Carcinoma', 'Fallopian Tube Undifferentiated Carcinoma', 'Malignant Ovarian Brenner Tumor', 'Ovarian Adenocarcinoma', 'Ovarian Clear Cell Adenocarcinoma', 'Ovarian Endometrioid Adenocarcinoma', 'Ovarian Mucinous Adenocarcinoma', 'Ovarian Seromucinous Carcinoma', 'Ovarian Serous Adenocarcinoma', 'Ovarian Transitional Cell Carcinoma', 'Ovarian Undifferentiated Carcinoma', 'Primary Peritoneal Serous Adenocarcinoma', 'Recurrent Fallopian Tube Carcinoma', 'Recurrent Ovarian Carcinoma', 'Recurrent Primary Peritoneal Carcinoma']
NCT00612339;Avastin in Combination With Temozolomide for Unresectable or Multifocal GBMs and Gliosarcomas;COMPLETED;['PHASE2'];INTERVENTIONAL;41.0;['Glioblastoma', 'Gliosarcoma']
NCT00354679;Irinotecan, Cisplatin, Bevacizumab, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Esophageal Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;34.0;['Esophageal Cancer']
NCT00536939;Trial of Paclitaxel, Bevacizumab, and Enzastaurin Versus Paclitaxel, Bevacizumab and Placebo for Breast Cancer;TERMINATED;['PHASE2'];INTERVENTIONAL;2.0;['Breast Cancer']
NCT03367871;Combination Pembrolizumab, Chemotherapy and Bevacizumab in Patients With Cervical Cancer;TERMINATED;['PHASE2'];INTERVENTIONAL;17.0;['Cervical Cancer']
NCT02641639;FOCUS: PCC + Bevacizumab + CA4P Versus PCC + Bevacizumab + Placebo for Subjects With Platinum Resistant Ovarian Cancer;TERMINATED;['PHASE2', 'PHASE3'];INTERVENTIONAL;91.0;['Platinum Resistant Ovarian Cancer']
NCT03574779;A Study to Evaluate the Efficacy and Safety of Novel Treatment Combinations in Participants With Ovarian Cancer;RECRUITING;['PHASE1', 'PHASE2'];INTERVENTIONAL;125.0;['Ovarian Neoplasms']
NCT00980239;HAI Irinotecan + IV Bevacizumab, Bevacizumab & Oxaliplatin or Bevacizumab & Cetuximab in Advanced Cancers Metastatic to Liver;COMPLETED;['PHASE1'];INTERVENTIONAL;115.0;['Liver Cancer', 'Advanced Cancer']
NCT00945139;Study of Bevacizumab/Doxil in Treatment of Platinum-Resistant/Refractory Ovarian Cancer (CA);COMPLETED;['PHASE2'];INTERVENTIONAL;46.0;['Ovarian Cancer']
NCT00019539;Monoclonal Antibody Therapy in Treating Patients With Advanced Kidney Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;;['Stage IV Renal Cell Cancer', 'Recurrent Renal Cell Cancer']
NCT00653939;A Safety and Efficacy Study of Carboplatin, Paclitaxel, Bevacizumab and CA4P in Non-Small Cell Lung Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;63.0;['Tumors']
NCT00401817;Bevacizumab + CHOP-Rituximab in Untreated Mantle Cell Lymphoma;COMPLETED;['PHASE2'];INTERVENTIONAL;11.0;['Untreated Mantle Cell Lymphoma']
NCT03272217;Atezolizumab With Bevacizumab in Previously Untreated Metastatic/Unresectable Urothelial Cancer;TERMINATED;['PHASE2'];INTERVENTIONAL;16.0;['Urothelial Carcinoma']
NCT01115517;Safety Study of Avastin Used as Adjunctive Therapy in Pterygium Surgery;COMPLETED;['PHASE2'];INTERVENTIONAL;51.0;['Pterygium']
NCT05007106;MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005);RECRUITING;['PHASE2'];INTERVENTIONAL;610.0;['Uterine Cervical Neoplasms', 'Endometrial Neoplasms', 'Squamous Cell Carcinoma of Head and Neck', 'Gallbladder Neoplasms', 'Cholangiocarcinoma', 'Esophageal Neoplasms', 'Triple Negative Breast Neoplasms', 'Hepatocellular Carcinoma', 'Urinary Bladder Neoplasms', 'Ovarian Neoplasms', 'Stomach Neoplasms']
NCT05480306;Phase 2 Study of DKN-01 in Colorectal Cancer;RECRUITING;['PHASE2'];INTERVENTIONAL;150.0;['Colorectal Cancer', 'Colorectal Adenocarcinoma', 'Colo-rectal Cancer', 'Colorectal Cancer Metastatic']
NCT00257608;A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS);COMPLETED;['PHASE3'];INTERVENTIONAL;1145.0;['Non-Small Cell Lung Cancer']
NCT00055809;Bevacizumab and PEG-Interferon Alfa-2b in Treating Patients With Metastatic or Unresectable Carcinoid Tumors;COMPLETED;['PHASE2'];INTERVENTIONAL;44.0;['Metastatic Gastrointestinal Carcinoid Tumor', 'Recurrent Gastrointestinal Carcinoid Tumor', 'Regional Gastrointestinal Carcinoid Tumor']
NCT02753127;A Study of Napabucasin (BBI-608) in Combination With FOLFIRI in Adult Patients With Previously Treated Metastatic Colorectal Cancer;COMPLETED;['PHASE3'];INTERVENTIONAL;1253.0;['Colorectal Cancer']
NCT00116506;Study of Bevacizumab, Erlotinib, FOLFOX for Patients With Untreated Metastatic Colorectal Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;35.0;['Colorectal Cancer', 'Neoplasm Metastasis']
NCT00450827;Iodine I 131 Monoclonal Antibody 3F8 and Bevacizumab in Treating Patients With Relapsed or Refractory Neuroblastoma;COMPLETED;['PHASE1'];INTERVENTIONAL;25.0;['Neuroblastoma']
NCT00095706;Treatment of HER2-Positive Metastatic Breast Cancer With Herceptin and Bevacizumab (Antibodies Against HER2 and VEGF);COMPLETED;['PHASE1', 'PHASE2'];INTERVENTIONAL;50.0;['Breast Cancer']
NCT01112527;PF-00299804 in Adult Patients With Relapsed/Recurrent Glioblastoma;COMPLETED;['PHASE2'];INTERVENTIONAL;58.0;['Glioblastoma', 'GBM', 'Glioblastoma Multiforme']
NCT00404404;ABI-007 and Bevacizumab in Treating Women With Recurrent or Metastatic Breast Cancer;UNKNOWN;['PHASE2'];INTERVENTIONAL;35.0;['Breast Cancer']
NCT02010606;Phase I Study of a Dendritic Cell Vaccine for Patients With Either Newly Diagnosed or Recurrent Glioblastoma;COMPLETED;['PHASE1'];INTERVENTIONAL;39.0;['Glioblastoma', 'Glioblastoma Multiforme', 'Glioma', 'Astrocytoma', 'Brain Tumor']
NCT01186406;Gliadel, XRT, Temodar, Avastin Followed by Avastin, Temodar for Newly Diagnosed Glioblastoma Multiforme (GBM);TERMINATED;['PHASE2'];INTERVENTIONAL;41.0;['Glioblastoma Multiforme', 'Gliosarcoma']
NCT00597506;Expanded Cohort for Metastatic Colorectal Cancer (MCRC) Using Bevacizumab + Everolimus;COMPLETED;['PHASE2'];INTERVENTIONAL;50.0;['Colorectal Adenocarcinoma']
NCT00891527;Pilot Study Using Avastin and Gleevec to Treat the Progression of Intraluminal Pulmonary Vein Stenosis;COMPLETED;['PHASE1', 'PHASE2'];INTERVENTIONAL;50.0;['Pulmonary Veno Occlusive Disease']
NCT00569127;Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor;ACTIVE_NOT_RECRUITING;['PHASE3'];INTERVENTIONAL;427.0;['Carcinoid Tumor', 'Colorectal Neuroendocrine Tumor G1', 'Gastric Neuroendocrine Tumor G1', 'Neuroendocrine Neoplasm', 'Neuroendocrine Tumor G2']
NCT00538005;Sorafenib, Bevacizumab, and Oxaliplatin in Treating Patients With Metastatic Malignant Melanoma;UNKNOWN;['PHASE1', 'PHASE2'];INTERVENTIONAL;54.0;['Melanoma (Skin)']
NCT01582152;Phase I/II Bevacizumab Versus Bevacizumab Plus TPI 287 for Recurrent Glioblastoma;TERMINATED;['PHASE1', 'PHASE2'];INTERVENTIONAL;12.0;['Brain Neoplasms', 'Central Nervous System Neoplasms']
NCT00626405;Bevacizumab and Temozolomide or Bevacizumab and Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed by Surgery;COMPLETED;['PHASE2'];INTERVENTIONAL;95.0;['Melanoma (Skin)']
NCT00405405;Phase I of Biologics and Chemoradiation Therapy for Advanced Head and Neck Cancer;COMPLETED;['PHASE1'];INTERVENTIONAL;13.0;['Head and Neck Cancer', 'Parotid Gland Cancer', 'Thyroid Gland Cancer', 'Melanoma', 'Stage IV Head and Neck Cancer']
NCT00234052;Carboplatin, Pemetrexed Disodium, and Bevacizumab in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;51.0;['Lung Cancer']
NCT05109052;Trial of PXS-5505 Combined With First Line Atezolizumab Plus Bevacizumab For Treating Patients With Unresectable Hepatocellular Carcinoma;WITHDRAWN;['PHASE1', 'PHASE2'];INTERVENTIONAL;0.0;['Hepatocellular Carcinoma', 'Cancer of Liver']
NCT00943826;A Study of Bevacizumab (AvastinÂ®) in Combination With Temozolomide and Radiotherapy in Participants With Newly Diagnosed Glioblastoma;COMPLETED;['PHASE3'];INTERVENTIONAL;921.0;['Glioblastoma']
NCT05249426;A Study to Test Whether Different Combinations of BI 765063, Ezabenlimab, Chemotherapy, Cetuximab, and BI 836880 Help People With Head and Neck Cancer or Liver Cancer;RECRUITING;['PHASE1'];INTERVENTIONAL;45.0;['Head and Neck Squamous Cell Carcinoma (HNSCC)']
NCT05281471;Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Platinum-doublet + Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (OnPrime, GOG-3076);RECRUITING;['PHASE3'];INTERVENTIONAL;186.0;['Platinum-resistant Ovarian Cancer', 'Platinum-refractory Ovarian Cancer', 'Fallopian Tube Cancer', 'Primary Peritoneal Cancer', 'High-grade Serous Ovarian Cancer', 'Endometrioid Ovarian Cancer', 'Ovarian Clear Cell Carcinoma']
NCT01871571;Bevacizumab, Fluorouracil, Leucovorin Calcium, and Oxaliplatin Before Surgery in Treating Patients With Stage II-III Rectal Cancer;ACTIVE_NOT_RECRUITING;['PHASE2'];INTERVENTIONAL;17.0;['Mucinous Adenocarcinoma of the Rectum', 'Signet Ring Adenocarcinoma of the Rectum', 'Stage IIA Rectal Cancer', 'Stage IIB Rectal Cancer', 'Stage IIC Rectal Cancer', 'Stage IIIA Rectal Cancer', 'Stage IIIB Rectal Cancer', 'Stage IIIC Rectal Cancer']
NCT01121939;Combination of Bevacizumab, Pertuzumab, and Sandostatin for Adv. Neuroendocrine Cancers;COMPLETED;['PHASE2'];INTERVENTIONAL;43.0;['Neuroendocrine Carcinoma']
NCT04524871;A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Advanced Liver Cancers (Morpheus-Liver);RECRUITING;['PHASE1', 'PHASE2'];INTERVENTIONAL;400.0;['Advanced Liver Cancers']
NCT01339039;Plerixafor (AMD3100) and Bevacizumab for Recurrent High-Grade Glioma;TERMINATED;['PHASE1'];INTERVENTIONAL;26.0;['High Grade Glioma: Glioblastoma (GBM)', 'High Grade Glioma: Gliosarcoma', 'Anaplastic Astrocytoma (AA)', 'Anaplastic Oligodendroglioma (AO)', 'Mixed Anaplastic Oligoastrocytoma (AOA)']
NCT02663271;TTFields and Pulsed Bevacizumab for Recurrent Glioblastoma;TERMINATED;['PHASE2'];INTERVENTIONAL;10.0;['Glioblastoma Multiforme', 'Glioblastoma', 'Malignant Glioma', 'GBM']
NCT02794571;Safety and Pharmacokinetics (PK) of Escalating Doses of Tiragolumab as a Single Agent and in Combination With Atezolizumab and/or Other Anti-Cancer Therapies in Locally Advanced or Metastatic Tumors;ACTIVE_NOT_RECRUITING;['PHASE1'];INTERVENTIONAL;518.0;['Advanced/Metastatic Tumors']
NCT05620771;TherasphereÂ® and Systemic Therapy for Patients With Hepatocellular Carcinoma That is High-risk;RECRUITING;['PHASE2'];INTERVENTIONAL;84.0;['Hepatocellular Carcinoma']
NCT00127920;Pilot Study of Taxol, Carboplatin, and Bevacizumab in Advanced Stage Ovarian Carcinoma Patients;COMPLETED;['PHASE2'];INTERVENTIONAL;20.0;['Ovarian Neoplasms']
NCT00906516;NeuradiabÂ® Combined With Bevacizumab (Avastin) Therapy in Patients With Recurrent Glioblastoma Multiforme;UNKNOWN;['PHASE2'];INTERVENTIONAL;60.0;['Brain Tumors']
NCT01086345;Radiosurgery Plus Bevacizumab in Glioblastoma;TERMINATED;['EARLY_PHASE1'];INTERVENTIONAL;9.0;['Glioblastoma', 'Gliosarcoma', 'Brain Tumor']
NCT00876993;Study of Irinotecan and Bevacizumab With Temozolomide in Refractory/Relapsed Central Nervous System (CNS) Tumors;COMPLETED;['PHASE1'];INTERVENTIONAL;26.0;['Central Nervous System Tumors']
NCT00845039;A Study of Irinotecan and Cetuximab With or Without IMC-A12 for Treatment of Participants With Colon or Rectum Cancer Who Got Worse After Their First Treatment With Oxaliplatin and Bevacizumab;TERMINATED;['PHASE2'];INTERVENTIONAL;4.0;['Colon Cancer', 'Rectal Cancer']
NCT01433991;A Study of E7050 in Combination With E7080 in Participants With Advanced Solid Tumors (Dose Escalation) and in Participants With Recurrent Glioblastoma or Unresectable Stage III or Stage IV Melanoma After Prior Systemic Therapy (Expansion Cohort and Phase 2);TERMINATED;['PHASE1', 'PHASE2'];INTERVENTIONAL;30.0;['Advanced Solid Tumors']
NCT04753216;Irinotecan Liposome and Bevacizumab for the Treatment of Platinum Resistant, Recurrent, or Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;3.0;['Platinum-Resistant Fallopian Tube Carcinoma', 'Platinum-Resistant Ovarian Carcinoma', 'Platinum-Resistant Primary Peritoneal Carcinoma', 'Recurrent Fallopian Tube Carcinoma', 'Recurrent Ovarian Carcinoma', 'Recurrent Primary Peritoneal Carcinoma', 'Refractory Fallopian Tube Carcinoma', 'Refractory Ovarian Carcinoma', 'Refractory Primary Peritoneal Carcinoma']
NCT00390416;Study of Docetaxel, Cisplatin, and Fluorouracil (Modified DCF) With Bevacizumab in Patients With Unresectable or Metastatic Gastroesophageal Adenocarcinoma;COMPLETED;['PHASE2'];INTERVENTIONAL;48.0;['Stomach Neoplasms', 'Esophageal Neoplasms']
NCT00651482;Treatment of Refractory Metastatic Renal Cell Carcinoma With Bevacizumab and RAD001 (Everolimus);TERMINATED;['PHASE2'];INTERVENTIONAL;10.0;['Kidney Neoplasms', 'Kidney (Renal Cell) Cancer']
NCT00394082;ABI-007 In Combination With Bevacizumab in Women With Metastatic Breast Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;50.0;['Metastatic Breast Cancer']
NCT01380782;BIBF 1120 for Recurrent High-Grade Gliomas;COMPLETED;['PHASE2'];INTERVENTIONAL;37.0;['Glioblastoma', 'Gliosarcoma', 'Anaplastic Astrocytoma', 'Anaplastic Oligodendroglioma', 'Anaplastic Oligoastrocytoma']
NCT01765582;Sequential and Concurrent FOLFOXIRI/Bevacizumab Regimens Versus FOLFOX/Bevacizumab in First-Line Metastatic Colorectal Cancer;TERMINATED;['PHASE2'];INTERVENTIONAL;280.0;['Colorectal Neoplasms']
NCT04486352;A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer;RECRUITING;['PHASE1', 'PHASE2'];INTERVENTIONAL;148.0;['Endometrial Cancer']
NCT00410605;Bevacizumab, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Stage II or III Multiple Myeloma;COMPLETED;['PHASE2'];INTERVENTIONAL;39.0;['Multiple Myeloma in Relapse', 'Stage II Multiple Myeloma', 'Stage III Multiple Myeloma']
NCT02076152;FMISO PET Study of Glioblastoma;COMPLETED;['NA'];INTERVENTIONAL;11.0;['Recurrent Glioblastoma']
NCT03178552;A Study to Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC);RECRUITING;['PHASE2', 'PHASE3'];INTERVENTIONAL;1000.0;['Non-Small Cell Lung Cancer']
NCT00407563;Bevacizumab With Abraxane in Patients With Recurrent Ovarian/ Peritoneal Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;48.0;['Epithelial Ovarian Cancer', 'Primary Peritoneal Carcinoma']
NCT00118105;S0408: Capecitabine, Oxaliplatin, and Bevacizumab in Pts Undergoing Surgery for Liver Mets From Colorectal Cancer;WITHDRAWN;['PHASE2'];INTERVENTIONAL;0.0;['Colorectal Cancer', 'Metastatic Cancer']
NCT02574663;TGR-1202 Alone and in Combination With Either Nab-paclitaxel + Gemcitabine or With FOLFOX in Patients With Select Relapsed or Refractory Solid Tumors;COMPLETED;['PHASE1'];INTERVENTIONAL;66.0;['Pancreatic Cancer', 'Colorectal Cancer', 'Rectal Cancer', 'Gastric Cancer', 'Esophageal Cancer', 'Gastrointestinal Stromal Tumor (GIST)']
NCT00955305;Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer;TERMINATED;['PHASE2'];INTERVENTIONAL;175.0;['Large Cell Lung Carcinoma', 'Lung Adenocarcinoma', 'Recurrent Non-Small Cell Lung Carcinoma', 'Stage IV Non-Small Cell Lung Cancer', 'Bronchioloalveolar Lung Carcinoma']
NCT01627249;Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema;COMPLETED;['PHASE3'];INTERVENTIONAL;660.0;['Diabetic Macular Edema']
NCT01972763;Ranibizumab for Recalcitrant Wet Age-related Macular Degeneration in Eyes Previously Switched From Bevacizumab and/or Ranibizumab to Aflibercept.;COMPLETED;['PHASE1', 'PHASE2'];INTERVENTIONAL;12.0;['Recalcitrant Wet Age-related Macular Degeneration']
NCT05063552;Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers;RECRUITING;['PHASE2', 'PHASE3'];INTERVENTIONAL;430.0;['Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8', 'Metastatic Head and Neck Squamous Cell Carcinoma', 'Metastatic Hypopharyngeal Squamous Cell Carcinoma', 'Metastatic Laryngeal Squamous Cell Carcinoma', 'Metastatic Lip and Oral Cavity Carcinoma', 'Metastatic Nasal Cavity Squamous Cell Carcinoma', 'Metastatic Nasopharyngeal Squamous Cell Carcinoma', 'Metastatic Pharyngeal Squamous Cell Carcinoma', 'Metastatic Sinonasal Squamous Cell Carcinoma', 'Recurrent Head and Neck Squamous Cell Carcinoma', 'Recurrent Hypopharyngeal Squamous Cell Carcinoma', 'Recurrent Laryngeal Squamous Cell Carcinoma', 'Recurrent Lip and Oral Cavity Squamous Cell Carcinoma', 'Recurrent Nasopharyngeal Squamous Cell Carcinoma', 'Recurrent Pharyngeal Squamous Cell Carcinoma', 'Recurrent Sinonasal Squamous Cell Carcinoma', 'Stage IV Hypopharyngeal Carcinoma AJCC v8', 'Stage IV Laryngeal Cancer AJCC v8', 'Stage IV Lip and Oral Cavity Cancer AJCC v8', 'Stage IV Nasopharyngeal Carcinoma AJCC v8', 'Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8', 'Stage IV Sinonasal Cancer AJCC v8']
NCT05185505;Atezolizumab and Bevacizumab Pre-Liver Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria;RECRUITING;['PHASE4'];INTERVENTIONAL;24.0;['Hepatocellular Carcinoma', 'Hepatocellular Cancer']
NCT00636805;Aloxi for Prevention of Chemotherapy Induced Nausea and Vomiting in Malignant Glioma Patients Receiving Irinotecan With Bevacizumab;TERMINATED;['PHASE2'];INTERVENTIONAL;63.0;['Brain Cancer']
NCT02511405;A Phase 3, Pivotal Trial of VB-111 Plus Bevacizumab vs. Bevacizumab in Patients With Recurrent Glioblastoma (GLOBE);COMPLETED;['PHASE3'];INTERVENTIONAL;252.0;['Glioblastoma']
NCT03555149;A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Metastatic Colorectal Cancer (Morpheus-CRC);TERMINATED;['PHASE1', 'PHASE2'];INTERVENTIONAL;96.0;['Colorectal Cancer']
NCT01007552;A Study of Gemcitabine, Capecitabine and Bevacizumab to Treat Cancer of the Gall Bladder or Bile Ducts;COMPLETED;['PHASE2'];INTERVENTIONAL;50.0;['Cholangiocarcinoma']
NCT02606305;Study of Mirvetuximab Soravtansine in Combination With Bevacizumab, Carboplatin, Pegylated Liposomal Doxorubicin, Pembrolizumab, or Bevacizumab + Carboplatin in Participants With Folate Receptor Alpha (FRÎ±) Positive Advanced Epithelial Ovarian Cancer, Primary Peritoneal, or Fallopian Tube Cancer;COMPLETED;['PHASE1', 'PHASE2'];INTERVENTIONAL;264.0;['Epithelial Ovarian Cancer', 'Primary Peritoneal Cancer', 'Fallopian Tube Cancer']
NCT01989052;Ph 1/2 CTO With Lomustine for Bevacizumab-Naive Recurrent Glioma;TERMINATED;['PHASE1'];INTERVENTIONAL;9.0;['Malignant Glioma (WHO Grade III or IV)']
NCT00403052;A Study of 1018 Immunostimulatory Sequence (ISS) Administered With Irinotecan and Cetuximab to Treat Patients With Previously Treated Metastatic Colorectal Cancer;TERMINATED;['PHASE1'];INTERVENTIONAL;14.0;['Colorectal Neoplasms']
NCT00271505;Avastin/Docetaxel/Carboplatin in Non-Small Cell Lung Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;43.0;['Non-Small Cell Lung Cancer']
NCT01736449;Role of Sub-Conjunctival Bevacizumab in Post Pterygium Excision Management;COMPLETED;['PHASE4'];INTERVENTIONAL;31.0;['Pterygium']
NCT00932152;Fulvestrant and Anastrozole as Consolidation Therapy in Postmenopausal Women With Advanced Non-small Cell Lung Cancer;TERMINATED;['PHASE2'];INTERVENTIONAL;3.0;['Non-small Cell Lung Cancer', 'Postmenopausal Women']
NCT00925652;Bevacizumab, Metronomic Chemotherapy (CM), Diet and Exercise After Preoperative Chemotherapy for Breast Cancer;TERMINATED;['PHASE2'];INTERVENTIONAL;55.0;['Breast Cancer']
NCT02343549;A Phase II Study of Optune (NovoTTF) in Combination With Bevacizumab (BEV) and Temozolomide (TMZ) in Patients With Newly Diagnosed Unresectable Glioblastoma (GBM);TERMINATED;['PHASE2'];INTERVENTIONAL;13.0;['Cancer of Brain and Nervous System']
NCT00324805;Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery;ACTIVE_NOT_RECRUITING;['PHASE3'];INTERVENTIONAL;1501.0;['Stage IB Lung Non-Small Cell Carcinoma AJCC v7', 'Stage IIA Lung Non-Small Cell Carcinoma AJCC v7', 'Stage IIB Lung Non-Small Cell Carcinoma AJCC v7', 'Stage IIIA Lung Non-Small Cell Cancer AJCC v7']
NCT00226005;PTK787 in Patients With Advanced Metastatic Pancreatic Adenocarcinoma;COMPLETED;['PHASE2'];INTERVENTIONAL;67.0;['Neoplasm']
NCT00370552;A Trial of 2 Schedules of Ixabepilone Plus Bevacizumab and Paclitaxel Plus Bevacizumab for Breast Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;136.0;['Metastatic Breast Cancer']
NCT00578149;Bevacizumab and Carboplatin/Paclitaxel and Radiation in Non-Small Cell Lung Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;45.0;['Non-Small Cell Lung Cancer']
NCT04837716;Ensartinib, Carboplatin, Pemetrexed and Bevacizumab for the Treatment of Stage IIIC or IV or Recurrent ALK-Positive Non-small Cell Lung Cancer;ACTIVE_NOT_RECRUITING;['PHASE1'];INTERVENTIONAL;12.0;['Metastatic Lung Non-Small Cell Carcinoma', 'Recurrent Lung Non-Small Cell Carcinoma', 'Stage IIIC Lung Cancer AJCC v8', 'Stage IV Lung Cancer AJCC v8', 'Stage IVA Lung Cancer AJCC v8', 'Stage IVB Lung Cancer AJCC v8']
NCT00924820;A Pilot Study of Bevacizumab for Neoplastic Meningitis;COMPLETED;['PHASE1', 'PHASE2'];INTERVENTIONAL;20.0;['Neoplastic Meningitis']
NCT00769093;Assessing Dynamic Magnetic Resonance (MR) Imaging in Patients With Recurrent High Grade Glioma Receiving Chemotherapy;TERMINATED;['PHASE1'];INTERVENTIONAL;6.0;['Brain Neoplasms']
NCT00866320;Sorafenib in Treating Patients With Metastatic Kidney Cancer That Has Not Responded to Sunitinib or Bevacizumab;COMPLETED;['PHASE2'];INTERVENTIONAL;49.0;['Kidney Cancer']
NCT00296816;TEACO: Taxotere, Eloxatin, Avastin in Cancer of the Ovary;COMPLETED;['PHASE2'];INTERVENTIONAL;132.0;['Ovarian Cancer']
NCT00023920;Bevacizumab, Idarubicin, and Cytarabine in Treating Patients With Blast Phase Chronic Myelogenous Leukemia;TERMINATED;['PHASE2'];INTERVENTIONAL;60.0;['Blastic Phase Chronic Myelogenous Leukemia', 'Chronic Myelogenous Leukemia, BCR-ABL1 Positive']
NCT01525082;Capecitabine, Temozolomide, and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors;COMPLETED;['PHASE2'];INTERVENTIONAL;20.0;['Gastrinoma', 'Glucagonoma', 'Insulinoma', 'Pancreatic Polypeptide Tumor', 'Recurrent Islet Cell Carcinoma', 'Recurrent Pancreatic Cancer', 'Somatostatinoma', 'Stage III Pancreatic Cancer', 'Stage IV Pancreatic Cancer']
NCT02158520;Nab-Paclitaxel and Bevacizumab or Ipilimumab as First-Line Therapy in Treating Patients With Stage IV Melanoma That Cannot Be Removed by Surgery;COMPLETED;['PHASE2'];INTERVENTIONAL;24.0;['Metastatic Melanoma', 'Mucosal Melanoma', 'Stage IV Cutaneous Melanoma AJCC v6 and v7', 'Stage IV Uveal Melanoma AJCC v7', 'Unresectable Melanoma']
NCT00217282;Study of Oxaliplatin and Gemcitabine With or Without Bevacizumab to Treat Advanced Non-Small Cell Lung Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;45.0;['Non-Small Cell Lung Cancer']
NCT01263782;BATTLE-FL: Front-Line Biomarker-Integrated Treatment Study in Non Small Cell Lung Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;64.0;['Lung Cancer']
NCT00378703;Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;361.0;['Clear Cell Renal Cell Carcinoma', 'Recurrent Renal Cell Carcinoma', 'Stage IV Renal Cell Cancer AJCC v7']
NCT00400803;Carboplatin and Gemcitabine With Bevacizumab Every 2 Weeks for Stage IIIb/IV Non-small Cell Lung Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;38.0;['Carcinoma, Non-Small-Cell Lung']
NCT02285959;Super-Selective Intraarterial Intracranial Infusion of Bevacizumab (Avastin) for Glioblastoma Multiforme;RECRUITING;['PHASE1'];INTERVENTIONAL;30.0;['Glioblastoma Multiforme']
NCT00193154;OSI-774 and Bevacizumab in the Treatment of Patients With Metastatic Renal Cell Carcinoma;COMPLETED;['PHASE2'];INTERVENTIONAL;63.0;['Kidney Cancer']
NCT02389959;Intranasal Bevacizumab for HHT-Related Epistaxis;COMPLETED;['PHASE4'];INTERVENTIONAL;40.0;['HHT', 'Hereditary Hemorrhagic Telangiectasia', 'Epistaxis', 'Nose Bleeds', 'Nasal Bleeding']
NCT00295503;Cisplatin, Pemetrexed and Bevacizumab for Untreated Malignant Mesothelioma;COMPLETED;['PHASE2'];INTERVENTIONAL;53.0;['Mesothelioma']
NCT00217503;Bortezomib and Antiviral Therapy Followed By Effusion Drainage, Bevacizumab, and Combination Chemotherapy in Treating Patients With Primary Effusion Lymphoma;COMPLETED;['PHASE2'];INTERVENTIONAL;15.0;['Lymphoma']
NCT00642759;Carboplatin, Abraxane, and Bevacizumab in Previously Untreated Patients With Advanced Non-Small Cell Lung Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;36.0;['Non-small Cell Lung Cancer']
NCT02348359;X-82 to Treat Age-related Macular Degeneration;TERMINATED;['PHASE2'];INTERVENTIONAL;157.0;['Age-Related Macular Degeneration (AMD)', 'Macular Degeneration', 'Exudative Age-related Macular Degeneration', 'AMD', 'Macular Degeneration, Age-related, 10', 'Eye Diseases', 'Retinal Degeneration', 'Retinal Diseases']
NCT00460603;Study With AG-013736 Combined With Chemotherapy And Bevacizumab In Patients With Metastatic Colorectal Cancer;COMPLETED;['PHASE1', 'PHASE2'];INTERVENTIONAL;187.0;['Colorectal Neoplasms']
NCT01180959;Erlotinib Plus Bevacizumab in Hepatocellular Carcinoma (HCC) as Second-line Therapy;COMPLETED;['PHASE2'];INTERVENTIONAL;45.0;['Liver Cancer']
NCT01048554;Temozolomide Plus Bevacizumab in Patients With Metastatic Melanoma Involving the Central Nervous System;COMPLETED;['PHASE2'];INTERVENTIONAL;34.0;['Melanoma']
NCT01721954;FOLFOX6m Plus SIR-Spheres Microspheres vs FOLFOX6m Alone in Patients With Liver Mets From Primary Colorectal Cancer;COMPLETED;['PHASE3'];INTERVENTIONAL;209.0;['Colorectal Cancer Metastatic']
NCT00268359;Bevacizumab and Irinotecan in Treating Patients With Recurrent or Refractory Gliomas;COMPLETED;['PHASE2'];INTERVENTIONAL;68.0;['Brain and Central Nervous System Tumors']
NCT00106054;Neoadjuvant Colorectal Cancer With Unresectable Liver Metastases;TERMINATED;['PHASE2'];INTERVENTIONAL;2.0;['Colorectal Neoplasms', 'Liver Neoplasms']
NCT02803203;Osimertinib and Bevacizumab as Treatment for EGFR-mutant Lung Cancers;COMPLETED;['PHASE1', 'PHASE2'];INTERVENTIONAL;49.0;['Non-small Cell Lung Cancer', 'EGFR-mutant Lung Cancers']
NCT00027703;Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant Mesothelioma;COMPLETED;['PHASE2'];INTERVENTIONAL;106.0;['Advanced Malignant Mesothelioma', 'Epithelial Mesothelioma', 'Localized Malignant Mesothelioma', 'Recurrent Malignant Mesothelioma', 'Sarcomatous Mesothelioma']
NCT01322815;A Pilot Trial of GI-4000 Plus Bevacizumab and Either FOLFOX or FOLFIRI;TERMINATED;['PHASE2'];INTERVENTIONAL;11.0;['Colon Cancer']
NCT00184015;"Bortezomib and Bevacizumab (""BB-mib-mab"") in Patients With Advanced or Recurrent Renal Cell Cancer (RCC)";UNKNOWN;['PHASE1', 'PHASE2'];INTERVENTIONAL;50.0;['Renal Cell Cancer']
NCT01367275;Irinotecan Plus Brivanib in Metastatic Colorectal Cancer (CRC) Enriched for Elevated Levels of Plasma FGF;TERMINATED;['PHASE2'];INTERVENTIONAL;8.0;['Colorectal Cancer', 'Colorectal Adenocarcinoma']
NCT00313768;Randomized Ph 2 Trial Of Paclitaxel/Carboplatin /Bevacizumab + PF-3512676 And P/C/B Alone In Advanced Nonsquamous NSCLC;TERMINATED;['PHASE2'];INTERVENTIONAL;23.0;['Carcinoma, Non-Small-Cell Lung']
NCT01933815;Dose-Escalation Study of TPI 287 + Avastin Followed by Randomized Study of the Same Versus Avastin for Glioblastoma;SUSPENDED;['PHASE1', 'PHASE2'];INTERVENTIONAL;92.0;['Glioblastoma Multiforme']
NCT02661815;A Phase 1b Study of Paclitaxel And Ricolinostat For The Treatment Of Gynecological Cancer;TERMINATED;['PHASE1'];INTERVENTIONAL;6.0;['Ovarian Cancer', 'Fallopian Tube Cancer', 'Primary Peritoneal Carcinoma']
NCT01182350;Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG);TERMINATED;['PHASE2'];INTERVENTIONAL;53.0;['Diffuse Intrinsic Pontine Glioma']
NCT03450850;Study Of NOVOTTF-200A In Bevacizumab-Naive Subjects With Recurrent Grade III Malignant Astrocytoma;ACTIVE_NOT_RECRUITING;['NA'];INTERVENTIONAL;34.0;['Astrocytoma, Grade III']
NCT00334815;Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery;ACTIVE_NOT_RECRUITING;['PHASE2'];INTERVENTIONAL;29.0;['Lung Adenocarcinoma', 'Lung Adenosquamous Carcinoma', 'Lung Large Cell Carcinoma', 'Lung Squamous Cell Carcinoma', 'Minimally Invasive Lung Adenocarcinoma', 'Stage IIIA Lung Non-Small Cell Cancer AJCC v7', 'Stage IIIB Lung Non-Small Cell Cancer AJCC v7']
NCT00948675;Study of Participants With Advanced Non-Small Cell Lung Cancer;COMPLETED;['PHASE3'];INTERVENTIONAL;361.0;['Advanced Non-Small Cell Lung Cancer']
NCT05053750;TAME: A Pilot Study of Weekly Paclitaxel, Bevacizumab, and Tumor Associated Macrophage Targeted Therapy (Zoledronic Acid) in Women With Recurrent, Platinum-resistant, Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer;ACTIVE_NOT_RECRUITING;['EARLY_PHASE1'];INTERVENTIONAL;14.0;['Epithelial Ovarian', 'Fallopian Tube', 'Primary Peritoneal Cancer']
NCT03149575;VAL-083 Phase 3 Study in Temozolomide-Avastin (Bevacizumab) Recurrent GBM;TERMINATED;['PHASE3'];INTERVENTIONAL;2.0;['Glioblastoma Multiforme', 'Glioblastoma', 'Glioma', 'GBM', 'Brain Cancer']
NCT00107315;Bevacizumab and Capecitabine as First-Line Therapy in Treating Older Patients With Metastatic Colorectal Cancer;TERMINATED;['PHASE2'];INTERVENTIONAL;16.0;['Colorectal Cancer']
NCT00290615;Capecitabine, Cetuximab, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal Cancer That Cannot Be Removed By Surgery;COMPLETED;['PHASE2'];INTERVENTIONAL;30.0;['Colorectal Cancer']
NCT01730950;Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma;COMPLETED;['PHASE2'];INTERVENTIONAL;182.0;['Adult Giant Cell Glioblastoma', 'Adult Glioblastoma', 'Adult Gliosarcoma', 'Recurrent Adult Brain Tumor']
NCT00280150;Combination Chemotherapy, Bev, RT, and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer;COMPLETED;['PHASE1', 'PHASE2'];INTERVENTIONAL;46.0;['Lung Cancer']
NCT00593450;Comparison of Age-related Macular Degeneration Treatments Trials: Lucentis-Avastin Trial;COMPLETED;['PHASE3'];INTERVENTIONAL;1208.0;['Age Related Macular Degeneration']
NCT00655850;Lower Dose Chemotherapy Given More Frequent With Avastin to Treat Advanced Non-Squamous Non-Small Cell Lung Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;39.0;['Non-Small Cell Lung Cancer']
NCT02229175;Laser vs Bevacizumab Injection Alone in Treatment of Diabetic Macular Edema;WITHDRAWN;['PHASE2', 'PHASE3'];INTERVENTIONAL;0.0;['Diabetic Macular Edema']
NCT00520975;Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU;TERMINATED;['PHASE3'];INTERVENTIONAL;96.0;['Breast Carcinoma', 'Recurrent Breast Carcinoma', 'Stage IV Breast Cancer']
NCT00455975;High-dose Bevacizumab in Advanced Renal Carcinoma Patients;COMPLETED;['PHASE2'];INTERVENTIONAL;119.0;['Renal Cancer', 'Kidney Cancer']
NCT01222715;Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma;COMPLETED;['PHASE2'];INTERVENTIONAL;87.0;['Adult Rhabdomyosarcoma', 'Childhood Alveolar Rhabdomyosarcoma', 'Childhood Pleomorphic Rhabdomyosarcoma', 'Childhood Rhabdomyosarcoma With Mixed Embryonal and Alveolar Features', 'Previously Treated Childhood Rhabdomyosarcoma', 'Recurrent Adult Soft Tissue Sarcoma', 'Recurrent Childhood Rhabdomyosarcoma']
NCT01937715;A Study Of PF-05212384 Plus FOLFIRI Versus Bevacizumab Plus FOLFIRI In Metastatic Colorectal Cancer;TERMINATED;['PHASE1', 'PHASE2'];INTERVENTIONAL;18.0;['Metastatic Colorectal Carcinoma']
NCT00265850;Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer;COMPLETED;['PHASE3'];INTERVENTIONAL;2334.0;['Colorectal Cancer']
NCT00399750;TREE-2: Three Regimens of Eloxatin in Advanced Colorectal Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;373.0;['Colorectal Cancer']
NCT00368875;Phase I-II Study of Vorinostat, Paclitaxel, and Bevacizumab in Metastatic Breast Cancer;COMPLETED;['PHASE1', 'PHASE2'];INTERVENTIONAL;54.0;['Male Breast Cancer', 'Stage IIIB Breast Cancer', 'Stage IIIC Breast Cancer', 'Stage IV Breast Cancer']
NCT04551950;Bintrafusp Alfa Combination Therapy in Participants With Cervical Cancer (INTR@PID 046);COMPLETED;['PHASE1'];INTERVENTIONAL;25.0;['Cervical Cancer']
NCT00052559;Bevacizumab, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer;COMPLETED;['PHASE1'];INTERVENTIONAL;32.0;['Adenocarcinoma of the Rectum', 'Stage II Rectal Cancer', 'Stage III Rectal Cancer']
NCT01220154;Study of Intraperitoneal Carboplatin With IV Paclitaxel and Bevacizumab in Untreated Ovarian Cancer;UNKNOWN;['PHASE1'];INTERVENTIONAL;9.0;['Ovarian Cancer', 'Fallopian Tube Cancer', 'Primary Peritoneal Cancer', 'No Prior Chemotherapy']
NCT03368859;A Study of ABT-165 Plus FOLFIRI vs Bevacizumab Plus FOLFIRI in Subjects With Metastatic Colorectal Cancer Previously Treated With Fluoropyrimidine, Oxaliplatin and Bevacizumab;TERMINATED;['PHASE2'];INTERVENTIONAL;70.0;['Cancer']
NCT00675259;Phase II NCT (Neoadjuvant Chemotherapy) w/ Weekly Abraxane in Combination With Carboplatin & Bevacizumab in Breast Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;33.0;['Breast Cancer']
NCT03376659;Durvalumab Plus CV301 With Maintenance Chemotherapy in Metastatic Colorectal or Pancreatic Adenocarcinoma;TERMINATED;['PHASE1', 'PHASE2'];INTERVENTIONAL;8.0;['Metastatic Colorectal Cancer', 'Colorectal Adenocarcinoma', 'Pancreatic Adenocarcinoma', 'Metastatic Pancreatic Cancer']
NCT05775159;Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer;RECRUITING;['PHASE2'];INTERVENTIONAL;260.0;['Hepatocellular Carcinoma', 'Biliary Tract Cancer']
NCT00304954;Infliximab, Sirolimus and Daclizumab to Treat Age-Related Macular Degeneration;COMPLETED;['PHASE2'];INTERVENTIONAL;13.0;['Age-Related Macular Degeneration', 'Choroidal Neovascularization']
NCT05468359;Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients;RECRUITING;['PHASE1', 'PHASE2'];INTERVENTIONAL;64.0;['Refractory Solid Tumor', 'Hepatocellular Carcinoma', 'Malignant Solid Tumor', 'Pediatric Cancer', 'Pediatric Solid Tumor', 'Fibrolamellar Carcinoma']
NCT00661154;Avastin/[18-F]-5-fluorouracil PET/CT Imaging Feasibility Project;COMPLETED;;OBSERVATIONAL;7.0;['Colorectal Neoplasms', 'Colon Cancer', 'Rectal Cancer', 'Anal Cancer']
NCT02698254;Radiation Therapy in Treating Patients With Recurrent Brain Tumors Who Have Undergone Previous Radiation Therapy;ACTIVE_NOT_RECRUITING;['NA'];INTERVENTIONAL;40.0;['Recurrent Brain Neoplasm']
NCT00511459;Phase 2 Study of AMG 386 Plus Paclitaxel With or Without Bevacizumab as First Line Therapy in Her2-Negative Breast Cancer Patients;COMPLETED;['PHASE2'];INTERVENTIONAL;228.0;['Locally Recurrent and Metastatic Breast Cancer']
NCT00419159;Efficacy and Safety of Everolimus in Patients With Metastatic Colorectal Cancer Who Have Failed Prior Targeted Therapy and Chemotherapy;COMPLETED;['PHASE2'];INTERVENTIONAL;199.0;['Colorectal Cancer']
NCT00879359;Trial of Vascular Endothelial Growth Factor (VEGF), Bevacizumab, in Combination With Cytotoxic Chemotherapy for Endometrial Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;15.0;['Endometrial Carcinoma']
NCT00022659;Bevacizumab in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;64.0;['Primary Peritoneal Cavity Cancer', 'Recurrent Ovarian Epithelial Cancer', 'Stage IV Ovarian Epithelial Cancer']
NCT01262859;Pilot Study for Locally Advanced Head and Neck Cancer;WITHDRAWN;['PHASE2'];INTERVENTIONAL;0.0;['Head and Neck Neoplasms']
NCT02096354;A Phase 2 Randomized, Open-Label Study of RRx-001 vs Regorafenib in Subjects With Metastatic Colorectal Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;57.0;['Colorectal Neoplasms']
NCT03798626;Gevokizumab With Standard of Care Anti-cancer Therapies for Metastatic Colorectal, Gastroesophageal, and Renal Cancers;ACTIVE_NOT_RECRUITING;['PHASE1'];INTERVENTIONAL;167.0;['Colorectal Cancer', 'Gastroesophageal Cancer', 'Renal Cell Carcinoma']
NCT00062426;Oxaliplatin and Bevacizumab (Avastinâ¢) With Either Fluorouracil and Leucovorin or Capecitabine in Treating Patients With Advanced Colorectal Cancer;COMPLETED;['PHASE3'];INTERVENTIONAL;;['Colorectal Cancer']
NCT00091026;Bevacizumab and Gemcitabine Combined With Either Cetuximab or Erlotinib in Treating Patients With Advanced Pancreatic Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;143.0;['Adenocarcinoma of the Pancreas', 'Recurrent Pancreatic Cancer', 'Stage II Pancreatic Cancer', 'Stage III Pancreatic Cancer', 'Stage IV Pancreatic Cancer']
NCT01010126;Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;252.0;['Adult Hepatocellular Carcinoma', 'Advanced Adult Hepatocellular Carcinoma', 'Endometrial Serous Adenocarcinoma', 'Localized Non-Resectable Adult Liver Carcinoma', 'Lung Carcinoid Tumor', 'Malignant Pancreatic Gastrinoma', 'Malignant Pancreatic Glucagonoma', 'Malignant Pancreatic Insulinoma', 'Malignant Pancreatic Somatostatinoma', 'Metastatic Digestive System Neuroendocrine Tumor G1', 'Ovarian Carcinosarcoma', 'Ovarian Endometrioid Adenocarcinoma', 'Ovarian Seromucinous Carcinoma', 'Ovarian Serous Surface Papillary Adenocarcinoma', 'Pancreatic Alpha Cell Adenoma', 'Pancreatic Beta Cell Adenoma', 'Pancreatic Delta Cell Adenoma', 'Pancreatic G-Cell Adenoma', 'Pancreatic Polypeptide Tumor', 'Recurrent Adult Liver Carcinoma', 'Recurrent Digestive System Neuroendocrine Tumor G1', 'Recurrent Fallopian Tube Carcinoma', 'Recurrent Ovarian Carcinoma', 'Recurrent Pancreatic Neuroendocrine Carcinoma', 'Recurrent Primary Peritoneal Carcinoma', 'Recurrent Uterine Corpus Carcinoma', 'Regional Digestive System Neuroendocrine Tumor G1', 'Stage IIIA Fallopian Tube Cancer', 'Stage IIIA Ovarian Cancer', 'Stage IIIA Primary Peritoneal Cancer', 'Stage IIIA Uterine Corpus Cancer', 'Stage IIIB Fallopian Tube Cancer', 'Stage IIIB Ovarian Cancer', 'Stage IIIB Primary Peritoneal Cancer', 'Stage IIIB Uterine Corpus Cancer', 'Stage IIIC Fallopian Tube Cancer', 'Stage IIIC Ovarian Cancer', 'Stage IIIC Primary Peritoneal Cancer', 'Stage IIIC Uterine Corpus Cancer', 'Stage IV Fallopian Tube Cancer', 'Stage IV Ovarian Cancer', 'Stage IV Primary Peritoneal Cancer', 'Stage IVA Uterine Corpus Cancer', 'Stage IVB Uterine Corpus Cancer', 'Uterine Carcinosarcoma']
NCT00885326;N2007-02:Bevacizumab,Cyclophosphamide,& Zoledronic Acid in Patients W/ Recurrent or Refractory High-Risk Neuroblastoma;COMPLETED;['PHASE1'];INTERVENTIONAL;29.0;['Neuroblastoma']
NCT01107626;Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer;COMPLETED;['PHASE3'];INTERVENTIONAL;1516.0;['Lung Cancer']
NCT02386826;INC280 Combined With Bevacizumab in Patients With Glioblastoma Multiforme;COMPLETED;['PHASE1'];INTERVENTIONAL;65.0;['Glioblastoma Multiforme', 'Gliosarcoma', 'Colorectal Cancer', 'Renal Cell Carcinoma']
NCT03768063;A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study;RECRUITING;['PHASE3'];INTERVENTIONAL;1000.0;['Cancer']
NCT05075993;Study of LVGN3616 and LVGN6051Â±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid Tumors;RECRUITING;['PHASE1'];INTERVENTIONAL;352.0;['Metastatic Esophageal', 'Gastric Cancer', 'Metastatic Head and Neck Carcinoma', 'Metastatic Hepatocellular Carcinoma', 'Metastatic HPV Related Solid Tumors', 'Metastatic Ovarian Carcinoma', 'Metastatic Soft Tissue Sarcoma', 'Metastatic Uveal Melanoma']
NCT03280563;A Study of Multiple Immunotherapy-Based Treatment Combinations in Hormone Receptor (HR)-Positive Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer;ACTIVE_NOT_RECRUITING;['PHASE1', 'PHASE2'];INTERVENTIONAL;138.0;['Breast Neoplasms']
NCT01052363;OXC401-PO1s/WVU 1309 - A Pilot Study of Fosbretabulin With Bevacizumab in Recurrent High-Grade Gliomas;WITHDRAWN;['PHASE1'];INTERVENTIONAL;0.0;['Central Nervous System Tumors']
NCT02436993;Phase II Breast Ca Carboplatin + Paclitaxel With Pertuzumab + Trastuzumab or Bevacizumab;ACTIVE_NOT_RECRUITING;['PHASE2'];INTERVENTIONAL;120.0;['Breast Carcinoma']
NCT05168163;Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer;RECRUITING;['PHASE2'];INTERVENTIONAL;122.0;['Locally Advanced Hepatocellular Carcinoma', 'Metastatic Hepatocellular Carcinoma', 'Stage III Hepatocellular Carcinoma AJCC v8', 'Stage IIIA Hepatocellular Carcinoma AJCC v8', 'Stage IIIB Hepatocellular Carcinoma AJCC v8', 'Stage IV Hepatocellular Carcinoma AJCC v8', 'Stage IVA Hepatocellular Carcinoma AJCC v8', 'Stage IVB Hepatocellular Carcinoma AJCC v8', 'Unresectable Hepatocellular Carcinoma']
NCT00615056;A Study Combining FOLFOX or FOLFIRI With AG-013736 or Bevacizumab (Avastin) in Patients With Metastatic Colorectal Cancer After Failure Of One First Line Regimen;COMPLETED;['PHASE2'];INTERVENTIONAL;171.0;['Colorectal Neoplasms']
NCT00126490;Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;19.0;['Recurrent Renal Cell Carcinoma', 'Stage IV Renal Cell Cancer']
NCT00028990;Paclitaxel With or Without Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer;COMPLETED;['PHASE3'];INTERVENTIONAL;722.0;['Breast Cancer']
NCT00023959;Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer;COMPLETED;['PHASE1'];INTERVENTIONAL;39.0;['Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma', 'Recurrent Adenoid Cystic Carcinoma of the Oral Cavity', 'Recurrent Basal Cell Carcinoma of the Lip', 'Recurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity', 'Recurrent Inverted Papilloma of the Paranasal Sinus and Nasal Cavity', 'Recurrent Lymphoepithelioma of the Nasopharynx', 'Recurrent Lymphoepithelioma of the Oropharynx', 'Recurrent Metastatic Squamous Neck Cancer With Occult Primary', 'Recurrent Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity', 'Recurrent Mucoepidermoid Carcinoma of the Oral Cavity', 'Recurrent Salivary Gland Cancer', 'Recurrent Squamous Cell Carcinoma of the Hypopharynx', 'Recurrent Squamous Cell Carcinoma of the Larynx', 'Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity', 'Recurrent Squamous Cell Carcinoma of the Nasopharynx', 'Recurrent Squamous Cell Carcinoma of the Oropharynx', 'Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity', 'Recurrent Verrucous Carcinoma of the Larynx', 'Recurrent Verrucous Carcinoma of the Oral Cavity', 'Stage III Adenoid Cystic Carcinoma of the Oral Cavity', 'Stage III Basal Cell Carcinoma of the Lip', 'Stage III Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity', 'Stage III Inverted Papilloma of the Paranasal Sinus and Nasal Cavity', 'Stage III Lymphoepithelioma of the Nasopharynx', 'Stage III Lymphoepithelioma of the Oropharynx', 'Stage III Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity', 'Stage III Mucoepidermoid Carcinoma of the Oral Cavity', 'Stage III Salivary Gland Cancer', 'Stage III Squamous Cell Carcinoma of the Hypopharynx', 'Stage III Squamous Cell Carcinoma of the Larynx', 'Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity', 'Stage III Squamous Cell Carcinoma of the Nasopharynx', 'Stage III Squamous Cell Carcinoma of the Oropharynx', 'Stage III Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity', 'Stage III Verrucous Carcinoma of the Larynx', 'Stage III Verrucous Carcinoma of the Oral Cavity', 'Stage IV Adenoid Cystic Carcinoma of the Oral Cavity', 'Stage IV Basal Cell Carcinoma of the Lip', 'Stage IV Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity', 'Stage IV Inverted Papilloma of the Paranasal Sinus and Nasal Cavity', 'Stage IV Lymphoepithelioma of the Nasopharynx', 'Stage IV Lymphoepithelioma of the Oropharynx', 'Stage IV Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity', 'Stage IV Mucoepidermoid Carcinoma of the Oral Cavity', 'Stage IV Salivary Gland Cancer', 'Stage IV Squamous Cell Carcinoma of the Hypopharynx', 'Stage IV Squamous Cell Carcinoma of the Larynx', 'Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity', 'Stage IV Squamous Cell Carcinoma of the Nasopharynx', 'Stage IV Squamous Cell Carcinoma of the Oropharynx', 'Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity', 'Stage IV Verrucous Carcinoma of the Larynx', 'Stage IV Verrucous Carcinoma of the Oral Cavity', 'Untreated Metastatic Squamous Neck Cancer With Occult Primary']
NCT05824559;ME-344 and Bevacizumab in Previously Treated Metastatic Colorectal Cancer;RECRUITING;['PHASE1'];INTERVENTIONAL;40.0;['Colorectal Cancer']
NCT02024607;A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Advanced Gastrointestinal Cancer;COMPLETED;['PHASE1', 'PHASE2'];INTERVENTIONAL;495.0;['Advanced Gastrointestinal Cancer']
NCT01212822;Bevacizumab and Combination Chemotherapy Before Surgery in Treating Patients With Locally Advanced Esophageal or Stomach Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;20.0;['Adenocarcinoma of the Esophagus', 'Adenocarcinoma of the Gastroesophageal Junction', 'Diffuse Adenocarcinoma of the Stomach', 'Intestinal Adenocarcinoma of the Stomach', 'Mixed Adenocarcinoma of the Stomach', 'Squamous Cell Carcinoma of the Esophagus', 'Stage IA Esophageal Cancer', 'Stage IA Gastric Cancer', 'Stage IB Esophageal Cancer', 'Stage IB Gastric Cancer', 'Stage IIA Esophageal Cancer', 'Stage IIA Gastric Cancer', 'Stage IIB Esophageal Cancer', 'Stage IIB Gastric Cancer', 'Stage IIIA Esophageal Cancer', 'Stage IIIA Gastric Cancer', 'Stage IIIB Esophageal Cancer', 'Stage IIIB Gastric Cancer', 'Stage IIIC Esophageal Cancer', 'Stage IIIC Gastric Cancer']
NCT00609622;Randomized Study Of Sunitinib Plus FOLFOX Versus Bevacizumab Plus FOLFOX In Metastatic Colorectal Cancer;TERMINATED;['PHASE2'];INTERVENTIONAL;191.0;['Colorectal Neoplasms']
NCT01015300;Bevacizumab (Avastin) in Unresectable/Recurrent Hemangioblastoma From Von-Hippel-Lindau Disease;TERMINATED;['EARLY_PHASE1'];INTERVENTIONAL;1.0;['Hemangioblastomas', 'Von Hippel Lindau Disease']
NCT00595322;Bevacizumab in the Radiation Treatment of Recurrent Malignant Glioma;COMPLETED;['NA'];INTERVENTIONAL;25.0;['Brain Cancer', 'Recurrent Malignant Gliomas', 'Primary Brain Tumor']
NCT00393497;A Pilot Study of VEGF Inhibition in Patients With Lymphedema Following Breast Cancer Treatment;COMPLETED;['PHASE1'];INTERVENTIONAL;11.0;['Breast Cancer', 'Lymphedema']
NCT00301990;Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer;UNKNOWN;['PHASE2'];INTERVENTIONAL;65.0;['Kidney Cancer']
NCT01012297;Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma;TERMINATED;['PHASE3'];INTERVENTIONAL;107.0;['Recurrent Uterine Corpus Sarcoma', 'Stage IIIA Uterine Sarcoma', 'Stage IIIB Uterine Sarcoma', 'Stage IIIC Uterine Sarcoma', 'Stage IVA Uterine Sarcoma', 'Stage IVB Uterine Sarcoma', 'Uterine Corpus Leiomyosarcoma']
NCT01604590;Imaging Biomarkers of Tissue Microstructure and Vasculature as Predictors of Glioblastoma Multiforme;COMPLETED;;OBSERVATIONAL;13.0;['Glioblastoma']
NCT00658697;Docetaxel, Bevacizumab and Androgen Deprivation Therapy After Definitive Local Therapy for Prostate Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;42.0;['Prostate Cancer']
NCT00070122;Combination Chemotherapy and Bevacizumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Colorectal Cancer;TERMINATED;['PHASE3'];INTERVENTIONAL;2200.0;['Adenocarcinoma of the Colon', 'Adenocarcinoma of the Rectum', 'Recurrent Colon Cancer', 'Recurrent Rectal Cancer', 'Stage III Colon Cancer', 'Stage III Rectal Cancer', 'Stage IV Colon Cancer', 'Stage IV Rectal Cancer']
NCT01700400;Study of Everolimus, Pemetrexed, Carboplatin, and Bevacizumab to Treat Stage IV Lung Cancer;COMPLETED;['PHASE1'];INTERVENTIONAL;13.0;['Non Small Cell Lung Cancer']
NCT00588900;Irinotecan and Cediranib in Treating Patients With Metastatic Colorectal Cancer That Did Not Respond to Previous Oxaliplatin, Fluoropyrimidine, and Bevacizumab;TERMINATED;['PHASE2'];INTERVENTIONAL;5.0;['Colorectal Cancer']
NCT01356290;Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma and ATRT;RECRUITING;['PHASE2'];INTERVENTIONAL;100.0;['Medulloblastoma Recurrent', 'Ependymoma Recurrent', 'ATRT Recurrent']
NCT03193190;A Study of Multiple Immunotherapy-Based Treatment Combinations in Participants With Metastatic Pancreatic Ductal Adenocarcinoma (Morpheus-Pancreatic Cancer);ACTIVE_NOT_RECRUITING;['PHASE1', 'PHASE2'];INTERVENTIONAL;340.0;['Pancreatic Adenocarcinoma']
NCT05322590;BXQ-350 in Newly Diagnosed Metastatic Colorectal Carcinoma;RECRUITING;['PHASE1', 'PHASE2'];INTERVENTIONAL;195.0;['Metastatic Colorectal Carcinoma', 'Neuropathy']
NCT02847559;Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma;RECRUITING;['PHASE2'];INTERVENTIONAL;27.0;['Anaplastic (Malignant) Meningioma', 'Atypical Meningioma', 'Grade II Meningioma', 'Grade III Meningioma', 'Recurrent Meningioma', 'Supratentorial Meningioma']
NCT01609790;Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumors;COMPLETED;['PHASE2'];INTERVENTIONAL;137.0;['Giant Cell Glioblastoma', 'Glioblastoma', 'Gliosarcoma', 'Oligodendroglioma', 'Recurrent Brain Neoplasm', 'Recurrent Glioblastoma']
NCT00782275;Avastin and Temsirolimus Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell Carcinoma;COMPLETED;['PHASE2'];INTERVENTIONAL;41.0;['Renal Cell Carcinoma', 'Kidney Cancer']
NCT01243359;Sunitinib Malate and Bevacizumab in Treating Patients With Kidney Cancer or Advanced Solid Malignancies;COMPLETED;['PHASE1'];INTERVENTIONAL;6.0;['Clear Cell Renal Cell Carcinoma', 'Recurrent Renal Cell Cancer', 'Stage I Renal Cell Cancer', 'Stage II Renal Cell Cancer', 'Stage III Renal Cell Cancer', 'Stage IV Renal Cell Cancer', 'Unspecified Adult Solid Tumor, Protocol Specific']
NCT00095459;BAY 43-9006 (Sorafenib) and Bevacizumab (Avastin) To Treat Solid Tumors;COMPLETED;['PHASE1'];INTERVENTIONAL;57.0;['Neoplasms']
NCT02776683;Open-label, Single Arm Trial of BI 695502 in Patients With Previously Untreated Metastatic Colorectal Cancer;COMPLETED;['PHASE3'];INTERVENTIONAL;123.0;['Colorectal Neoplasms']
NCT01320683;Combination Chemotherapy and Bevacizumab Before Surgery and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal Cancer;TERMINATED;['PHASE2'];INTERVENTIONAL;1.0;['Liver Metastases', 'Recurrent Colon Cancer', 'Recurrent Rectal Cancer', 'Stage IVA Colon Cancer', 'Stage IVA Rectal Cancer', 'Stage IVB Colon Cancer', 'Stage IVB Rectal Cancer']
NCT00601900;Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer;ACTIVE_NOT_RECRUITING;['PHASE3'];INTERVENTIONAL;394.0;['Invasive Breast Carcinoma', 'Recurrent Breast Carcinoma', 'Stage III Breast Cancer AJCC v6', 'Stage IV Breast Cancer AJCC v6 and v7']
NCT04739800;Comparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic Agents;ACTIVE_NOT_RECRUITING;['PHASE2'];INTERVENTIONAL;149.0;['Fallopian Tube Mucinous Adenocarcinoma', 'Ovarian Seromucinous Carcinoma', 'Platinum-Refractory Fallopian Tube Carcinoma', 'Platinum-Refractory Ovarian Carcinoma', 'Platinum-Refractory Primary Peritoneal Carcinoma', 'Recurrent Fallopian Tube Clear Cell Adenocarcinoma', 'Recurrent Fallopian Tube Endometrioid Adenocarcinoma', 'Recurrent Fallopian Tube High Grade Serous Adenocarcinoma', 'Recurrent Fallopian Tube Mucinous Adenocarcinoma', 'Recurrent Fallopian Tube Transitional Cell Carcinoma', 'Recurrent Fallopian Tube Undifferentiated Carcinoma', 'Recurrent Low Grade Fallopian Tube Serous Adenocarcinoma', 'Recurrent Ovarian Clear Cell Adenocarcinoma', 'Recurrent Ovarian Endometrioid Adenocarcinoma', 'Recurrent Ovarian High Grade Serous Adenocarcinoma', 'Recurrent Ovarian Low Grade Serous Adenocarcinoma', 'Recurrent Ovarian Mucinous Adenocarcinoma', 'Recurrent Ovarian Seromucinous Carcinoma', 'Recurrent Ovarian Transitional Cell Carcinoma', 'Recurrent Ovarian Undifferentiated Carcinoma', 'Recurrent Platinum-Resistant Fallopian Tube Carcinoma', 'Recurrent Platinum-Resistant Ovarian Carcinoma', 'Recurrent Platinum-Resistant Primary Peritoneal Carcinoma', 'Recurrent Primary Peritoneal Clear Cell Adenocarcinoma', 'Recurrent Primary Peritoneal Endometrioid Adenocarcinoma', 'Recurrent Primary Peritoneal High Grade Serous Adenocarcinoma', 'Recurrent Primary Peritoneal Low Grade Serous Adenocarcinoma', 'Recurrent Primary Peritoneal Transitional Cell Carcinoma', 'Recurrent Primary Peritoneal Undifferentiated Carcinoma', 'Refractory Fallopian Tube Clear Cell Adenocarcinoma', 'Refractory Fallopian Tube Endometrioid Adenocarcinoma', 'Refractory Fallopian Tube High Grade Serous Adenocarcinoma', 'Refractory Fallopian Tube Mucinous Adenocarcinoma', 'Refractory Fallopian Tube Transitional Cell Carcinoma', 'Refractory Fallopian Tube Undifferentiated Carcinoma', 'Refractory Low Grade Fallopian Tube Serous Adenocarcinoma', 'Refractory Ovarian Clear Cell Adenocarcinoma', 'Refractory Ovarian Endometrioid Adenocarcinoma', 'Refractory Ovarian High Grade Serous Adenocarcinoma', 'Refractory Ovarian Low Grade Serous Adenocarcinoma', 'Refractory Ovarian Mucinous Adenocarcinoma', 'Refractory Ovarian Seromucinous Carcinoma', 'Refractory Ovarian Transitional Cell Carcinoma', 'Refractory Ovarian Undifferentiated Carcinoma', 'Refractory Primary Peritoneal Clear Cell Adenocarcinoma', 'Refractory Primary Peritoneal Endometrioid Adenocarcinoma', 'Refractory Primary Peritoneal High Grade Serous Adenocarcinoma', 'Refractory Primary Peritoneal Low Grade Serous Adenocarcinoma', 'Refractory Primary Peritoneal Transitional Cell Carcinoma', 'Refractory Primary Peritoneal Undifferentiated Carcinoma']
NCT00826800;Neoadjuvant FOLFOX Plus Bevacizumab Chemotherapy in Patients With Locally Advanced Colon Cancer;TERMINATED;['NA'];INTERVENTIONAL;2.0;['Colon Cancer']
NCT03181100;Atezolizumab With Chemotherapy in Treating Patients With Anaplastic or Poorly Differentiated Thyroid Cancer;ACTIVE_NOT_RECRUITING;['PHASE2'];INTERVENTIONAL;50.0;['Metastatic Thyroid Gland Carcinoma', 'Poorly Differentiated Thyroid Gland Carcinoma', 'Stage IVA Thyroid Gland Anaplastic Carcinoma AJCC v8', 'Stage IVB Thyroid Gland Anaplastic Carcinoma AJCC v8', 'Stage IVC Thyroid Gland Anaplastic Carcinoma AJCC v8', 'Thyroid Gland Anaplastic Carcinoma', 'Unresectable Thyroid Gland Carcinoma']
NCT02620800;Study of 5-fluorouracil (5-FU), NabÂ®1-paclitaxel, Bevacizumab, Leucovorin, and Oxaliplatin in Patients With Metastatic Pancreatic Cancer;COMPLETED;['PHASE1'];INTERVENTIONAL;12.0;['Metastatic Pancreas Adenocarcinoma']
NCT00025337;Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously Treated;COMPLETED;['PHASE3'];INTERVENTIONAL;880.0;['Adenocarcinoma of the Colon', 'Adenocarcinoma of the Rectum', 'Recurrent Colon Cancer', 'Recurrent Rectal Cancer', 'Stage III Colon Cancer', 'Stage III Rectal Cancer', 'Stage IV Colon Cancer', 'Stage IV Rectal Cancer']
NCT01217437;Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors;COMPLETED;['PHASE2'];INTERVENTIONAL;108.0;['Central Nervous System Neoplasm', 'Pineoblastoma', 'Recurrent Medulloblastoma', 'Recurrent Primitive Neuroectodermal Tumor', 'Refractory Medulloblastoma', 'Refractory Peripheral Primitive Neuroectodermal Tumor']
NCT00227617;Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors;TERMINATED;['PHASE2', 'PHASE3'];INTERVENTIONAL;36.0;['Gastrointestinal Carcinoid Tumor', 'Islet Cell Tumor', 'Lung Cancer', 'Neoplastic Syndrome', 'Neuroendocrine Tumor']
NCT02138617;Genotype-Directed Study Of Irinotecan Dosing In FOLFIRI + BevacizumabTreated Metastatic Colorectal Cancer;ACTIVE_NOT_RECRUITING;['PHASE2'];INTERVENTIONAL;100.0;['Colon Cancer']
NCT00365417;Therapy With Bevacizumab (BEV), Doxorubicin, and Cyclophosphamide Followed by BEV, Docetaxel, and Capecitabine Before Surgery Followed by BEV Alone After Surgery for Women With Locally Advanced Breast Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;45.0;['Breast Cancer']
NCT00423917;Fulvestrant and Bevacizumab in Treating Patients With Metastatic Breast Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;36.0;['Breast Cancer']
NCT02210117;Nivolumab With or Without Bevacizumab or Ipilimumab Before Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed by Surgery;ACTIVE_NOT_RECRUITING;['EARLY_PHASE1'];INTERVENTIONAL;104.0;['Clear Cell Renal Cell Carcinoma', 'Metastatic Kidney Carcinoma', 'Stage IV Renal Cell Cancer AJCC v7']
NCT00532909;Phase I Vandetanib Plus Capecitabine, Oxaliplatin and Bevacizumab for Metastatic Colorectal Cancer;COMPLETED;['PHASE1'];INTERVENTIONAL;13.0;['Anal, Colon, and Rectal Cancers', 'Colorectal Neoplasms', 'Colon/Rectal Cancer']
NCT03166306;Angiogenic Imaging in Pulmonary Arterial Hypertension;COMPLETED;['PHASE1', 'PHASE2'];INTERVENTIONAL;5.0;['Pulmonary Arterial Hypertension', 'Exercise Associated Pulmonary Arterial Hypertension']
NCT02665416;Study Evaluating the Safety, Pharmacokinetics (PK), Pharmacodynamics (PD), and Therapeutic Activity of Selicrelumab (RO7009789) With Vanucizumab or Bevacizumab in Participants With Metastatic Solid Tumors;COMPLETED;['PHASE1'];INTERVENTIONAL;94.0;['Advanced/Metastatic Solid Tumors']
NCT00728845;Hydroxychloroquine, Carboplatin, Paclitaxel, and Bevacizumab in Recurrent Advanced Non-Small Cell Lung Cancer;TERMINATED;['PHASE1', 'PHASE2'];INTERVENTIONAL;8.0;['Lung Cancer']
NCT00851045;Ph II Trial of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Second-line Treatment of Metastatic Colorectal Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;17.0;['Colorectal Cancer (CRC)']
NCT01254526;Study of the Safety and Pharmacology of GDC-0980 in Combination With Paclitaxel With or Without Bevacizumab in Patients With Locally Recurrent or Metastatic Breast Cancer;COMPLETED;['PHASE1'];INTERVENTIONAL;52.0;['Breast Cancer']
NCT00618826;A Study of Biweekly Gemcitabine, Paclitaxel, and Avastin in Patients With Metastatic Breast Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;14.0;['Metastatic Breast Cancer']
NCT00601926;Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney Cancer;TERMINATED;['PHASE2'];INTERVENTIONAL;5.0;['Kidney Cancer']
NCT00472693;Bevacizumab and Abraxane as Second-line Therapy in Triple Negative Metastatic Breast Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;5.0;['Breast Cancer']
NCT06190093;A 3-month Study to Assess the Safety and Effectiveness of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD);RECRUITING;['PHASE3'];INTERVENTIONAL;400.0;['Neovascular Age-related Macular Degeneration', 'Age-Related Macular Degeneration', 'Wet Macular Degeneration']
NCT00811993;A Study of R1507 in Combination With Multiple Standard Chemotherapy Treatments in Patients With Advanced Solid Tumors;TERMINATED;['PHASE1'];INTERVENTIONAL;104.0;['Neoplasms']
NCT01137968;Imetelstat as Maintenance Therapy After Initial Induction Chemotherapy in Non-small Cell Lung Cancer (NSCLC);COMPLETED;['PHASE2'];INTERVENTIONAL;116.0;['Non-small Cell Lung Cancer']
NCT00436215;Sorafenib and Bevacizumab to Treat Ovarian, Fallopian and Peritoneal Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;55.0;['Ovarian Neoplasm', 'Fallopian Tube Cancer', 'Primary Peritoneal Cancer']
NCT00268450;Cisplatin, Bevacizumab, and Gemcitabine Followed by Surgery, Bevacizumab, and Paclitaxel in Treating Patients With Locally Advanced Nonmetastatic Bladder Cancer That Can Be Removed By Surgery;TERMINATED;['PHASE2'];INTERVENTIONAL;21.0;['Bladder Cancer']
NCT01017250;Radiosurgery and Avastin for Recurrent Malignant Gliomas;COMPLETED;['NA'];INTERVENTIONAL;15.0;['Malignant Glioma']
NCT01201850;The Role of Bevacizumab in the Treatment of Radiation Necrosis in Children With Central Nervous System Tumors;TERMINATED;['NA'];INTERVENTIONAL;7.0;['Radiation Necrosis']
NCT01202890;Study of Revlimid With Doxil and Avastin for Patients With Platinum Resistant Ovarian Cancer;TERMINATED;['PHASE1'];INTERVENTIONAL;1.0;['Ovarian Cancer', 'Epithelial Ovarian Cancer', 'Fallopian Tube Carcinoma', 'Primary Peritoneal Carcinoma']
NCT01063283;Dose Escalation of Bevacizumab With Ambulatory Blood Pressure Monitoring in Patients With Advanced Non-squamous NSCLC;COMPLETED;['NA'];INTERVENTIONAL;20.0;['Advanced Non-squamous Non-Small Cell Lung Cancer']
NCT04829383;A Study of Atezolizumab and Bevacizumab in Hepatocellular Carcinoma;ACTIVE_NOT_RECRUITING;['PHASE2'];INTERVENTIONAL;50.0;['Unresectable Hepatocellular Carcinoma']
NCT00550537;Proteomic Profiling in Predicting Response in Patients Receiving Erlotinib for Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;116.0;['Lung Cancer']
NCT02047214;Safety & Efficacy Study of TPI 287 + Avastin in Adults With Glioblastoma That Progressed Following Prior Avastin Therapy;TERMINATED;['PHASE2'];INTERVENTIONAL;17.0;['Glioblastoma Multiforme']
NCT00317200;A Study of Paclitaxel Plus Bevacizumab in Patients With Chemosensitive Relapsed Small Cell Lung Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;34.0;['Small Cell Lung Cancer']
NCT01231633;Comparison of Initial Ozurdex (Dexamethasone Implant) to Avastin (Bevacizumab) for Treatment of Macular Edema Caused by Central Retinal Vein Occlusion (CRVO);COMPLETED;['NA'];INTERVENTIONAL;27.0;['Macular Edema', 'Central Retinal Vein Occlusion']
NCT03115333;DSC-MRI in Measuring rCBV for Early Response to Bevacizumab in Patients With Recurrent Glioblastoma;RECRUITING;['NA'];INTERVENTIONAL;146.0;['Gliosarcoma', 'Recurrent Glioblastoma']
NCT01132014;Autologous OC-DC Vaccine in Ovarian Cancer;COMPLETED;['EARLY_PHASE1'];INTERVENTIONAL;67.0;['Chemotherapy', 'Tumor', 'Ovarian Cancer']
NCT05337137;A Study of Nivolumab and Relatlimab in Combination With Bevacizumab in Advanced Liver Cancer;RECRUITING;['PHASE1', 'PHASE2'];INTERVENTIONAL;162.0;['Carcinoma, Hepatocellular']
NCT00081614;A Study Evaluating Tarceva in Combination With Avastin Versus Avastin Alone in Treating Metastatic Renal Cell Carcinoma;COMPLETED;['PHASE2'];INTERVENTIONAL;100.0;['Renal Cell Carcinoma', 'Metastases']
NCT03050814;Standard of Care Alone or in Combination With Ad-CEA Vaccine and Avelumab in People With Previously Untreated Metastatic Colorectal Cancer QUILT-2.004;TERMINATED;['PHASE2'];INTERVENTIONAL;30.0;['Colorectal Tumors', 'Colorectal Neoplasms', 'Colorectal Carcinoma', 'Colorectal Adenocarcinoma', 'Colorectal Cancer']
NCT00580333;Preoperative Cisplatin and Bevacizumab in ER-, PR-, HER2 Negative Breast Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;51.0;['Breast Cancer']
NCT00110214;Docetaxel and Prednisone With or Without Bevacizumab in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy;COMPLETED;['PHASE3'];INTERVENTIONAL;1050.0;['Adenocarcinoma of the Prostate', 'Hormone-resistant Prostate Cancer', 'Recurrent Prostate Cancer', 'Stage IV Prostate Cancer']
NCT00879437;Valproic Acid, Radiation, and Bevacizumab in Children With High Grade Gliomas or Diffuse Intrinsic Pontine Glioma;COMPLETED;['PHASE2'];INTERVENTIONAL;38.0;['Glial Cell Tumors', 'Malignant Gliomas', 'Glioblastoma Multiforme', 'Anaplastic Astrocytoma', 'Gliomatosis Cerebri', 'Gliosarcoma', 'Brainstem Glioma', 'Diffuse Intrinsic Pontine Glioma']
NCT04761614;Riluzole in Combination With mFOLFOX6 and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer;ACTIVE_NOT_RECRUITING;['PHASE1'];INTERVENTIONAL;13.0;['Metastatic Colorectal Carcinoma', 'Stage IV Colorectal Cancer AJCC v8', 'Stage IVA Colorectal Cancer AJCC v8', 'Stage IVB Colorectal Cancer AJCC v8', 'Stage IVC Colorectal Cancer AJCC v8']
NCT02591914;An Open-Label Investigator Sponsored Trial to Investigate the Safety, Tolerability and Development of Subfoveal Fibrosis By Intravitreal Administration of Altering Regimens of Fovista and Anti-VEGF Therapy in Subjects With Neovascular Age-Related Macular Degeneration;COMPLETED;['PHASE1'];INTERVENTIONAL;30.0;['Neovascular Age-Related Macular Degeneration']
NCT01191697;CAPOX, Bevacizumab and Trastuzumab for Patients With HER2-Positive Metastatic Esophagogastric Cancer;ACTIVE_NOT_RECRUITING;['PHASE2'];INTERVENTIONAL;37.0;['Esophageal Cancer', 'Gastric Cancer']
NCT00142467;Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Patients With Hepatocellular Carcinoma;COMPLETED;['PHASE2'];INTERVENTIONAL;33.0;['Hepatocellular Carcinoma']
NCT03635567;Efficacy and Safety Study of First-line Treatment With Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Women With Persistent, Recurrent, or Metastatic Cervical Cancer (MK-3475-826/KEYNOTE-826);ACTIVE_NOT_RECRUITING;['PHASE3'];INTERVENTIONAL;617.0;['Cervical Cancer']
NCT02988843;Study of Brentuximab Vedotin And Bevacizumab In Refractory CD-30 Positive Germ Cell Tumors;TERMINATED;['PHASE2'];INTERVENTIONAL;1.0;['Germ Cell Tumor']
NCT01383343;Sorafenib Tosylate, Bevacizumab, Irinotecan Hydrochloride, Leucovorin Calcium, and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer;COMPLETED;['PHASE1'];INTERVENTIONAL;17.0;['Recurrent Colon Carcinoma', 'Recurrent Rectal Carcinoma', 'Stage IVA Colon Cancer', 'Stage IVA Rectal Cancer', 'Stage IVB Colon Cancer', 'Stage IVB Rectal Cancer']
NCT01493843;Safety and Efficacy of Carboplatin/Paclitaxel and Carboplatin/Paclitaxel/Bevacizumab With and Without Pictilisib in Previously Untreated Advanced or Recurrent Non-small Cell Lung Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;501.0;['Non-Small Cell Lung Cancer']
NCT03554707;SGT-53 in Children With Recurrent or Progressive CNS Malignancies;NOT_YET_RECRUITING;['EARLY_PHASE1'];INTERVENTIONAL;6.0;['Childhood CNS Tumor']
NCT00381797;Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma;COMPLETED;['PHASE2'];INTERVENTIONAL;97.0;['Childhood Cerebral Anaplastic Astrocytoma', 'Childhood Oligodendroglioma', 'Childhood Spinal Cord Neoplasm', 'Recurrent Childhood Brain Stem Glioma', 'Recurrent Childhood Ependymoma', 'Recurrent Childhood Medulloblastoma']
NCT00737243;Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site;COMPLETED;['PHASE2'];INTERVENTIONAL;289.0;['Carcinoma']
NCT00328497;A Combination Study to Determine the Safety and Efficacy of Panzem NCD With Avastin in Metastatic Carcinoid Tumors;COMPLETED;['PHASE2'];INTERVENTIONAL;31.0;['Carcinoid Tumor']
NCT01598597;An Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite);COMPLETED;;OBSERVATIONAL;276.0;['Breast Cancer', 'Colorectal Cancer', 'Non-Small Cell Lung Cancer', 'Glioblastoma', 'Renal Cell Cancer']
NCT00675597;Docetaxel (Taxotere), Vinorelbine, and Bevacizumab, as Adjuvant Chemotherapy for Patients With Resected Stage I-III Non-small Cell Lung Cancer;COMPLETED;['NA'];INTERVENTIONAL;25.0;['Lung Cancer']
NCT05284643;Spectroscopic MRI, Proton Therapy, and Avastin for Recurrent Glioblastoma;RECRUITING;['NA'];INTERVENTIONAL;96.0;['Recurrent Glioblastoma']
NCT00177307;Safety and Efficacy Study Using Bevacizumab, Capecitabine and Oxaliplatin for Colorectal Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;40.0;['Cancer']
NCT03737643;Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer Patients;ACTIVE_NOT_RECRUITING;['PHASE3'];INTERVENTIONAL;1407.0;['Advanced Ovarian Cancer']
NCT00528567;BEATRICE Study: A Study of Bevacizumab (Avastin) Adjuvant Therapy in Triple Negative Breast Cancer;COMPLETED;['PHASE3'];INTERVENTIONAL;2591.0;['Breast Cancer']
NCT02296567;Comparison of Pharmacokinetics of and Effect on Systemic VEGF Levels in Age Related Macular Degeneration Patients;UNKNOWN;['PHASE2', 'PHASE3'];INTERVENTIONAL;80.0;['Age Related Macular Degeneration']
NCT02366143;A Study of Atezolizumab in Combination With Carboplatin Plus (+) Paclitaxel With or Without Bevacizumab Compared With Carboplatin+Paclitaxel+Bevacizumab in Participants With Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC);COMPLETED;['PHASE3'];INTERVENTIONAL;1202.0;['Carcinoma, Non-Small-Cell Lung']
NCT02157103;A Study of Subcutaneous Bevacizumab in Relapsed / Progressive Glioblastoma;COMPLETED;['PHASE2'];INTERVENTIONAL;3.0;['Glioblastoma']
NCT00915603;Trial of Paclitaxel/Bevacizumab +/- Everolimus for Patients With HER2-Negative Metastatic Breast Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;113.0;['Metastatic Breast Cancer']
NCT00724503;FOLFOX Plus SIR-SPHERES MICROSPHERES Versus FOLFOX Alone in Patients With Liver Mets From Primary Colorectal Cancer;COMPLETED;['NA'];INTERVENTIONAL;530.0;['Colorectal Cancer', 'Colorectal Carcinoma', 'Liver Metastases']
NCT00873756;A Study of Dulanermin Administered in Combination With the FOLFOX Regimen and Bevacizumab in Patients With Previously Untreated, Locally Advanced, Recurrent, or Metastatic Colorectal Cancer;COMPLETED;['PHASE1'];INTERVENTIONAL;23.0;['Metastatic Colorectal Cancer']
NCT00720356;Bevacizumab and Erlotinib After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma;COMPLETED;['PHASE2'];INTERVENTIONAL;115.0;['Brain and Central Nervous System Tumors']
NCT03585556;AAVCAGsCD59 for the Treatment of Wet AMD;COMPLETED;['PHASE1'];INTERVENTIONAL;25.0;['Wet Age-related Macular Degeneration']
NCT00732056;A Study of GRN163L With Paclitaxel and Bevacizumab to Treat Patients With Locally Recurrent Or Metastatic Breast Cancer;COMPLETED;['PHASE1'];INTERVENTIONAL;24.0;['Breast Cancer']
NCT01959490;Trastuzumab and Pertuzumab or Bevacizumab With Combination Chemotherapy in Treating Patients With Stage II-III Breast Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;16.0;['Stage II Breast Cancer', 'Stage IIIA Breast Cancer', 'Stage IIIB Breast Cancer', 'Stage IIIC Breast Cancer']
NCT00820456;Metastatic Colorectal Cancer: Treatment Response With Dynamic Contrast MRI;TERMINATED;;OBSERVATIONAL;6.0;['Colorectal Neoplasm', 'Hepatic Neoplasm']
NCT00140556;Angiogenic and EGFR Blockade With Curative Chemoradiation for Advanced Head and Neck Cancer;COMPLETED;['EARLY_PHASE1'];INTERVENTIONAL;28.0;['Head and Neck Cancer', 'Pharynx Cancer']
NCT00126503;Sorafenib Tosylate and Bevacizumab in Treating Patients With Advanced Kidney Cancer;COMPLETED;['PHASE1', 'PHASE2'];INTERVENTIONAL;73.0;['Chromophobe Renal Cell Carcinoma', 'Clear Cell Renal Cell Carcinoma', 'Papillary Renal Cell Carcinoma', 'Recurrent Renal Cell Carcinoma', 'Sarcomatoid Renal Cell Carcinoma', 'Stage IV Renal Cell Cancer']
NCT00390156;Imatinib, Bevacizumab, and Cyclophosphamide in Patients With Refractory Metastatic Solid Tumors;COMPLETED;['PHASE1'];INTERVENTIONAL;35.0;['Unspecified Adult Solid Tumor']
NCT00782756;Bevacizumab, Temozolomide and Hypofractionated Radiotherapy for Patients With Newly Diagnosed Malignant Glioma;COMPLETED;['PHASE2'];INTERVENTIONAL;40.0;['Brain Cancer', 'Malignant Glioma']
NCT03602859;A Comparison of Platinum-based Therapy With TSR-042 and Niraparib Versus Standard of Care (SOC) Platinum-based Therapy as First-line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer;ACTIVE_NOT_RECRUITING;['PHASE3'];INTERVENTIONAL;1402.0;['Ovarian Neoplasms', 'Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma']
NCT03149003;A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy;COMPLETED;['PHASE3'];INTERVENTIONAL;221.0;['Glioblastoma']
NCT02142803;TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors;ACTIVE_NOT_RECRUITING;['PHASE1'];INTERVENTIONAL;50.0;['Adult Glioblastoma', 'Endometrial Clear Cell Adenocarcinoma', 'Endometrial Serous Adenocarcinoma', 'Ovarian Clear Cell Cystadenocarcinoma', 'Ovarian Endometrioid Adenocarcinoma', 'Ovarian Mucinous Cystadenocarcinoma', 'Ovarian Serous Cystadenocarcinoma', 'Recurrent Fallopian Tube Carcinoma', 'Recurrent Ovarian Carcinoma', 'Recurrent Primary Peritoneal Carcinoma', 'Recurrent Uterine Corpus Cancer', 'Solid Neoplasm', 'Stage IIIA Fallopian Tube Cancer AJCC v7', 'Stage IIIA Ovarian Cancer AJCC v6 and v7', 'Stage IIIA Primary Peritoneal Cancer AJCC v7', 'Stage IIIB Fallopian Tube Cancer AJCC v7', 'Stage IIIB Ovarian Cancer AJCC v6 and v7', 'Stage IIIB Primary Peritoneal Cancer AJCC v7', 'Stage IIIC Fallopian Tube Cancer AJCC v7', 'Stage IIIC Ovarian Cancer AJCC v6 and v7', 'Stage IIIC Primary Peritoneal Cancer AJCC v7', 'Stage IV Fallopian Tube Cancer AJCC v6 and v7', 'Stage IV Ovarian Cancer AJCC v6 and v7', 'Stage IV Primary Peritoneal Cancer AJCC v7']
NCT00798603;Pemetrexed, Carboplatin, and Bevacizumab as First-Line Therapy in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;65.0;['Lung Cancer']
NCT01821859;Abraxane/Bevacizumab;TERMINATED;['PHASE2'];INTERVENTIONAL;5.0;['Ovarian Cancer', 'Peritoneal Cancer']
NCT01471054;Dexamethasone Intravitreal Implant for Treatment of Macular Edema After Plaque Radiotherapy of Uveal Melanoma;TERMINATED;['PHASE2'];INTERVENTIONAL;6.0;['Macular Edema', 'Cystoid Macular Edema', 'Uveal Melanoma', 'Radiation Maculopathy', 'Radiation Retinopathy']
NCT00642603;A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer;TERMINATED;['PHASE2'];INTERVENTIONAL;41.0;['Colorectal Cancer']
NCT00486759;A Study of Bevacizumab (Avastin) in Combination With Rituximab (MabThera) and CHOP (Cyclophosphamide, Hydroxydaunorubicin [Doxorubicin], Oncovin [Vincristine], Prednisone) Chemotherapy in Patients With Diffuse Large B-cell Lymphoma;TERMINATED;['PHASE3'];INTERVENTIONAL;787.0;['B-cell Lymphoma']
NCT00276575;Bevacizumab, Everolimus, and Erlotinib in Treating Patients With Advanced Solid Tumors;COMPLETED;['PHASE1'];INTERVENTIONAL;65.0;['Unspecified Adult Solid Tumor, Protocol Specific']
NCT02839707;Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer;ACTIVE_NOT_RECRUITING;['PHASE2', 'PHASE3'];INTERVENTIONAL;443.0;['Fallopian Tube High Grade Serous Adenocarcinoma', 'Ovarian High Grade Serous Adenocarcinoma', 'Ovarian Seromucinous Carcinoma', 'Primary Peritoneal High Grade Serous Adenocarcinoma', 'Recurrent Fallopian Tube Carcinoma', 'Recurrent Fallopian Tube Clear Cell Adenocarcinoma', 'Recurrent Fallopian Tube Endometrioid Adenocarcinoma', 'Recurrent Fallopian Tube Undifferentiated Carcinoma', 'Recurrent Ovarian Carcinoma', 'Recurrent Ovarian Clear Cell Adenocarcinoma', 'Recurrent Ovarian Endometrioid Adenocarcinoma', 'Recurrent Ovarian Undifferentiated Carcinoma', 'Recurrent Platinum-Resistant Fallopian Tube Carcinoma', 'Recurrent Platinum-Resistant Ovarian Carcinoma', 'Recurrent Platinum-Resistant Primary Peritoneal Carcinoma', 'Recurrent Primary Peritoneal Carcinoma', 'Recurrent Primary Peritoneal Clear Cell Adenocarcinoma', 'Recurrent Primary Peritoneal Endometrioid Adenocarcinoma', 'Recurrent Primary Peritoneal Undifferentiated Carcinoma']
NCT01229943;Everolimus and Octreotide Acetate With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed by Surgery;COMPLETED;['PHASE2'];INTERVENTIONAL;150.0;['Advanced Pancreatic Neuroendocrine Tumor', 'Locally Advanced Pancreatic Neuroendocrine Tumor', 'Pancreatic Gastrinoma', 'Pancreatic Neuroendocrine Tumor G1', 'Pancreatic Neuroendocrine Tumor G2', 'Pancreatic Vipoma']
NCT00262067;A Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy in Untreated Metastatic Breast Cancer (RIBBON 1);UNKNOWN;['PHASE3'];INTERVENTIONAL;1237.0;['Metastatic Breast Cancer']
NCT01091259;Irinotecan and Bevacizumab for Recurrent Ovarian Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;29.0;['Ovarian Cancer', 'Fallopian Tube Cancer', 'Primary Peritoneal Carcinoma']
NCT01993043;39946-I Laser and Bevacizumab Treatment for Retinopathy of Prematurity;COMPLETED;;OBSERVATIONAL;150.0;['ROP Threshold']
NCT02020707;Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers;ACTIVE_NOT_RECRUITING;['PHASE1'];INTERVENTIONAL;73.0;['Cervical Adenocarcinoma', 'Cervical Adenosarcoma', 'Cervical Adenosquamous Carcinoma', 'Cervical Carcinosarcoma', 'Cervical Squamous Cell Carcinoma', 'Clinical Stage IV Cutaneous Melanoma AJCC v8', 'Endometrial Adenosquamous Carcinoma', 'Endometrial Clear Cell Adenocarcinoma', 'Endometrial Endometrioid Adenocarcinoma', 'Endometrial Mixed Cell Adenocarcinoma', 'Endometrial Mucinous Adenocarcinoma', 'Endometrial Serous Adenocarcinoma', 'Endometrial Undifferentiated Carcinoma', 'Fallopian Tube Adenocarcinoma', 'Fallopian Tube Carcinosarcoma', 'Fallopian Tube Clear Cell Adenocarcinoma', 'Fallopian Tube Endometrioid Adenocarcinoma', 'Fallopian Tube Mucinous Adenocarcinoma', 'Fallopian Tube Serous Adenocarcinoma', 'Fallopian Tube Squamous Cell Carcinoma', 'Fallopian Tube Transitional Cell Carcinoma', 'Fallopian Tube Undifferentiated Carcinoma', 'Malignant Female Reproductive System Neoplasm', 'Malignant Ovarian Clear Cell Tumor', 'Malignant Ovarian Endometrioid Tumor', 'Malignant Ovarian Epithelial Tumor', 'Malignant Ovarian Mucinous Tumor', 'Malignant Peritoneal Neoplasm', 'Malignant Solid Neoplasm', 'Ovarian Carcinosarcoma', 'Ovarian Clear Cell Adenocarcinoma', 'Ovarian Endometrioid Adenocarcinoma', 'Ovarian High Grade Serous Adenocarcinoma', 'Ovarian Mucinous Adenocarcinoma', 'Ovarian Serous Adenocarcinoma', 'Ovarian Transitional Cell Carcinoma', 'Ovarian Undifferentiated Carcinoma', 'Platinum-Resistant Fallopian Tube Carcinoma', 'Platinum-Resistant Ovarian Carcinoma', 'Platinum-Resistant Primary Peritoneal Carcinoma', 'Platinum-Sensitive Ovarian Carcinoma', 'Primary Peritoneal Carcinosarcoma', 'Primary Peritoneal Clear Cell Adenocarcinoma', 'Primary Peritoneal Serous Adenocarcinoma', 'Primary Peritoneal Transitional Cell Carcinoma', 'Primary Peritoneal Undifferentiated Carcinoma', 'Unresectable Melanoma', 'Uterine Corpus Carcinosarcoma']
NCT00337207;Bevacizumab in Treating Patients With Recurrent or Progressive Glioma;COMPLETED;['PHASE2'];INTERVENTIONAL;55.0;['Brain and Central Nervous System Tumors']
NCT01152203;Bendamustine and Bevacizumab for Advanced Cancers;COMPLETED;['PHASE1'];INTERVENTIONAL;59.0;['Advanced Cancer']
NCT01189643;Irinotecan, Temozolomide and Bevacizumab in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Newly Diagnosed Patients With Desmoplastic Small Round Cell Tumor;ACTIVE_NOT_RECRUITING;['EARLY_PHASE1'];INTERVENTIONAL;15.0;['Sarcoma', 'Desmoplastic Small Round Cell Tumor (DSRCT)']
NCT00786643;Study of Gamma Interfereon in Metastatic Colorectal Carcinoma;COMPLETED;['PHASE2'];INTERVENTIONAL;48.0;['Colorectal Cancer']
NCT00874107;Efficacy/Safety of Imprime PGGÂ® Injection With Bevacizumab and Paclitaxel/Carboplatin in Patients With Untreated Advanced Non-Small Cell Lung Cancer (NSCLC);COMPLETED;['PHASE2'];INTERVENTIONAL;90.0;['Non-Small Cell Lung Cancer']
NCT00022607;Bevacizumab With or Without Thalidomide in Treating Patients With Relapsed or Refractory Multiple Myeloma;COMPLETED;['PHASE2'];INTERVENTIONAL;;['Multiple Myeloma and Plasma Cell Neoplasm']
NCT01966003;Efficacy and Safety Study of ABP 215 Compared With Bevacizumab in Patients With Advanced Non-Small Cell Lung Cancer;COMPLETED;['PHASE3'];INTERVENTIONAL;642.0;['Non-small Cell Lung Cancer Metastatic']
NCT01133990;FOLFIRI Alone Versus FOLFIRI Plus Bevacizumab Versus FOLFIRI Plus E7820 as Second-Line Therapy in Patients With Locally Advanced or Metastatic Colorectal Cancer;TERMINATED;['PHASE1', 'PHASE2'];INTERVENTIONAL;5.0;['Colorectal Cancer']
NCT03607643;A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies;UNKNOWN;['PHASE1', 'PHASE2'];INTERVENTIONAL;160.0;['Cancer of Pancreas', 'Cancer of Liver', 'Cancer of Rectum', 'Cancer of Colon', 'Cancer, Gall Bladder', 'Myeloma Multiple', 'Glioblastoma Multiforme']
NCT00605943;Detection of Neutralizing Antibodies in Patients Treated With Bevacizumab or Ranibizumab;COMPLETED;;OBSERVATIONAL;30.0;['Macular Degeneration']
NCT00888043;Safety/Biomarker Study of CNTO 95 and Avastin in Solid Tumors;COMPLETED;['PHASE1'];INTERVENTIONAL;13.0;['Solid Tumors']
NCT00546156;Preoperative Dose-dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Bevacizumab in Operable Breast Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;104.0;['Breast Cancer']
NCT01208103;Bevacizumab, Capecitabine, and Oxaliplatin in Treating Advanced Small Intestinal or Ampulla of Vater Adenocarcinoma;COMPLETED;['PHASE2'];INTERVENTIONAL;30.0;['Ampulla of Vater Adenocarcinoma', 'Small Intestinal Adenocarcinoma', 'Stage III Ampulla of Vater Cancer AJCC v8', 'Stage III Small Intestinal Adenocarcinoma AJCC v8', 'Stage IIIA Ampulla of Vater Cancer AJCC v8', 'Stage IIIA Small Intestinal Adenocarcinoma AJCC v8', 'Stage IIIB Ampulla of Vater Cancer AJCC v8', 'Stage IIIB Small Intestinal Adenocarcinoma AJCC v8', 'Stage IV Ampulla of Vater Cancer AJCC v8', 'Stage IV Small Intestinal Adenocarcinoma AJCC v8']
NCT00734890;Vandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or Lymphoma;COMPLETED;['PHASE1'];INTERVENTIONAL;18.0;['Lung Cancer', 'Lymphoma', 'Lymphoproliferative Disorder', 'Small Intestine Cancer', 'Unspecified Adult Solid Tumor, Protocol Specific']
NCT01950390;Ipilimumab With or Without Bevacizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery;ACTIVE_NOT_RECRUITING;['PHASE2'];INTERVENTIONAL;169.0;['Stage IIIC Cutaneous Melanoma AJCC v7', 'Stage IV Cutaneous Melanoma AJCC v6 and v7', 'Unresectable Melanoma']
NCT03977467;Atezolizumab and Tiragolumab in Patients With NSCLC or Advanced Solid Tumors Having Had Prior Treatment With a PD-1 Inhibitor;ACTIVE_NOT_RECRUITING;['PHASE2'];INTERVENTIONAL;80.0;['Non-Small Cell Lung Cancer', 'Solid Tumor']
NCT01684397;Pazopanib Hydrochloride and Bevacizumab in Treating Patients With Previously Untreated Metastatic Kidney Cancer;ACTIVE_NOT_RECRUITING;['PHASE1', 'PHASE2'];INTERVENTIONAL;51.0;['Clear Cell Renal Cell Carcinoma', 'Stage IV Renal Cell Cancer']
NCT00960297;Preoperative Chemotherapy and Bevacizumab in Patients With Stage IB (>4 cm), II, or Select Stage III NSCLC;TERMINATED;['PHASE2'];INTERVENTIONAL;4.0;['Non-Small Cell Lung Cancer']
NCT00530907;Valproic Acid and Bevacizumab in Patients With Advanced Cancer;COMPLETED;['PHASE1'];INTERVENTIONAL;71.0;['Advanced Cancer']
NCT00047307;Flavopiridol Plus Radiation Therapy Followed By Gemcitabine Hydrochloride in Treating Patients With Locally Advanced, Unresectable Pancreatic Cancer;COMPLETED;['PHASE1'];INTERVENTIONAL;46.0;['Adenocarcinoma of the Pancreas', 'Recurrent Pancreatic Cancer', 'Stage II Pancreatic Cancer', 'Stage III Pancreatic Cancer', 'Stage IV Pancreatic Cancer']
NCT00586443;BEP Study Phase I (Bevacizumab, Everolimus, Panitumumab);COMPLETED;['PHASE1'];INTERVENTIONAL;56.0;['Solid Tumors']
NCT02429843;A Study of TRC105 in Combination With Paclitaxel/Carboplatin and Bevacizumab in Non-Squamous Cell Lung Cancer;COMPLETED;['PHASE1'];INTERVENTIONAL;16.0;['Lung Cancer']
NCT01280643;Combination Chemotherapy and Cetuximab or Bevacizumab in Treating Patients With Metastatic Colorectal Cancer;TERMINATED;['NA'];INTERVENTIONAL;3.0;['Metastatic Colorectal Cancer']
NCT03414983;An Investigational Immunotherapy Study of Nivolumab With Standard of Care Therapy vs Standard of Care Therapy for First-Line Treatment of Colorectal Cancer That Has Spread;COMPLETED;['PHASE2', 'PHASE3'];INTERVENTIONAL;196.0;['Colorectal Cancer']
NCT02121990;Dose-Escalation Study of Intraperitoneal (IP) Cisplatin, IV/IP Paclitaxel, IV Bevacizumab, and Oral Olaparib for Newly Diagnosed Ovarian, Primary Peritoneal, and Fallopian Tube Cancer;COMPLETED;['PHASE1'];INTERVENTIONAL;17.0;['Ovarian Cancer', 'Primary Peritoneal Cancer', 'Fallopian Tube Cancer']
NCT00052390;Doxorubicin and Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Soft Tissue Sarcoma;COMPLETED;['PHASE2'];INTERVENTIONAL;;['Sarcoma']
NCT00373256;A Study Of SU011248 Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel In Patients With Advanced Breast Cancer;COMPLETED;['PHASE3'];INTERVENTIONAL;488.0;['Breast Neoplasms']
NCT00410956;Floxuridine and Dexamethasone as a Hepatic Arterial Infusion and Bevacizumab in Treating Patients With Primary Liver Cancer That Cannot be Removed by Surgery;ACTIVE_NOT_RECRUITING;['PHASE2'];INTERVENTIONAL;55.0;['Liver Cancer']
NCT00665990;Phase I Study of Bevacizumab and Sorafenib Combined With Low Dose Cyclophosphamide in Patients With Refractory Solid Tumors and Leukemia;COMPLETED;['PHASE1'];INTERVENTIONAL;49.0;['Refractory Solid Tumors', 'Leukemia']
NCT00025233;Bevacizumab in Treating Patients With Persistent or Recurrent Cancer of the Cervix;COMPLETED;['PHASE2'];INTERVENTIONAL;50.0;['Cervical Squamous Cell Carcinoma', 'Recurrent Cervical Cancer']
NCT00394433;Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;38.0;['Esophageal Cancer', 'Stomach Cancer']
NCT00588237;Intravenous and Intraperitoneal Paclitaxel, Intraperitoneal Cisplatin, and Intravenous Bevacizumab for the Initial Treatment of Optimal Stage II or III Ovarian, Primary Peritoneal, and Fallopian Tube Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;42.0;['Ovarian Cancer', 'Primary PERITONEUM', 'Fallopian Tube Cancer']
NCT00217737;Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer;ACTIVE_NOT_RECRUITING;['PHASE3'];INTERVENTIONAL;3610.0;['Colon Mucinous Adenocarcinoma', 'Colon Signet Ring Cell Adenocarcinoma', 'Lynch Syndrome', 'Stage IIA Colon Cancer AJCC v7', 'Stage IIB Colon Cancer AJCC v7', 'Stage IIC Colon Cancer AJCC v7']
NCT01526837;Bevacizumab (Avastin) Into the Tumor Resection Cavity in Subjects With Glioblastoma Multiforme at First Recurrence;TERMINATED;['PHASE1'];INTERVENTIONAL;1.0;['Glioblastoma Multiforme']
NCT00126633;Gemcitabine, Cisplatin, and Bevacizumab in Treating Patients With Metastatic Pancreatic Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;53.0;['Pancreatic Cancer']
NCT00442507;Erlotinib and Avastin in Patients With Cancer of the Esophagus or Gastroesophageal Junction;TERMINATED;['PHASE2'];INTERVENTIONAL;6.0;['Esophageal Neoplasms', 'Esophageal Diseases']
NCT00016107;Combination Chemotherapy Plus Bevacizumab in Treating Patients With Metastatic Prostate Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;72.0;['Adenocarcinoma of the Prostate', 'Hormone-resistant Prostate Cancer', 'Recurrent Prostate Cancer', 'Stage IV Prostate Cancer']
NCT02120807;Certolizumab in Combination With Chemotherapy for Patients With Stage IV Lung Adenocarcinomas;COMPLETED;['PHASE1'];INTERVENTIONAL;30.0;['Stage IV Lung Adenocarcinoma']
NCT04185883;Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101);RECRUITING;['PHASE1', 'PHASE2'];INTERVENTIONAL;1126.0;['Advanced Solid Tumors', 'Kirsten Rat Sarcoma (KRAS) pG12C Mutation']
NCT00402883;Chemotherapy, Radiotherapy and Bevacizumab in Patients With Unresectable Stage III Non-Small-Cell Lung Cancer;TERMINATED;['PHASE2'];INTERVENTIONAL;5.0;['Lung Cancer']
NCT01661283;SARC016: Study of Everolimus With Bevacizumab to Treat Refractory Malignant Peripheral Nerve Sheath Tumors;COMPLETED;['PHASE2'];INTERVENTIONAL;25.0;['Malignant Peripheral Nerve Sheath Tumors', 'MPNST', 'Sarcoma']
NCT00320541;A Trial of Paclitaxel and Bevacizumab vs. Gemcitabine, Paclitaxel, and Bevacizumab in Advanced Breast Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;187.0;['Breast Cancer']
NCT00936936;High-dose Chemotherapy for Poor-Prognosis Relapsed Germ-Cell Tumors;COMPLETED;['PHASE2'];INTERVENTIONAL;64.0;['Testicular Cancer']
NCT00121134;Bevacizumab With or Without Cyclophosphamide and Methotrexate: A Pilot Study in Women With Operable Breast Cancer;COMPLETED;['NA'];INTERVENTIONAL;164.0;['Breast Cancer']
NCT00493636;1st or 2nd Line MBC (Metastatic Breast Cancer) With Previous Avastin (Bevacizumab) Therapy;COMPLETED;['PHASE2'];INTERVENTIONAL;160.0;['Breast Cancer']
NCT02997228;Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer, the COMMIT Study;RECRUITING;['PHASE3'];INTERVENTIONAL;120.0;['Metastatic Colorectal Adenocarcinoma', 'Stage IV Colorectal Cancer AJCC v7']
NCT00735436;A Study of Gliadel Followed by Avastin + Irinotecan for Glioblastoma Multiforme (GBM);TERMINATED;['PHASE2'];INTERVENTIONAL;18.0;['Malignant Glioma', 'Glioblastoma Multiforme', 'Gliosarcoma']
NCT01498328;A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma;COMPLETED;['PHASE2'];INTERVENTIONAL;127.0;['Glioblastoma', 'Small Cell Glioblastoma', 'Giant Cell Glioblastoma', 'Gliosarcoma', 'Glioblastoma With Oligodendroglial Component', 'Recurrent Glioblastoma', 'Relapsed Glioblastoma']
NCT00548418;Topotecan, Cisplatin and Bevacizumab for Recurrent/Persistent Cervical Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;27.0;['Cervical Cancer']
NCT02000102;Outcomes of Diabetic Macula Edema Patients Switched to Aflibercept From Bevacizumab and/or Ranibizumab;COMPLETED;;OBSERVATIONAL;14.0;['Diabetic Macular Edema']
NCT00250978;Ph I:Bevacizumab + Chemotherapy in Pts w/Malig Pleural Effusion Due to Adv NSCLC;COMPLETED;['PHASE1'];INTERVENTIONAL;15.0;['Carcinoma, Non-Small-Cell Lung']
NCT02724878;Study of Atezolizumab + Bevacizumab in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma;ACTIVE_NOT_RECRUITING;['PHASE2'];INTERVENTIONAL;65.0;['Advanced Non-Clear Cell Kidney Cancer']
NCT01478178;Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma;COMPLETED;['PHASE1', 'PHASE2'];INTERVENTIONAL;55.0;['Glioma', 'Glioblastoma', 'Glioblastoma Multiforme', 'GBM', 'Brain Cancer']
NCT00996502;Study of Bevacizumab and Erlotinib for Patients With Hormone Refractory Prostate Cancer;TERMINATED;['PHASE1', 'PHASE2'];INTERVENTIONAL;4.0;['Prostate Cancer']
NCT02853318;Pembrolizumab, Bevacizumab, and Cyclophosphamide in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;40.0;['Fallopian Tube Clear Cell Adenocarcinoma', 'Fallopian Tube Endometrioid Adenocarcinoma', 'Fallopian Tube Mucinous Adenocarcinoma', 'Fallopian Tube Serous Adenocarcinoma', 'Ovarian Clear Cell Adenocarcinoma', 'Ovarian Endometrioid Adenocarcinoma', 'Ovarian Mucinous Adenocarcinoma', 'Ovarian Serous Adenocarcinoma', 'Primary Peritoneal Serous Adenocarcinoma', 'Recurrent Fallopian Tube Carcinoma', 'Recurrent Ovarian Carcinoma', 'Recurrent Primary Peritoneal Carcinoma', 'Undifferentiated Fallopian Tube Carcinoma', 'Undifferentiated Ovarian Carcinoma']
NCT01454102;Study of Nivolumab (BMS-936558) in Combination With Gemcitabine/Cisplatin, Pemetrexed/Cisplatin, Carboplatin/Paclitaxel, Bevacizumab Maintenance, Erlotinib, Ipilimumab or as Monotherapy in Subjects With Stage IIIB/IV Non-small Cell Lung Cancer (NSCLC) (CheckMate 012);COMPLETED;['PHASE1'];INTERVENTIONAL;472.0;['Non-small Cell Lung Cancer']
NCT00572078;Sorafenib and Bevacizumab in Combination With Paclitaxel in Patients With Solid Tumors;COMPLETED;['PHASE1'];INTERVENTIONAL;27.0;['SOLID TUMORS']
NCT02187302;CRLX101(NLG207) in Combination With Bevacizumab for Metastatic Renal Cell Carcinoma (mRCC) Versus Standard of Care (SOC);COMPLETED;['PHASE2'];INTERVENTIONAL;115.0;['Metastatic Renal Cell Carcinoma']
NCT04516278;A 3-month Study to Assess the Safety of ONS-5010 in Subjects With Visual Impairment Due to Retinal Disorders;COMPLETED;['PHASE3'];INTERVENTIONAL;195.0;['Age-related Macular Degeneration', 'Neovascular Age-related Macular Degeneration', 'Wet Macular Degeneration', 'BRVO - Branch Retinal Vein Occlusion', 'Diabetic Macular Edema']
NCT00203502;Primary Systemic Therapy in Operable/Locally Advanced Breast Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;40.0;['Breast Cancer']
NCT00597402;Avastin in Combination With Radiation (XRT) & Temozolomide, Followed by Avastin, Temozolomide and Irinotecan for Glioblastoma (GBM) and Gliosarcomas;COMPLETED;['PHASE2'];INTERVENTIONAL;125.0;['Glioblastoma', 'Gliosarcoma', 'Brain Tumor']
NCT02348918;Phase 2 Randomized Clinical Trial of LuminateÂ® as Compared to AvastinÂ® in the Treatment of Diabetic Macular Edema;COMPLETED;['PHASE2'];INTERVENTIONAL;218.0;['Diabetic Macular Edema']
NCT00100841;Phase II Trial of FOLFOX6, Bevacizumab and Cetuximab in Patients With Colorectal Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;66.0;['Adenocarcinoma of the Rectum', 'Mucinous Adenocarcinoma of the Colon', 'Recurrent Colon Cancer', 'Recurrent Rectal Cancer', 'Signet Ring Adenocarcinoma of the Colon', 'Stage IV Colon Cancer', 'Stage IV Rectal Cancer']
NCT00121836;A Study of Xeloda (Capecitabine) in Women With HER2-Negative Metastatic Breast Cancer;COMPLETED;['PHASE4'];INTERVENTIONAL;109.0;['Breast Cancer']
NCT00336323;A Phase 2 Evaluation of Anti-VEGF Therapy for Diabetic Macular Edema: Bevacizumab (Avastin);COMPLETED;['PHASE2'];INTERVENTIONAL;121.0;['Diabetic Retinopathy']
NCT04857684;SBRT + Atezolizumab + Bevacizumab in Resectable HCC;RECRUITING;['EARLY_PHASE1'];INTERVENTIONAL;20.0;['Hepatocellular Carcinoma', 'Resectable Hepatocellular Carcinoma']
NCT03942328;Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer;RECRUITING;['PHASE1', 'PHASE2'];INTERVENTIONAL;54.0;['Stage III Hepatocellular Carcinoma AJCC v8', 'Stage III Intrahepatic Cholangiocarcinoma AJCC v8', 'Stage IV Hepatocellular Carcinoma AJCC v8', 'Stage IV Intrahepatic Cholangiocarcinoma AJCC v8', 'Unresectable Hepatocellular Carcinoma', 'Unresectable Intrahepatic Cholangiocarcinoma']
NCT00613028;Ph II Bev + Either Temozolomide/Etoposide for GBM Pts Who Have Failed Bev + Irinotecan;COMPLETED;['PHASE2'];INTERVENTIONAL;23.0;['Glioblastoma', 'Gliosarcoma']
NCT00321828;Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colon Cancer That Cannot Be Removed By Surgery;COMPLETED;['PHASE2'];INTERVENTIONAL;90.0;['Colorectal Cancer']
NCT00281528;Weekly vs. Every 2 Week vs. Every 3 Week Administration of ABI-007 (Abraxane)/Bevacizumab Combination in Metastatic Breast Cancer;TERMINATED;['PHASE2'];INTERVENTIONAL;208.0;['Breast Neoplasms', 'Neoplasm Metastasis']
NCT00242502;Efficacy and Safety Study of Bevacizumab and Erlotinib to Treat Primary Liver Cancer That Cannot be Removed By Surgery;COMPLETED;['PHASE2'];INTERVENTIONAL;62.0;['Hepatocellular Carcinoma', 'Liver Cancer']
NCT05445778;Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Ovarian, Fallopian Tube, or Peritoneal Cancer (GLORIOSA);RECRUITING;['PHASE3'];INTERVENTIONAL;418.0;['Ovarian Cancer', 'Peritoneal Cancer', 'Fallopian Tube Cancer']
NCT00357318;Bevacizumab and Sunitinib in Treating Patients With Solid Tumors;COMPLETED;['PHASE1'];INTERVENTIONAL;60.0;['Unspecified Adult Solid Tumor, Protocol Specific']
NCT00464178;A Phase II Study of Bevacizumab and Bortezomib in Patients With Relapsed/Refractory Multiple Myeloma;TERMINATED;['PHASE2'];INTERVENTIONAL;7.0;['Multiple Myeloma']
NCT04421378;A Study of Selinexor in Combination With Standard of Care Therapy for Newly Diagnosed or Recurrent Glioblastoma;TERMINATED;['PHASE1', 'PHASE2'];INTERVENTIONAL;74.0;['Glioblastoma Multiforme']
NCT00942578;A Phase 2 Trial of Bevacizumab, Lenalidomide, Docetaxel, and Prednisone (ART-P) for Treatment of Metastatic Castrate-Resistant Prostate Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;63.0;['Metastatic Prostate Cancer']
NCT02292758;Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With RAS Wild-Type Locally Advanced or Metastatic Colorectal Cancer That Cannot Be Removed by Surgery;COMPLETED;['PHASE2'];INTERVENTIONAL;36.0;['Colorectal Adenocarcinoma', 'RAS Wild Type', 'Stage IV Colorectal Cancer AJCC v7', 'Stage IVA Colorectal Cancer AJCC v7', 'Stage IVB Colorectal Cancer AJCC v7']
NCT00096278;Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer;COMPLETED;['PHASE3'];INTERVENTIONAL;2710.0;['Colon Adenocarcinoma', 'Stage IIA Colon Cancer AJCC v7', 'Stage IIB Colon Cancer AJCC v7', 'Stage IIC Colon Cancer AJCC v7', 'Stage IIIA Colon Cancer AJCC v7', 'Stage IIIB Colon Cancer AJCC v7', 'Stage IIIC Colon Cancer AJCC v7']
NCT00462423;Abraxane and Avastin as Therapy for Patients With Malignant Melanoma, a Phase II Study;COMPLETED;['PHASE2'];INTERVENTIONAL;50.0;['Metastatic Malignant Melanoma']
NCT01468623;Study Comparing Optimized 5-FU Dosing and Standard Dosing in Metastatic Colorectal Cancer Patients Treated With mFOLFOX6;TERMINATED;['PHASE4'];INTERVENTIONAL;51.0;['Colorectal Cancer, Metastatic']
NCT03423823;Ziv-aflibercept Efficacy in Better Regulating AMD;COMPLETED;['PHASE2'];INTERVENTIONAL;62.0;['Wet Macular Degeneration', 'Wet Age-related Macular Degeneration']
NCT01749384;Tivantinib and Bevacizumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery;COMPLETED;['PHASE1'];INTERVENTIONAL;12.0;['Solid Neoplasm']
NCT00537823;Pre- and Post-operative FOLFOX Based Therapy for Patients With Colorectal Cancer With Liver Involvement;TERMINATED;['PHASE2'];INTERVENTIONAL;9.0;['Colorectal Cancer', 'Metastases']
NCT04929223;A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC);RECRUITING;['PHASE1'];INTERVENTIONAL;422.0;['Metastatic Colorectal Cancer']
NCT00335829;Bevacizumab and Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery;COMPLETED;['PHASE2'];INTERVENTIONAL;26.0;['Liver Cancer']
NCT05330429;Study of Magrolimab Given Together With FOLFIRI/BEV in Patients With Previously Treated Advanced Inoperable Metastatic Colorectal Cancer (mCRC);RECRUITING;['PHASE2'];INTERVENTIONAL;135.0;['Metastatic Colorectal Cancer']
NCT00118261;Erlotinib, Modified FOLFOX6, and Bevacizumab as First-Line Therapy Metastatic Colorectal Cancer;COMPLETED;['PHASE1'];INTERVENTIONAL;17.0;['Colorectal Cancer']
NCT01139723;A Study of the Safety and Pharmacokinetics of MINT1526A, Administered Intravenously As a Single Agent and in Combination With Bevacizumab to Patients With Advanced Solid Tumors;COMPLETED;['PHASE1'];INTERVENTIONAL;54.0;['Solid Cancers']
NCT00866723;Avastin in Patients With Epithelial Ovarian, Primary Peritoneal Serous or Fallopian Tube Cancer;TERMINATED;['PHASE2'];INTERVENTIONAL;5.0;['Ovarian Cancer', 'Primary Peritoneal Serous Cancer', 'Fallopian Tube Cancer']
NCT02715284;Study of TSR-042, an Anti-programmed Cell Death-1 Receptor (PD-1) Monoclonal Antibody, in Participants With Advanced Solid Tumors;RECRUITING;['PHASE1'];INTERVENTIONAL;740.0;['Neoplasms']
NCT02490878;Corticosteroids + Bevacizumab vs. Corticosteroids + Placebo (BEST) for Radionecrosis After Radiosurgery for Brain Metastases;TERMINATED;['PHASE2'];INTERVENTIONAL;19.0;['Radionecrosis', 'Brain Metastases']
NCT02743078;OptuneÂ® Plus Bevacizumab in Bevacizumab-Refractory Recurrent Glioblastoma;TERMINATED;['PHASE2'];INTERVENTIONAL;3.0;['Glioblastoma', 'Glioma', 'Gliosarcoma']
NCT01198158;Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy;TERMINATED;['PHASE3'];INTERVENTIONAL;77.0;['Clear Cell Renal Cell Carcinoma', 'Recurrent Renal Cell Carcinoma', 'Stage III Renal Cell Cancer AJCC v7', 'Stage IV Renal Cell Cancer AJCC v7']
NCT00097578;A Study of Avastin With Chemotherapy for Treatment of Metastatic or Advanced and Unresectable Colorectal Adenocarcinoma;COMPLETED;;OBSERVATIONAL;1953.0;['Colorectal Cancer']
NCT00354978;Study of FOLFIRI Plus Bevacizumab in Colorectal Cancer Patients;COMPLETED;['PHASE2'];INTERVENTIONAL;49.0;['Colorectal Cancer']
NCT00870636;Use of Pan-vascular Endothelial Growth Factor Receptor (Pan-VEGF) Blockade for the Treatment of Retinopathy of Prematurity (ROP) (Compassionate Use BLOCK-ROP);NO_LONGER_AVAILABLE;;EXPANDED_ACCESS;;['Retinopathy of Prematurity']
NCT00762034;A Study of Pemetrexed, Carboplatin and Bevacizumab in Participants With Nonsquamous Non-Small Cell Lung Cancer;COMPLETED;['PHASE3'];INTERVENTIONAL;939.0;['Non-small Cell Lung Cancer']
NCT05410301;Golden Halo, Static Magnetic and Electric Field Device, in Recurrent Glioblastoma;WITHDRAWN;['NA'];INTERVENTIONAL;0.0;['Glioblastoma', 'Recurrent Glioblastoma']
NCT01514123;Study of VGX-100 Administered Alone and Co-administered With Bevacizumab in Adult Subjects With Advanced Solid Tumors;COMPLETED;['PHASE1'];INTERVENTIONAL;43.0;['Neoplasms', 'Cancer']
NCT03661723;Pembrolizumab and Reirradiation in Bevacizumab NaÃ¯ve and Bevacizumab Resistant Recurrent Glioblastoma;ACTIVE_NOT_RECRUITING;['PHASE2'];INTERVENTIONAL;60.0;['Glioblastoma']
NCT00974584;A Study of the Safety and Pharmacology Of PI3-Kinase Inhibitor GDC-0941 In Combination With Either Paclitaxel And Carboplatin (With or Without Bevacizumab) or Pemetrexed, Cisplatin, And Bevacizumab in Patients With Advanced Non-Small Cell Lung Cancer;COMPLETED;['PHASE1'];INTERVENTIONAL;65.0;['Non-Squamous Non-Small Cell Lung Cancer']
NCT00970684;Bevacizumab, Docetaxel, and Gemcitabine Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;13.0;['Lung Cancer']
NCT01740258;Bevacizumab Beyond Progression (BBP);COMPLETED;['PHASE2'];INTERVENTIONAL;68.0;['Malignant Glioma', 'Grade 4 Malignant Glioma', 'Glioblastoma', 'Gliosarcoma']
NCT03032484;TVB- 2640 in Combination With Bevacizumab in Patients With First Relapse of High Grade Astrocytoma;COMPLETED;['PHASE2'];INTERVENTIONAL;25.0;['Astrocytoma']
NCT03141684;Testing Atezolizumab Alone or Atezolizumab Plus Bevacizumab in People With Advanced Alveolar Soft Part Sarcoma;RECRUITING;['PHASE2'];INTERVENTIONAL;63.0;['Metastatic Alveolar Soft Part Sarcoma', 'Unresectable Alveolar Soft Part Sarcoma']
NCT01399684;A Study Evaluating the Efficacy and Safety of MEGF0444A Dosed to Progression in Combination With Bevacizumab and mFOLFOX-6 in Participants With Previously Untreated Metastatic Colorectal Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;127.0;['Metastatic Colorectal Cancer']
NCT00043823;Avastin and Tarceva for Locally Advanced or Metastatic Non-Squamous Non-Small-Cell Lung Cancer;COMPLETED;['PHASE1', 'PHASE2'];INTERVENTIONAL;41.0;['Lung Cancer']
NCT05211323;A Study to Determine Whether Chemotherapy and Atezolizumab is Better Than Chemotherapy, Bevacizumab and Atezolizumab in Patients With Advanced Liver Cancer;RECRUITING;['PHASE2'];INTERVENTIONAL;88.0;['Combined Hepatocellular Carcinoma and Cholangiocarcinoma', 'Stage III Liver Cancer', 'Stage IV Liver Cancer']
NCT00884741;Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma;COMPLETED;['PHASE3'];INTERVENTIONAL;637.0;['Glioblastoma', 'Gliosarcoma', 'Supratentorial Glioblastoma']
NCT04171141;Study to Test the Safety and Tolerability of PF-07062119 in Patients With Selected Advanced or Metastatic Gastrointestinal Tumors.;TERMINATED;['PHASE1'];INTERVENTIONAL;78.0;['Gastrointestinal Tumors', 'Colorectal Adenocarcinomas', 'Gastric Adenocarcinomas', 'Esophageal Adenocarcinomas']
NCT00735241;FOLFOX6 Plus Sir-Spheres Microspheres Plus Avastin in Patients With Nonresectable Liver Metastases From Colorectal Carcinoma;WITHDRAWN;['PHASE2', 'PHASE3'];INTERVENTIONAL;0.0;['Colorectal Carcinoma', 'Liver Metastases']
NCT00654836;Carboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;32.0;['Breast Cancer']
NCT00130728;A Study to Evaluate the Efficacy of Bevacizumab in Combination With Tarceva for Advanced Non-Small Cell Lung Cancer;COMPLETED;['PHASE3'];INTERVENTIONAL;636.0;['Non-Small Cell Lung Cancer']
NCT00632541;A Phase II Study of Bevacizumab + Sorafenib in Metastatic Breast Cancer;TERMINATED;['PHASE2'];INTERVENTIONAL;18.0;['Metastatic Breast Cancer']
NCT01055028;Paclitaxel + Bevacizumab (Avastin) for the Treatment of Metastatic or Unresectable Angiosarcoma;TERMINATED;['PHASE2'];INTERVENTIONAL;18.0;['Angiosarcomas', 'Soft Tissue Sarcoma']
NCT01397695;Topical Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT);COMPLETED;['PHASE2'];INTERVENTIONAL;20.0;['Hereditary Hemorrhagic Telangiectasia (HHT)']
NCT00816595;Pentostatin, Cyclophosphamide, and Rituximab With or Without Bevacizumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma;COMPLETED;['PHASE2'];INTERVENTIONAL;68.0;['Leukemia', 'Lymphoma']
NCT01435395;Trial of Temozolomide, Bevacizumab Plus Bortezomib for Recurrent Glioblastoma Multiforme;COMPLETED;['PHASE1'];INTERVENTIONAL;12.0;['Glioblastoma Multiforme']
NCT00625898;BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab;TERMINATED;['PHASE3'];INTERVENTIONAL;3509.0;['Breast Cancer']
NCT00028834;Bevacizumab and Gemcitabine in Treating Patients With Advanced Pancreatic Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;50.0;['Adenocarcinoma of the Pancreas', 'Recurrent Pancreatic Cancer', 'Stage III Pancreatic Cancer', 'Stage IV Pancreatic Cancer']
NCT05039801;IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors;RECRUITING;['PHASE1'];INTERVENTIONAL;54.0;['Advanced Endometrial Carcinoma', 'Advanced Head and Neck Squamous Cell Carcinoma', 'Advanced Malignant Solid Neoplasm', 'Advanced Melanoma', 'Advanced Ovarian Clear Cell Adenocarcinoma', 'Chondrosarcoma', 'Clinical Stage III Cutaneous Melanoma AJCC v8', 'Clinical Stage IV Cutaneous Melanoma AJCC v8', 'Pathologic Stage III Cutaneous Melanoma AJCC v8', 'Pathologic Stage IIIA Cutaneous Melanoma AJCC v8', 'Pathologic Stage IIIB Cutaneous Melanoma AJCC v8', 'Pathologic Stage IIIC Cutaneous Melanoma AJCC v8', 'Pathologic Stage IIID Cutaneous Melanoma AJCC v8', 'Pathologic Stage IV Cutaneous Melanoma AJCC v8', 'Recurrent Ovarian High Grade Serous Adenocarcinoma', 'Refractory Endometrial Carcinoma', 'Refractory Head and Neck Squamous Cell Carcinoma', 'Refractory Melanoma', 'Refractory Ovarian Clear Cell Adenocarcinoma', 'Refractory Ovarian High Grade Serous Adenocarcinoma', 'Stage III Ovarian Cancer AJCC v8', 'Stage III Uterine Corpus Cancer AJCC v8', 'Stage IIIA Ovarian Cancer AJCC v8', 'Stage IIIA Uterine Corpus Cancer AJCC v8', 'Stage IIIA1 Ovarian Cancer AJCC v8', 'Stage IIIA2 Ovarian Cancer AJCC v8', 'Stage IIIB Ovarian Cancer AJCC v8', 'Stage IIIB Uterine Corpus Cancer AJCC v8', 'Stage IIIC Ovarian Cancer AJCC v8', 'Stage IIIC Uterine Corpus Cancer AJCC v8', 'Stage IIIC1 Uterine Corpus Cancer AJCC v8', 'Stage IIIC2 Uterine Corpus Cancer AJCC v8', 'Stage IV Ovarian Cancer AJCC v8', 'Stage IV Uterine Corpus Cancer AJCC v8', 'Stage IVA Ovarian Cancer AJCC v8', 'Stage IVA Uterine Corpus Cancer AJCC v8', 'Stage IVB Ovarian Cancer AJCC v8', 'Stage IVB Uterine Corpus Cancer AJCC v8']
NCT00150657;Study of Carboplatin/Gemcitabine Plus Bevacizumab in Advanced Lung Cancer;UNKNOWN;['PHASE2'];INTERVENTIONAL;45.0;['Non-Small Cell Lung Cancer']
NCT03387098;QUILT-3.070:Pancreatic Cancer Vaccine: Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy;UNKNOWN;['PHASE1', 'PHASE2'];INTERVENTIONAL;173.0;['Pancreatic Cancer']
NCT00601198;A Study of Amifostine (Ethyol) in Patients With Colorectal Cancer;TERMINATED;['PHASE2'];INTERVENTIONAL;4.0;['Colorectal Cancer']
NCT03476798;Bevacizumab and Rucaparib in Recurrent Carcinoma of the Cervix or Endometrium;COMPLETED;['PHASE2'];INTERVENTIONAL;49.0;['Cervical Cancer', 'Endometrial Cancer']
NCT02971501;Osimertinib With or Without Bevacizumab in Treating Patients With EGFR Positive Non-small Cell Lung Cancer and Brain Metastases;ACTIVE_NOT_RECRUITING;['PHASE2'];INTERVENTIONAL;112.0;['Metastatic Lung Non-Small Cell Carcinoma', 'Metastatic Malignant Neoplasm in the Brain', 'Stage IV Lung Cancer AJCC v8']
NCT00417976;Gemcitabine, Infusional 5 Fluorouracil and Bevacizumab in Patients With Advanced Pancreas Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;42.0;['Pancreatic Cancer']
NCT00592176;The Effect of Bevacizumab (Avastin) on Pterygium;COMPLETED;['PHASE2'];INTERVENTIONAL;5.0;['Pterygium']
NCT01113476;Nab-paclitaxel, Gemcitabine, and Bevacizumab in Advanced Malignancies;COMPLETED;['PHASE1'];INTERVENTIONAL;176.0;['Advanced Cancer']
NCT00267696;Study of Gemcitabine/Carboplatin/Bevacizumab to Treat Ovarian, Fallopian Tube or Primary Peritoneal Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;45.0;['Ovarian Cancer', 'Fallopian Tube Cancer', 'Peritoneal Cancer']
NCT01223235;Polyvalent Vaccine-KLH Conjugate + Opt-821 Given in Combination With Bevacizumab;COMPLETED;['NA'];INTERVENTIONAL;22.0;['Fallopian Tubes Cancer', 'Ovarian Cancer', 'Peritoneal Cancer']
NCT00384176;First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX;COMPLETED;['PHASE2', 'PHASE3'];INTERVENTIONAL;1814.0;['Colorectal Cancer']
NCT03295396;ONC201 in Adults With Recurrent H3 K27M-mutant Glioma;ACTIVE_NOT_RECRUITING;['PHASE2'];INTERVENTIONAL;95.0;['Glioma']
NCT00462501;Combination Chemotherapy and Bevacizumab With or Without Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer;COMPLETED;['NA'];INTERVENTIONAL;35.0;['Colorectal Cancer']
NCT02396511;TRC105 Combined With Standard-dose Bevacizumab for Two Patients With Metastatic And Refractory Choriocarcinoma;COMPLETED;['PHASE2'];INTERVENTIONAL;2.0;['Choriocarcinoma']
NCT00060411;A Phase I, Pharmacological, and Biological Study of OSI-774 in Combination With FOLFOX 4 (5-FU, Leucovorin, and Oxaliplatin) and Bevacizumab (Avastin) in Patients With Advanced Colorectal Cancer;COMPLETED;['PHASE1'];INTERVENTIONAL;24.0;['Mucinous Adenocarcinoma of the Colon', 'Mucinous Adenocarcinoma of the Rectum', 'Recurrent Colon Cancer', 'Recurrent Rectal Cancer', 'Signet Ring Adenocarcinoma of the Colon', 'Signet Ring Adenocarcinoma of the Rectum', 'Stage IIIA Colon Cancer', 'Stage IIIA Rectal Cancer', 'Stage IIIB Colon Cancer', 'Stage IIIB Rectal Cancer', 'Stage IIIC Colon Cancer', 'Stage IIIC Rectal Cancer', 'Stage IVA Colon Cancer', 'Stage IVA Rectal Cancer', 'Stage IVB Colon Cancer', 'Stage IVB Rectal Cancer']
NCT00055913;Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer;COMPLETED;['PHASE1', 'PHASE2'];INTERVENTIONAL;58.0;['Recurrent Squamous Cell Carcinoma of the Hypopharynx', 'Recurrent Squamous Cell Carcinoma of the Larynx', 'Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity', 'Recurrent Squamous Cell Carcinoma of the Nasopharynx', 'Recurrent Squamous Cell Carcinoma of the Oropharynx', 'Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity', 'Salivary Gland Squamous Cell Carcinoma', 'Stage IV Squamous Cell Carcinoma of the Hypopharynx', 'Stage IV Squamous Cell Carcinoma of the Larynx', 'Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity', 'Stage IV Squamous Cell Carcinoma of the Nasopharynx', 'Stage IV Squamous Cell Carcinoma of the Oropharynx', 'Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity']
NCT00588770;Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma;ACTIVE_NOT_RECRUITING;['PHASE3'];INTERVENTIONAL;403.0;['Neck Squamous Cell Carcinoma of Unknown Primary', 'Recurrent Hypopharyngeal Squamous Cell Carcinoma', 'Recurrent Laryngeal Squamous Cell Carcinoma', 'Recurrent Laryngeal Verrucous Carcinoma', 'Recurrent Lip and Oral Cavity Squamous Cell Carcinoma', 'Recurrent Neck Squamous Cell Carcinoma of Unknown Primary', 'Recurrent Oral Cavity Verrucous Carcinoma', 'Recurrent Oropharyngeal Squamous Cell Carcinoma', 'Recurrent Salivary Gland Carcinoma', 'Recurrent Sinonasal Squamous Cell Carcinoma', 'Salivary Gland Squamous Cell Carcinoma', 'Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7', 'Stage IV Major Salivary Gland Cancer AJCC v7', 'Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7', 'Stage IVA Laryngeal Verrucous Carcinoma AJCC v7', 'Stage IVA Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7', 'Stage IVA Major Salivary Gland Cancer AJCC v7', 'Stage IVA Oral Cavity Cancer AJCC v6 and v7', 'Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7', 'Stage IVA Sinonasal Squamous Cell Carcinoma AJCC v7', 'Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7', 'Stage IVB Laryngeal Verrucous Carcinoma AJCC v7', 'Stage IVB Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7', 'Stage IVB Major Salivary Gland Cancer AJCC v7', 'Stage IVB Oral Cavity Cancer AJCC v6 and v7', 'Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7', 'Stage IVB Sinonasal Squamous Cell Carcinoma AJCC v7', 'Stage IVC Laryngeal Squamous Cell Carcinoma AJCC v7', 'Stage IVC Laryngeal Verrucous Carcinoma AJCC v7', 'Stage IVC Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7', 'Stage IVC Major Salivary Gland Cancer AJCC v7', 'Stage IVC Oral Cavity Cancer AJCC v6 and v7', 'Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7', 'Stage IVC Sinonasal Squamous Cell Carcinoma AJCC v7', 'Tongue Carcinoma']
NCT01418222;FOLFOX/Bevacizumab With Onartuzumab (MetMAb) Versus Placebo as First-Line Treatment in Patients With Metastatic Colorectal Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;194.0;['Colorectal Cancer']
NCT03872947;A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors;RECRUITING;['PHASE1'];INTERVENTIONAL;187.0;['Solid Tumor', 'Colorectal Cancer', 'Cholangiocarcinoma', 'Bladder Cancer', 'Ovarian Cancer', 'Gastric Cancer', 'Palpable Subcutaneous Malignant Lesions', 'Renal Cell Carcinoma', 'Melanoma', 'Epithelial Ovarian Cancer', 'Primary Peritoneal Cancer', 'Fallopian Tube Cancer']
NCT00583622;Bevacizumab Plus Gemcitabine, Docetaxel, Melphalan, and Carboplatin in Ovarian Cancer Patients;TERMINATED;['PHASE2'];INTERVENTIONAL;13.0;['Ovarian Cancer']
NCT00464347;TAC-PF, AvastinÂ® in Combination With Photodynamic Therapy to Treat Age Related Macular Degeneration;TERMINATED;['PHASE2'];INTERVENTIONAL;100.0;['Age-Related Macular Degeneration']
NCT03203447;Suprachoroidal Injection of Triamcinolone Acetonide With IVT Anti-VEGF in Subjects With Macular Edema Following RVO;TERMINATED;['PHASE3'];INTERVENTIONAL;325.0;['Macular Edema', 'Retinal Vein Occlusion']
NCT00324987;Imatinib Mesylate With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor;TERMINATED;['PHASE3'];INTERVENTIONAL;12.0;['Gastrointestinal Stromal Tumor']
NCT00262847;Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer;COMPLETED;['PHASE3'];INTERVENTIONAL;1873.0;['Fallopian Tube Clear Cell Adenocarcinoma', 'Fallopian Tube Endometrioid Adenocarcinoma', 'Fallopian Tube Mucinous Adenocarcinoma', 'Fallopian Tube Serous Adenocarcinoma', 'Fallopian Tube Transitional Cell Carcinoma', 'Malignant Ovarian Mixed Epithelial Tumor', 'Ovarian Brenner Tumor', 'Ovarian Clear Cell Adenocarcinoma', 'Ovarian Endometrioid Adenocarcinoma', 'Ovarian Mucinous Adenocarcinoma', 'Ovarian Serous Adenocarcinoma', 'Ovarian Transitional Cell Carcinoma', 'Primary Peritoneal Serous Adenocarcinoma', 'Stage IIIA Fallopian Tube Cancer', 'Stage IIIA Ovarian Cancer', 'Stage IIIA Primary Peritoneal Cancer', 'Stage IIIB Fallopian Tube Cancer', 'Stage IIIB Ovarian Cancer', 'Stage IIIB Primary Peritoneal Cancer', 'Stage IIIC Fallopian Tube Cancer', 'Stage IIIC Ovarian Cancer', 'Stage IIIC Primary Peritoneal Cancer', 'Stage IV Fallopian Tube Cancer', 'Stage IV Ovarian Cancer', 'Stage IV Primary Peritoneal Cancer', 'Undifferentiated Fallopian Tube Carcinoma', 'Undifferentiated Ovarian Carcinoma']
NCT00496587;Capecitabine, Gemcitabine, and Bevacizumab in Combination for Patients With Sarcomatoid Renal Cell Carcinoma;COMPLETED;['PHASE2'];INTERVENTIONAL;34.0;['Renal Cell Carcinoma', 'Kidney Cancer']
NCT03394885;Atezolizumab With Neoadjuvant Chemotherapy for Patients With Newly-Diagnosed Advanced-Stage Ovarian Cancer;COMPLETED;['PHASE1', 'PHASE2'];INTERVENTIONAL;18.0;['Ovarian Cancer', 'Ovarian Neoplasms']
NCT01649947;Modulation of Autophagy in Patients With Advanced/Recurrent Non-small Cell Lung Cancer - Phase II;COMPLETED;['PHASE2'];INTERVENTIONAL;32.0;['Non-small Cell Lung Cancer', 'Advanced Non-small Cell Lung Cancer', 'Recurrent Non-small Cell Lung Cancer']
NCT00101686;Trial Of Irinotecan In Combination With Three Methods Of Administration Of Fluoropyrimidine.;COMPLETED;['PHASE3'];INTERVENTIONAL;547.0;['Colorectal Neoplasms']
NCT00588666;Phase II Trial of Gemcitabine, Carboplatin, and Bevacizumab in Chemotherapy Naive Patients With Advanced/Metastatic Urothelial Carcinoma;COMPLETED;['PHASE2'];INTERVENTIONAL;51.0;['Myeloproliferative Disorder', 'Urothelial Carcinoma', 'Cancer']
NCT00621686;Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme;COMPLETED;['PHASE2'];INTERVENTIONAL;54.0;['Brain and Central Nervous System Tumors']
NCT01860586;Eye Injections of Bevacizumab for Lowering Risk of Scar Tissue in the Retina and Repeated Retinal Detachment.;COMPLETED;['NA'];INTERVENTIONAL;20.0;['Retinal Detachment', 'Vitreoretinopathy Proliferative']
NCT00908219;A Study of Bevacizumab to Prevent Malignant Ascites;WITHDRAWN;['PHASE2'];INTERVENTIONAL;0.0;['Malignant Ascites']
NCT00457119;Combination of RAD001 With Carboplatin, Paclitaxel and Bevacizumab in Non-small-cell Lung Cancer (NSCLC) Patients;COMPLETED;['PHASE1'];INTERVENTIONAL;69.0;['Non Small Cell Lung Cancer']
NCT00193219;Bevacizumab and Cetuximab in Combination With FOLFOX6 in Patients With Metastatic Colorectal Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;36.0;['Colon Cancer']
NCT00448019;FCR and Bevacizumab in the Treatment of Relapsed Chronic Lymphocytic Leukemia (CLL);COMPLETED;['PHASE2'];INTERVENTIONAL;64.0;['Chronic Lymphocytic Leukemia']
NCT00702819;Pan-VEGF Blockade for the Treatment of Retinopathy of Prematurity;TERMINATED;['PHASE1'];INTERVENTIONAL;2.0;['Retinopathy of Prematurity']
NCT03382886;Nivolumab and Bevacizumab in Patients With Advanced and or Metastatic Hepatocellular Carcinoma;TERMINATED;['PHASE1'];INTERVENTIONAL;1.0;['Hepatocellular Carcinoma']
NCT00513786;Evaluation of Carboplatin/Paclitaxel/Bevacizumab in the Treatment of Advanced Stage Endometrial Carcinoma;COMPLETED;['PHASE2'];INTERVENTIONAL;38.0;['Endometrial Cancer']
NCT00612586;Study of Enzastaurin With 5-Fluorouracil/Leucovorin (5-FU/LV) Plus Bevacizumab as Maintenance Regimen Following First Line Therapy for Metastatic Colon Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;117.0;['Colorectal Cancer']
NCT00055237;Bevacizumab to Treat Kaposi's Sarcoma in HIV-Positive and HIV-Negative Patients;COMPLETED;['PHASE2'];INTERVENTIONAL;19.0;"[""Kaposi's Sarcoma"", 'HIV Infections', 'HIV Seronegativity']"
NCT03024437;Atezolizumab in Combination With Entinostat and Bevacizumab in Patients With Advanced Renal Cell Carcinoma;SUSPENDED;['PHASE1', 'PHASE2'];INTERVENTIONAL;72.0;['Metastatic Cancer', 'Renal Cancer']
NCT02835833;Study of Nintedanib Plus Bevacizumab in Advanced Solid Tumors;COMPLETED;['PHASE1'];INTERVENTIONAL;21.0;['Renal Cell Carcinoma', 'Colorectal Adenocarcinoma', 'Non-squamous Non-small Cell Lung Cancer', 'Platinum-refractory Ovarian Carcinoma', 'Cervical Carcinoma']
NCT00623233;Gemcitabine Plus Bevacizumab in Locally Recurrent or Metastatic Breast Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;52.0;['Metastatic Breast Cancer', 'Locally Advanced Breast Cancer']
NCT03307785;Study of Niraparib, TSR-022, Bevacizumab, and Platinum-Based Doublet Chemotherapy in Combination With TSR-042;ACTIVE_NOT_RECRUITING;['PHASE1'];INTERVENTIONAL;58.0;['Neoplasms', 'Metastatic Cancer', 'Advanced Cancer', 'Solid Tumor', 'Non Small Cell Lung Cancer Metastatic', 'Non Small Cell Lung Cancer Stage IIIB', 'Non Small Cell Lung Cancer']
NCT01871766;Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy;ACTIVE_NOT_RECRUITING;['PHASE2'];INTERVENTIONAL;98.0;['Rhabdomyosarcoma']
NCT00998166;A Study of Cisplatin + Pemetrexed + Avastin as First-Line Therapy in Patients With Advanced Non-Small Cell Lung Carcinoma (NSCLC);TERMINATED;['PHASE2'];INTERVENTIONAL;4.0;['Non-Small Cell Lung Cancer']
NCT00006786;Combination Chemotherapy Plus Bevacizumab in Treating Patients With Advanced Colorectal Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;;['Colorectal Cancer']
NCT02496286;Feasibility Study of Intraperitoneal Bevacizumab for Palliation of Intractable Malignant Ascites;TERMINATED;['PHASE1'];INTERVENTIONAL;10.0;['Malignant Ascites']
NCT00254319;Previously Untreated Advanced Non-Small Cell Lung Cancer (NSCLC);UNKNOWN;['PHASE2'];INTERVENTIONAL;;['Untreated Advanced Non-Small Cell Lung Cancer']
NCT05253651;A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer;RECRUITING;['PHASE3'];INTERVENTIONAL;400.0;['Colorectal Neoplasms']
NCT01648348;Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma Multiforme;COMPLETED;['PHASE1', 'PHASE2'];INTERVENTIONAL;116.0;['Adult Anaplastic Astrocytoma', 'Adult Anaplastic Oligodendroglioma', 'Adult Giant Cell Glioblastoma', 'Adult Glioblastoma', 'Adult Gliosarcoma', 'Adult Mixed Glioma', 'Recurrent Adult Brain Neoplasm']
NCT00015951;Bevacizumab, Cytarabine, and Mitoxantrone on Treating Patients With Hematologic Cancers;COMPLETED;['PHASE2'];INTERVENTIONAL;;['Leukemia', 'Myelodysplastic Syndromes']
NCT00336648;Preop Chemoradiation Resectable Pancreas;COMPLETED;['PHASE2'];INTERVENTIONAL;11.0;['Pancreatic Neoplasms']
NCT01283048;Bevacizumab and BKM-120 in Patients With Metastatic Renal Cell Carcinoma;COMPLETED;['PHASE1'];INTERVENTIONAL;32.0;['Renal Cell Carcinoma']
NCT02078648;Safety and Efficacy Study of SL-701, a Glioma-Associated Antigen Vaccine To Treat Recurrent Glioblastoma Multiforme;COMPLETED;['PHASE1', 'PHASE2'];INTERVENTIONAL;74.0;['Adult Brain Glioblastoma', 'Glioblastoma Multiforme']
NCT00089648;SU011248 In The Treatment Of Patients With Bevacizumab (Avastin)-Refractory Metastatic Renal Cell Carcinoma;COMPLETED;['PHASE2'];INTERVENTIONAL;61.0;['Carcinoma, Renal Cell']
NCT05718466;Stereotactic Radiology Versus Chemotherapy for Recurrent/Progressive Glioblastoma After Second-Line Chemotherapy;COMPLETED;['PHASE3'];INTERVENTIONAL;35.0;['Recurrent or Progressive Glioblastoma']
NCT03750786;A Study to Compare the Efficacy of Arfolitixorin Versus Leucovorin in Combination With 5 Fluorouracil, Oxaliplatin, and Bevacizumab in Patients With Advanced Colorectal Cancer;COMPLETED;['PHASE3'];INTERVENTIONAL;490.0;['Colo-rectal Cancer']
NCT05904886;A Study Evaluating Atezolizumab and Bevacizumab, With or Without Tiragolumab, in Participants With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma (IMbrave152);RECRUITING;['PHASE3'];INTERVENTIONAL;650.0;['Carcinoma, Hepatocellular']
NCT00890786;A Study of Bevacizumab Therapy in Patients With Newly Diagnosed High-Grade Gliomas and Diffuse Intrinsic Pontine Gliomas;COMPLETED;['EARLY_PHASE1'];INTERVENTIONAL;27.0;['Newly Diagnosed High-Grade Gliomas', 'Diffuse Intrinsic Pontine Glioma']
NCT01130519;A Phase II Study of Bevacizumab and Erlotinib in Subjects With Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary Renal Cell Cancer;ACTIVE_NOT_RECRUITING;['PHASE2'];INTERVENTIONAL;83.0;['HLRCC', 'Sporadic Papillary Renal Cell Cancer']
NCT02502266;Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer;ACTIVE_NOT_RECRUITING;['PHASE2', 'PHASE3'];INTERVENTIONAL;562.0;['Fallopian Tube Clear Cell Adenocarcinoma', 'Fallopian Tube Endometrioid Adenocarcinoma', 'Fallopian Tube Serous Adenocarcinoma', 'Fallopian Tube Transitional Cell Carcinoma', 'Fallopian Tube Undifferentiated Carcinoma', 'Ovarian Clear Cell Adenocarcinoma', 'Ovarian Endometrioid Adenocarcinoma', 'Ovarian Seromucinous Carcinoma', 'Ovarian Serous Adenocarcinoma', 'Ovarian Transitional Cell Carcinoma', 'Ovarian Undifferentiated Carcinoma', 'Primary Peritoneal Serous Adenocarcinoma', 'Recurrent Fallopian Tube Carcinoma', 'Recurrent Ovarian Carcinoma', 'Recurrent Primary Peritoneal Carcinoma']
NCT03929666;A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer;RECRUITING;['PHASE2'];INTERVENTIONAL;362.0;['HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer']
NCT00468585;Study of Biweekly Capecitabine Dosing With Bevacizumab for the Treatment of Metastatic Breast Cancer Based Upon the Norton-Simon Mathematical Model;COMPLETED;['PHASE1', 'PHASE2'];INTERVENTIONAL;62.0;['Breast Cancer']
NCT01891747;A Phase I Study of High-dose L-methylfolate in Combination With Temozolomide and Bevacizumab in Recurrent High Grade Glioma;COMPLETED;['PHASE1'];INTERVENTIONAL;14.0;['Malignant Glioma']
NCT00321100;Combination of Cetuximab, Capecitabine, and Oxaliplatin With or Without Bevacizumab;TERMINATED;['PHASE2'];INTERVENTIONAL;23.0;['Colorectal Neoplasms']
NCT00200200;Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combination With Chemotherapy With/Without Bevacizumab for Hepatic Metastases From Colorectal Cancer;ACTIVE_NOT_RECRUITING;['PHASE2'];INTERVENTIONAL;73.0;['Hepatic Metastases', 'Colon Cancer', 'Rectal Cancer']
NCT00287222;Bevacizumab and Erlotinib in Inoperable and Metastatic Hepatocellular Carcinoma;COMPLETED;['PHASE2'];INTERVENTIONAL;21.0;['Hepatocellular Carcinoma']
NCT05146687;Real-world Evaluation of Prevalence of Ocular Adverse Events in Patients With Neovascular (Wet) Age-related Macular Degeneration (AMD) Who Received Anti-vascular Endothelial Growth Factor (VEGF) Agents (Komodo Health);COMPLETED;;OBSERVATIONAL;369600.0;['Age-related Macular Degeneration (AMD)']
NCT00049322;Chemoembolization and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed With Surgery;COMPLETED;['PHASE2'];INTERVENTIONAL;30.0;['Liver Cancer']
NCT05908786;A Study Evaluating The Efficacy and Safety of Neoadjuvant Immunotherapy Combinations in Patients With Surgically Resectable Hepatocellular Carcinoma;RECRUITING;['PHASE1', 'PHASE2'];INTERVENTIONAL;150.0;['Carcinoma, Hepatocellular']
NCT06006286;A Study Evaluating Atezolizumab and Bevacizumab Plus ADI-PEG 20 in Patients With Locally Advanced / Metastatic Hepatocellular Carcinoma;WITHDRAWN;['PHASE1', 'PHASE2'];INTERVENTIONAL;0.0;['Metastatic Hepatocellular Carcinoma']
NCT03573986;Pilot Study of 18F-FMISO PET/CT and MRI Imaging to Explore Tissue Hypoxia and Arteriovenous Shunting in Subjects With Recurrent Glioblastoma Before and After Bevacizumab Treatment;TERMINATED;['PHASE1'];INTERVENTIONAL;2.0;['Recurrent Glioblastoma']
NCT02519348;A Study of Durvalumab or Tremelimumab Monotherapy, or Durvalumab in Combination With Tremelimumab or Bevacizumab in Advanced Hepatocellular Carcinoma;ACTIVE_NOT_RECRUITING;['PHASE2'];INTERVENTIONAL;433.0;['Hepatocellular Carcinoma']
NCT00022048;Bevacizumab in Treating Patients With Myelodysplastic Syndrome;COMPLETED;['PHASE1', 'PHASE2'];INTERVENTIONAL;;['Leukemia', 'Myelodysplastic Syndromes', 'Myelodysplastic/Myeloproliferative Neoplasms']
NCT00698451;A Study of Carboplatin and DOXIL Plus Bevacizumab in Patients With Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers;COMPLETED;['PHASE2'];INTERVENTIONAL;54.0;['Ovarian Neoplasms', 'Fallopian Tube Neoplasms', 'Peritoneal Neoplasms']
NCT01777412;Efficacy of Bevacizumab (Avastin) in Treatment of Acute NMO Exacerbations;COMPLETED;['PHASE1'];INTERVENTIONAL;10.0;['Neuromyelitis Optica', 'Neuromyelitis Optica Spectrum Disorder']
NCT00708448;Early Prediction of Therapeutic Response to Targeted Therapy in Stage IIIB/IV or Recurrent Lung Cancer Patients;COMPLETED;['PHASE1'];INTERVENTIONAL;26.0;['Cancer', 'Non Small Cell Lung Cancer']
NCT00989651;Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer;COMPLETED;['PHASE1'];INTERVENTIONAL;431.0;['Fallopian Tube Carcinoma', 'Fallopian Tube Carcinosarcoma', 'Fallopian Tube Clear Cell Adenocarcinoma', 'Fallopian Tube Endometrioid Adenocarcinoma', 'Fallopian Tube Mucinous Adenocarcinoma', 'Fallopian Tube Serous Neoplasm', 'Fallopian Tube Transitional Cell Carcinoma', 'Fallopian Tube Undifferentiated Carcinoma', 'Ovarian Brenner Tumor', 'Ovarian Carcinoma', 'Ovarian Carcinosarcoma', 'Ovarian Clear Cell Adenocarcinoma', 'Ovarian Endometrioid Adenocarcinoma', 'Ovarian Mucinous Adenocarcinoma', 'Ovarian Seromucinous Tumor', 'Ovarian Serous Adenocarcinoma', 'Ovarian Transitional Cell Carcinoma', 'Ovarian Undifferentiated Carcinoma', 'Primary Peritoneal Carcinoma', 'Primary Peritoneal Serous Adenocarcinoma', 'Stage IIA Fallopian Tube Cancer AJCC v6 and v7', 'Stage IIA Ovarian Cancer AJCC V6 and v7', 'Stage IIB Fallopian Tube Cancer AJCC v6 and v7', 'Stage IIB Ovarian Cancer AJCC v6 and v7', 'Stage IIC Fallopian Tube Cancer AJCC v6 and v7', 'Stage IIC Ovarian Cancer AJCC v6 and v7', 'Stage IIIA Fallopian Tube Cancer AJCC v7', 'Stage IIIA Ovarian Cancer AJCC v6 and v7', 'Stage IIIA Primary Peritoneal Cancer AJCC v7', 'Stage IIIB Fallopian Tube Cancer AJCC v7', 'Stage IIIB Ovarian Cancer AJCC v6 and v7', 'Stage IIIB Primary Peritoneal Cancer AJCC v7', 'Stage IIIC Fallopian Tube Cancer AJCC v7', 'Stage IIIC Ovarian Cancer AJCC v6 and v7', 'Stage IIIC Primary Peritoneal Cancer AJCC v7', 'Stage IV Fallopian Tube Cancer AJCC v6 and v7', 'Stage IV Ovarian Cancer AJCC v6 and v7', 'Stage IV Primary Peritoneal Cancer AJCC v7']
NCT00445848;S0636: Erlotinib and Bevacizumab in Never-Smokers With Stage IIIB or Stage IV Primary Non-Small Cell Lung Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;89.0;['Lung Cancer']
NCT05839951;An Observational Study Called STAR-T to Learn More About the Sequential Treatment With Regorafenib and TAS-102 in Adults With Metastatic Colorectal Cancer Under Real World Conditions;ACTIVE_NOT_RECRUITING;;OBSERVATIONAL;818.0;['Metastatic Colorectal Cancer (mCRC)']
NCT01309451;Ozurdex as Adjunct to Avastin Compared to Avastin Alone in Treatment of Patients With Diabetic Macular Edema;COMPLETED;['PHASE4'];INTERVENTIONAL;40.0;['Diabetic Macular Edema']
NCT01383148;Phase IIB/III Of TG4010 Immunotherapy In Patients With Stage IV Non-Small Cell Lung Cancer;TERMINATED;['PHASE2', 'PHASE3'];INTERVENTIONAL;222.0;['Non-Small-Cell Lung Carcinoma']
NCT00394251;Study of Dose-dense Adriamycin Plus Cytoxan (AC) Followed by Either ABI-007 (Abraxane) or Taxol With Bevacizumab as Adjuvant Therapy for Patients With Breast Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;197.0;['Breast Cancer']
NCT00652119;Intraperitoneal Paclitaxel and Carboplatin With IV Avastin Therapy in Patients With Carcinomas of Mullerian Origin;UNKNOWN;['PHASE1'];INTERVENTIONAL;46.0;['Ovarian Cancer', 'Peritoneal Cancer', 'Fallopian Tube Cancer']
NCT00227019;Phase 2 Trial of Bevacizumab in Combination With Pemetrexed;COMPLETED;['PHASE2'];INTERVENTIONAL;16.0;['Non-small Cell Lung Cancer (NSCLC)', 'Lung Cancer', 'Neoplasm Metastasis']
NCT02065466;Combo of Abraxane, TMZ, Bevacizumab in Metastatic Melanoma With Brain Metastases;WITHDRAWN;['PHASE1', 'PHASE2'];INTERVENTIONAL;0.0;['Metastatic Melanoma', 'Brain Metastases']
NCT01314066;Efficacy of Bevacizumab in Preventing Acute Respiratory Distress Syndrome (ARDS);WITHDRAWN;['PHASE2'];INTERVENTIONAL;0.0;['Severe Sepsis', 'Acute Respiratory Distress Syndrome']
NCT00428922;Trastuzumab (Herceptin), Bevacizumab, and Docetaxel (Taxotere) Trial in Stage IV Metastatic Breast Cancer (MBC) Patients;COMPLETED;['PHASE2'];INTERVENTIONAL;26.0;['Breast Cancer']
NCT00949247;Docetaxel,Carboplatin,Trastuzumab and Bevacizumab for Breast Cancer and Bone Marrow Micrometastases;COMPLETED;['EARLY_PHASE1'];INTERVENTIONAL;20.0;['Breast Cancer']
NCT01020747;Bevacizumab for Treatment of Recurrent Respiratory Papillomatosis (RRP);COMPLETED;['PHASE1'];INTERVENTIONAL;20.0;['Recurrent Respiratory Papillomatosis']
NCT00859222;LBH589 and Bevacizumab in Patients With Recurrent High Grade Glioma;COMPLETED;['PHASE1', 'PHASE2'];INTERVENTIONAL;51.0;['Malignant Glioma']
NCT00365547;Topotecan and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Did Not Respond to Previous Systemic Chemotherapy;COMPLETED;['PHASE2'];INTERVENTIONAL;46.0;['Lung Cancer']
NCT01205022;Radiolabeled Monoclonal Antibody Therapy, Combination Chemotherapy, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer;COMPLETED;['PHASE1'];INTERVENTIONAL;3.0;['Recurrent Colon Cancer', 'Recurrent Rectal Cancer', 'Stage IV Colon Cancer', 'Stage IV Rectal Cancer']
NCT05647122;First in Human Study of AZD9592 in Solid Tumors;RECRUITING;['PHASE1'];INTERVENTIONAL;108.0;['Advanced Solid Tumours', 'Carcinoma Non-small Cell Lung', 'Head and Neck Neoplasms', 'Colorectal Neoplasms']
NCT00356122;Docetaxel & Oxaliplatin in Combination With Bevacizumab as First-Line Treatment in Subjects With Non-Small Cell Lung Cancer (NSCLC);COMPLETED;['PHASE2'];INTERVENTIONAL;53.0;['Non-Small Cell Lung Cancer']
NCT00369122;Bevacizumab, Radiation Therapy, and Cisplatin in Treating Patients With Previously Untreated Locally Advanced Cervical Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;60.0;['Cervical Adenocarcinoma', 'Cervical Adenosquamous Carcinoma', 'Cervical Squamous Cell Carcinoma, Not Otherwise Specified', 'Stage IB Cervical Cancer AJCC v6 and v7', 'Stage IIA Cervical Cancer AJCC v7', 'Stage IIB Cervical Cancer AJCC v6 and v7', 'Stage III Cervical Cancer AJCC v6 and v7']
NCT05488522;SBRT With Atezo/Bev for HCC;RECRUITING;['PHASE1'];INTERVENTIONAL;18.0;['Hepatocellular Carcinoma']
NCT00553800;Study of Bevacizumab and Erlotinib in Patients With Advanced Non-small Cell Lung Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;32.0;['Carcinoma, Non-Small-Cell Lung']
NCT03038100;A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer;COMPLETED;['PHASE3'];INTERVENTIONAL;1301.0;['Ovarian Cancer', 'Fallopian Tube Cancer', 'Peritoneal Neoplasms']
NCT01564914;A Phase 2 Evaluation of TRC105 In Combination With Bevacizumab in Patients With Glioblastoma;COMPLETED;['PHASE2'];INTERVENTIONAL;22.0;['Glioblastoma', 'Glioblastoma Multiforme']
NCT03761914;Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers;UNKNOWN;['PHASE1', 'PHASE2'];INTERVENTIONAL;90.0;['Acute Myelogenous Leukemia', 'Ovarian Cancer', 'Colorectal Cancer', 'Triple-negative Breast Cancer', 'Small-cell Lung Cancer']
NCT05717400;Improving Response to Immunotherapy in Patients With Advanced Hepatocellular Carcinoma and Chronic Hepatitis C Virus Infection With Direct-Acting Antiviral Therapy;RECRUITING;['PHASE4'];INTERVENTIONAL;15.0;['Liver Cancer']
NCT01083368;Temsirolimus and Bevacizumab in Hormone-Resistant Metastatic Prostate Cancer That Did Not Respond to Chemotherapy;COMPLETED;['PHASE1', 'PHASE2'];INTERVENTIONAL;22.0;['Prostate Cancer']
NCT00100815;Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Metastatic or Unresectable Pancreatic Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;50.0;['Pancreatic Cancer']
NCT01061515;Biweekly Intraperitoneal Oxaliplatin With Systemic Capecitabine and Bevacizumab for Patients With Peritoneal Carcinomatosis From Appendiceal or Colorectal Cancer;ACTIVE_NOT_RECRUITING;['PHASE1'];INTERVENTIONAL;21.0;['Carcinoma']
NCT00920868;XAD - Xelox (Capecitabine + Oxaliplatin) + Bevacizumab + Dasatinib;COMPLETED;['PHASE1'];INTERVENTIONAL;22.0;['Solid Tumor', 'Metastatic Colorectal Cancer']
NCT00393068;Chemotherapy, Radiation Therapy and Immunotherapy Prior to Surgery in Operable Esophageal Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;62.0;['Esophageal Cancer']
NCT01351415;A Study of Bevacizumab in Combination With Standard of Care Treatment in Participants With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC);COMPLETED;['PHASE3'];INTERVENTIONAL;485.0;['Non-Squamous Non-Small Cell Lung Cancer']
NCT00530868;Comparing Letrozole Given Alone to Letrozole Given With Avastin in Post-Menopausal Women Breast Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;75.0;['Breast Cancer', 'Cancer of the Breast', 'Breast Neoplasm']
NCT04607668;Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving FOLFOXIRI/Bevacizumab for Metastatic Colorectal Cancer (mCRC):;TERMINATED;['PHASE3'];INTERVENTIONAL;326.0;['Colorectal Cancer Metastatic', 'Myelosuppression-Adult', 'Chemotherapeutic Toxicity']
NCT01290263;Amgen 386 for Recurrent Glioblastoma;COMPLETED;['PHASE1', 'PHASE2'];INTERVENTIONAL;48.0;['Glioblastoma Multiforme']
NCT01183663;Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX);COMPLETED;['PHASE1'];INTERVENTIONAL;180.0;['Advanced Cancers']
NCT00861705;Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery;ACTIVE_NOT_RECRUITING;['PHASE2'];INTERVENTIONAL;454.0;['Male Breast Carcinoma', 'Stage IIA Breast Cancer AJCC v6 and v7', 'Stage IIB Breast Cancer AJCC v6 and v7', 'Stage IIIA Breast Cancer AJCC v7', 'Triple-Negative Breast Carcinoma']
NCT01262820;Pazopanib In Stage IIIB/IV NSCLC Lung Cancer After Progression on First Line Therapy Containing Bevacizumab;COMPLETED;['PHASE2'];INTERVENTIONAL;15.0;['Lung Cancer']
NCT00398320;Phase II Capecitabine, Oxaliplatin & Bevacizumab for Metastatic / Unresectable Neuroendocrine Tumors;COMPLETED;['PHASE2'];INTERVENTIONAL;40.0;['Neuroendocrine Tumors']
NCT03424005;A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer;RECRUITING;['PHASE1', 'PHASE2'];INTERVENTIONAL;242.0;['Breast Cancer']
NCT00203905;A Study of Chemoradiotherapy for Intermediate Stage/Selected Stage IV Cancers of the Head and Neck;COMPLETED;['PHASE2'];INTERVENTIONAL;23.0;['Head and Neck Cancer']
NCT00621049;Carboplatin, Docetaxel, Bevacizumab, and Erlotinib Versus Chemotherapy Alone in Resected NSCLC;COMPLETED;['PHASE2'];INTERVENTIONAL;112.0;['Non-Small Cell Lung Cancer']
NCT00016549;Bevacizumab to Treat Inflammatory Breast Cancer or Locally Advanced Breast Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;21.0;['Breast Cancer']
NCT00334763;Radiation Therapy, Chemotherapy, and Bevacizumab in Treating Patients With Recurrent, Unresectable or Stage III or Stage IV Non-Small Cell Lung Cancer;TERMINATED;['PHASE2'];INTERVENTIONAL;32.0;['Lung Cancer']
NCT02681549;Pembrolizumab Plus Bevacizumab for Treatment of Brain Metastases in Metastatic Melanoma or Non-small Cell Lung Cancer;RECRUITING;['PHASE2'];INTERVENTIONAL;53.0;['Melanoma', 'Non-small Cell Lung Cancer', 'Brain Metastasis']
NCT01248949;A Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumors;COMPLETED;['PHASE1'];INTERVENTIONAL;162.0;['Advanced Solid Tumors', 'Advanced Recurrent Ovarian Tumors']
NCT00449163;Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer;TERMINATED;['PHASE2'];INTERVENTIONAL;25.0;['Colorectal Cancer']
NCT06268015;Botensilimab and Balstilimab Optimization in Colorectal Cancer;NOT_YET_RECRUITING;['PHASE2'];INTERVENTIONAL;15.0;['Colorectal Cancer']
NCT01164215;Biomarker-Guided Fluorouracil in Treating Patients With Colorectal Cancer Receiving Combination Chemotherapy;COMPLETED;['PHASE1'];INTERVENTIONAL;76.0;['Colorectal Cancer', 'Diarrhea', 'Neutropenia']
NCT00288015;Bevacizumab in Treating Patients With Angiosarcoma;COMPLETED;['PHASE2'];INTERVENTIONAL;32.0;['Sarcoma']
NCT00165568;Using Positron Emission Tomography to Evaluate the Effects of Bevacizumab on Intra-tumoral Pharmacokinetics of 5-fluorouracil in Metastatic Colorectal Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;20.0;['Colorectal Cancer', 'Neoplasm Metastasis']
NCT01664182;Trebananib With or Without Bevacizumab, Pazopanib Hydrochloride, Sorafenib Tosylate, or Sunitinib Malate in Treating Patients With Advanced Kidney Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;41.0;['Advanced Renal Cell Carcinoma', 'Advanced Sarcomatoid Renal Cell Carcinoma', 'Stage III Renal Cell Cancer AJCC v7', 'Stage IV Renal Cell Cancer AJCC v7']
NCT01213082;ProspectiveTrial of Proton Beam Combined With Anti-VEGF Therapy for Exudative Age-related Macular Degeneration (AMD);COMPLETED;['PHASE1', 'PHASE2'];INTERVENTIONAL;34.0;['Exudative Age-related Macular Degeneration']
NCT00418093;Oxaliplatin, Gemcitabine and Bevacizumab in Women With Recurrent Mullerian Carcinoma;TERMINATED;['PHASE2'];INTERVENTIONAL;19.0;['Ovarian Cancer', 'Fallopian Tube Cancer', 'Primary Peritoneal Cancer']
NCT00610493;Bevacizumab and Temsirolimus in Patients With Advanced Malignancy;COMPLETED;['PHASE1'];INTERVENTIONAL;193.0;['Advanced Cancer']
NCT00611793;PTK787/ZK222584 With Bevacizumab in Patients With Refractory and/or Advanced Malignancies;COMPLETED;['PHASE1'];INTERVENTIONAL;50.0;['Refractory Malignancy', 'Advanced Malignancies']
NCT00130520;Bevacizumab and Erlotinib Study in Advanced Ovarian Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;40.0;['Ovarian Neoplasms']
NCT03326193;A Study of Niraparib Combined With Bevacizumab Maintenance Treatment in Participants With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy;ACTIVE_NOT_RECRUITING;['PHASE2'];INTERVENTIONAL;105.0;['Ovarian Neoplasms']
NCT00911820;Cisplatin, Irinotecan and Bevacizumab (PCA) Versus Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;88.0;['Esophageal Cancer', 'Gastric Cancer', 'Stomach Cancer']
NCT01047293;RAD001, FOLFOX and Bevacizumab in Treatment of Colorectal Carcinoma;COMPLETED;['PHASE1', 'PHASE2'];INTERVENTIONAL;47.0;['Colorectal Cancer']
NCT00876382;Community Oncology Setting Disease Outcomes of Sorafenib (Nexavar) Use in Advanced Renal Cell Carcinoma;COMPLETED;;OBSERVATIONAL;47.0;['Renal Cell Carcinoma']
NCT00698516;Study of Oral Topotecan With Bevacizumab for Recurrent Small Cell Lung Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;50.0;['Recurrent Small-cell Lung Cancer (SCLC)', 'Lung Cancer, Small Cell']
NCT04042116;A Study to Evaluate Lucitanib in Combination With Nivolumab in Patients With a Solid Tumor;SUSPENDED;['PHASE1', 'PHASE2'];INTERVENTIONAL;227.0;['Advanced Solid Tumor', 'Gynecologic Cancer']
NCT05096715;Atezolizumab+Bevacizumab+SBRT in Unresectable HCC;NOT_YET_RECRUITING;['PHASE1'];INTERVENTIONAL;20.0;['Unresectable Hepatocellular Carcinoma']
NCT00397982;Temsirolimus and Bevacizumab in Treating Patients With Stage III or Stage IV Malignant Melanoma;COMPLETED;['PHASE2'];INTERVENTIONAL;17.0;['Recurrent Melanoma', 'Stage IIIB Skin Melanoma', 'Stage IIIC Skin Melanoma', 'Stage IV Skin Melanoma']
NCT00308516;5-Fluorouracil, Bevacizumab, and Radiation Followed by Modified FOLFOX6 and Bevacizumab in Stage II/III Rectal Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;66.0;['Rectal Cancer', 'Cancer of the Rectum', 'Colorectal Cancer']
NCT05482516;Evaluating Novel Therapies in ctDNA Positive GI Cancers;RECRUITING;['PHASE3'];INTERVENTIONAL;20.0;['Colon Adenocarcinoma', 'Rectal Adenocarcinoma', 'Gastric Adenocarcinoma', 'Pancreatic Adenocarcinoma', 'Hepatocellular Carcinoma', 'Adenocarcinoma of Biliary Tract', 'Gallbladder Adenocarcinoma']
NCT05110209;Real-world Evaluation of Prevalence of Ocular Adverse Events in Patients With Neovascular (Wet) Agerelated Macular Degeneration (AMD) Who Received Anti-VEGF Agents (IRIS Registry);COMPLETED;;OBSERVATIONAL;331541.0;['Age-related Macular Degeneration (AMD)']
NCT00586508;Trial of Enzastaurin and Bevacizumab in Participants With Recurrent Malignant Gliomas;COMPLETED;['PHASE2'];INTERVENTIONAL;81.0;['Recurrent Glioblastoma']
NCT00113217;Neoadjuvant Clinical Trial to Evaluate the Efficacy of Bevacizumab for Renal Cell Carcinoma;COMPLETED;['PHASE2'];INTERVENTIONAL;52.0;['Renal Cell Carcinoma', 'Kidney Cancer']
NCT02017717;A Study of the Effectiveness and Safety of Nivolumab Compared to Bevacizumab and of Nivolumab With or Without Ipilimumab in Glioblastoma Patients;ACTIVE_NOT_RECRUITING;['PHASE3'];INTERVENTIONAL;529.0;['Recurrent Glioblastoma']
NCT00979017;Avastin/Temozolomide/Irinotecan for Unresectable/Multifocal Glioblastoma Multiforme;COMPLETED;['PHASE2'];INTERVENTIONAL;41.0;['Glioblastoma Multiforme', 'Gliosarcoma']
NCT01137604;A Study in Subjects With Recurrent Malignant Glioma;COMPLETED;['PHASE2'];INTERVENTIONAL;151.0;['Glioma']
NCT00923117;Sunitinib to Treat Recurrent Brain Cancer;TERMINATED;['PHASE2'];INTERVENTIONAL;87.0;['Glioblastoma Multiforme', 'Malignant Gliomas', 'Anaplastic Gliomas']
NCT00084604;Irinotecan, Cisplatin, and Bevacizumab in Treating Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma;COMPLETED;['PHASE2'];INTERVENTIONAL;47.0;['Adenocarcinoma of the Gastroesophageal Junction', 'Diffuse Adenocarcinoma of the Stomach', 'Intestinal Adenocarcinoma of the Stomach', 'Mixed Adenocarcinoma of the Stomach', 'Recurrent Gastric Cancer', 'Stage IIIA Gastric Cancer', 'Stage IIIB Gastric Cancer', 'Stage IIIC Gastric Cancer', 'Stage IV Gastric Cancer']
NCT00670982;Bevacizumab in Combination With Vinorelbine and Trastuzumab for HER2-Positive, Metastatic Breast Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;29.0;['Breast Cancer']
NCT00428545;Bevacizumab and Bortezomib in Patients With Advanced Malignancy;COMPLETED;['PHASE1'];INTERVENTIONAL;104.0;['Advanced Malignancy', 'Lymphoma', 'Myeloma', 'Solid Tumors']
NCT01803282;Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Chemotherapy in Participants With Advanced Solid Tumors;COMPLETED;['PHASE1'];INTERVENTIONAL;236.0;['Pancreatic Cancer', 'Non-small Cell Lung Cancer', 'Esophagogastric Cancer', 'Colorectal Cancer', 'Breast Cancer']
NCT01516216;Study of Vitamin D in Untreated Metastatic Colorectal Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;139.0;['Metastatic Colorectal Cancer']
NCT02312245;Avatar-Directed Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;13.0;['Recurrent Fallopian Tube Carcinoma', 'Recurrent Ovarian Carcinoma', 'Recurrent Primary Peritoneal Carcinoma']
NCT01301716;A Study of the Safety and Pharmacology of GDC-0980 in Combination With Either Paclitaxel and Carboplatin (With or Without Bevacizumab) or Pemetrexed and Cisplatin in Patients With Solid Tumors;COMPLETED;['PHASE1'];INTERVENTIONAL;75.0;['Solid Cancers']
NCT01551745;Salvage Ovarian FANGâ¢ Vaccine + Bevacizumab;COMPLETED;['PHASE2'];INTERVENTIONAL;5.0;['Stage III Ovarian Cancer', 'Stage IV Ovarian Cancer']
NCT00733408;Nab-Paclitaxel and Bevacizumab Followed By Bevacizumab and Erlotinib in Metastatic Breast Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;59.0;['Estrogen Receptor-negative Breast Cancer', 'HER2-negative Breast Cancer', 'Progesterone Receptor-negative Breast Cancer', 'Recurrent Breast Cancer', 'Stage IV Breast Cancer', 'Triple-negative Breast Cancer']
NCT02348008;Phase Ib and Phase II Studies of MK-3475 in Combination + for Renal Cell Carcinoma:;COMPLETED;['PHASE1', 'PHASE2'];INTERVENTIONAL;61.0;['Clear Cell Renal Carcinoma']
NCT04981509;Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer;RECRUITING;['PHASE2'];INTERVENTIONAL;65.0;['Hereditary Leiomyomatosis and Renal Cell Carcinoma', 'Papillary Renal Cell Carcinoma', 'Renal Cell Carcinoma', 'Sporadic Papillary Renal Cell Carcinoma', 'Stage III Renal Cell Cancer AJCC v8', 'Stage IV Renal Cell Cancer AJCC v8']
NCT00828009;BLP25 Liposome Vaccine and Bevacizumab After Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery;COMPLETED;['PHASE2'];INTERVENTIONAL;70.0;['Lung Cancer']
NCT03136406;QUILT-3.039: NANT Pancreatic Cancer Vaccine: Combination Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy;UNKNOWN;['PHASE1', 'PHASE2'];INTERVENTIONAL;3.0;['Pancreatic Cancer']
NCT06160206;Retifanlimab With Bevacizumab and Hypofractionated Radiotherapy for the Treatment of Recurrent Glioblastoma;NOT_YET_RECRUITING;['PHASE2'];INTERVENTIONAL;134.0;['Recurrent Glioblastoma', 'Recurrent WHO Grade 4 Glioma']
NCT03082209;A Study of the Safety and Tolerability of ABBV-621 in Participants With Previously-Treated Solid Tumors and Hematologic Malignancies;COMPLETED;['PHASE1'];INTERVENTIONAL;153.0;['Advanced Solid Tumors', 'Cancer', 'Hematologic Malignancies']
NCT01392209;Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant Glioma;COMPLETED;['PHASE1'];INTERVENTIONAL;15.0;['Brain Cancer', 'MALIGNANT GLIOMA', 'Glioblastoma', 'Anaplastic Astrocytoma (AA)', 'Anaplastic Oligodendroglioma (AO)', 'Anaplastic Oligo-astrocytoma (AOA)', 'Anaplastic Mixed Gliomas', 'Malignant Glioma NOS']
NCT00873275;Ursodiol, Combination Chemotherapy, and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer;ACTIVE_NOT_RECRUITING;['PHASE1'];INTERVENTIONAL;11.0;['Colorectal Cancer']
NCT02457975;Photobiomodulation for the Treatment of Diabetic Macular Edema;COMPLETED;['EARLY_PHASE1'];INTERVENTIONAL;16.0;['Diabetic Retinopathy']
NCT00635050;Therapy for Locally Advanced Breast Cancer Using Doxil, Paclitaxel, and Cyclophosphamide With Avastin;COMPLETED;['PHASE2'];INTERVENTIONAL;32.0;['Invasive Breast Cancer']
NCT01149850;Bevacizumab and Temozolomide in Treating Older Patients With Newly-Diagnosed Glioblastoma Multiforme or Gliosarcoma;ACTIVE_NOT_RECRUITING;['PHASE2'];INTERVENTIONAL;50.0;['Giant Cell Glioblastoma', 'Glioblastoma', 'Gliosarcoma']
NCT00849550;Safety and Dosage Study of RAD001 (Everolimus) in Combination With Current Standard of Care to Treat Advanced Solid Tumors.;COMPLETED;['PHASE1'];INTERVENTIONAL;32.0;['Unspecified Adult Solid Tumor, Protocol Specific', 'Cancer']
NCT01743950;A Phase II Study of Pulse Reduced Dose Rate Radiation Therapy With Bevacizumab;RECRUITING;['PHASE2'];INTERVENTIONAL;80.0;['Glioma']
NCT05776875;Atezolizumab and Bevacizumab in Combination With TACE for Patients With BCLC B HCC;RECRUITING;['PHASE2'];INTERVENTIONAL;24.0;['Hepatocellular Carcinoma', 'BCLC Stage B Hepatocellular Carcinoma']
NCT03743662;Nivolumab With Radiation Therapy and Bevacizumab for Recurrent MGMT Methylated Glioblastoma;ACTIVE_NOT_RECRUITING;['PHASE2'];INTERVENTIONAL;39.0;['Glioblastoma']
NCT01106872;Bevacizumab, Chemotherapy and Valproic Acid in Advanced Sarcomas;COMPLETED;['PHASE1'];INTERVENTIONAL;47.0;['Sarcoma', 'Soft Tissue Sarcoma', 'Locally Advanced Sarcoma', 'Unresectable Sarcoma', 'Metastatic Sarcoma']
NCT02330562;"Stage 1: Marizomib + Bevacizumab in WHO Gr IV GBM; Stage 2: Marizomib Alone; Stage 3: Combination of Marizomib and Bevacizumab";COMPLETED;['PHASE1', 'PHASE2'];INTERVENTIONAL;121.0;['Malignant Glioma', 'Glioblastoma']
NCT03698162;Precise DCE-MRI in Diagnosing Participants With Recurrent High Grade Glioma or Melanoma Brain Metastases;TERMINATED;['NA'];INTERVENTIONAL;14.0;['Brain Metastases', 'Glioma of Brain', 'Brain Tumor', 'Metastatic Melanoma']
NCT02754362;A Toll-like Receptor Agonist as an Adjuvant to Tumor Associated Antigens (TAA) Mixed With Montanide ISA-51 VG With Bevacizumab for Patients With Recurrent Glioblastoma;WITHDRAWN;['PHASE2'];INTERVENTIONAL;0.0;['Glioblastoma', 'Glioma']
NCT02717962;Study of VAL-083 in Patients With MGMT Unmethylated, Bevacizumab-naive Glioblastoma in the Adjuvant or Recurrent Setting;ACTIVE_NOT_RECRUITING;['PHASE2'];INTERVENTIONAL;119.0;['Glioma', 'Glioblastoma', 'Glioblastoma Multiforme', 'GBM', 'Brain Cancer']
NCT03829410;Onvansertib in Combination With FOLFIRI and Bevacizumab for Second Line Treatment of Metastatic Colorectal Cancer Patients With a Kras Mutation;ACTIVE_NOT_RECRUITING;['PHASE1', 'PHASE2'];INTERVENTIONAL;68.0;['Metastatic Colorectal Cancer', 'KRAS Gene Mutation']
NCT01063010;Pilot Study of Bevacizumab (Avastin) in Patients With Septic Shock;WITHDRAWN;['NA'];INTERVENTIONAL;0.0;['Septic Shock']
NCT03340610;IAI for Persistent DME After Treatment With Bevacizumab And Ranibizumab;COMPLETED;['PHASE4'];INTERVENTIONAL;30.0;['Diabetic Macular Edema']
NCT00408772;Oxaliplatin, Capecitabine, and Bevacizumab Followed By Surgery and/or Radiofrequency Ablation in Patients With Colorectal Cancer;WITHDRAWN;['PHASE2'];INTERVENTIONAL;0.0;['Colorectal Cancer', 'Metastatic Cancer']
NCT00596362;Treatment With Intravitreal Avastin for Large Uveal Melanomas;COMPLETED;['NA'];INTERVENTIONAL;1.0;['Uveal Melanoma']
NCT00255762;Carboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery;COMPLETED;['PHASE2'];INTERVENTIONAL;47.0;['Recurrent Melanoma', 'Stage IV Melanoma']
NCT00066846;Bevacizumab Plus Fluorouracil and Leucovorin in Treating Patients With Locally Advanced or Metastatic Stage IV Colorectal Cancer That Has Progressed After Standard Chemotherapy;COMPLETED;['PHASE2'];INTERVENTIONAL;;['Colorectal Cancer']
NCT05797246;Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP);RECRUITING;['PHASE2'];INTERVENTIONAL;50.0;['Respiratory Tract Diseases', 'Neoplasms', 'Neoplasms by Histologic Type', 'Neoplasms, Glandular and Epithelial', 'Neoplasms, Squamous Cell', 'Tumor Virus Infections', 'Infections', 'Virus Diseases', 'DNA Virus Infections', 'Pathologic Processes', 'Disease Attributes', 'Recurrence', 'Papilloma', 'Respiratory Tract Infections', 'Papillomavirus Infections']
NCT02045446;Maintenance Chemotherapy Versus Consolidative Stereotactic Body Radiation Therapy (SBRT) Plus Maintenance Chemotherapy for Stage IV Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II Trial;COMPLETED;['PHASE2'];INTERVENTIONAL;29.0;['Stage IV Non-Small Cell Lung Cancer']
NCT00777673;Preoperative Chemotherapy in Triple Negative Invasive Breast Cancer That Can be Removed by Surgery.;UNKNOWN;['PHASE2'];INTERVENTIONAL;60.0;['Breast Cancer']
NCT01057264;HAI Abraxane With Gemcitabine and Bevacizumab;COMPLETED;['PHASE1'];INTERVENTIONAL;78.0;['Advanced Cancers']
NCT00976573;Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma;COMPLETED;['PHASE2'];INTERVENTIONAL;149.0;['Melanoma (Skin)']
NCT00461773;Randomized Phase II Study of Preoperative Letrozole (Femara) in Combination With Avastin in Hormone Receptor Positive Breast Cancer;TERMINATED;['PHASE2'];INTERVENTIONAL;5.0;['Hormone-Sensitive Breast Cancer', 'Breast Cancer']
NCT04541173;Study of Atezolizumab and Bevacizumab With Y-90 TARE in Patients With Unresectable Hepatocellular Carcinoma (HCC);RECRUITING;['PHASE2'];INTERVENTIONAL;128.0;['Hepatocellular Carcinoma']
NCT00729846;Bevacizumab in Combination With Visudyne Photodynamic Therapy (PDT);COMPLETED;['PHASE2'];INTERVENTIONAL;22.0;['Age Related Macular Degeneration', 'Choroidal Neovascularization', 'Macular Edema']
NCT01925573;Optune(NOVOTTF-100A)+ Bevacizumab+ Hypofractionated Stereotactic Irradiation Bevacizumab-Naive Recurrent Glioblastoma (GCC 1344);TERMINATED;['NA'];INTERVENTIONAL;7.0;['RECURRENT GLIOBLASTOMA', 'Brain Tumor']
NCT00508872;Folfox-B Study for Patients With Colorectal Liver Metastases;TERMINATED;['PHASE2'];INTERVENTIONAL;2.0;['Colorectal Liver Metastases']
NCT02174172;A Study to Assess the Safety and Tolerability of Atezolizumab in Combination With Other Immune-Modulating Therapies in Participants With Locally Advanced or Metastatic Solid Tumors;COMPLETED;['PHASE1'];INTERVENTIONAL;158.0;['Solid Cancers']
NCT00119262;Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;226.0;['Male Breast Cancer', 'Stage II Breast Cancer', 'Stage IIIA Breast Cancer', 'Stage IIIB Breast Cancer']
NCT01248962;Standard Infusion Carboplatin Versus Prophylactic Extended Infusion Carboplatin in Patients With Patients With Recurrent, Ovary, Fallopian Tube, and Primary Peritoneal Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;146.0;['Ovarian Cancer', 'Fallopian Tube Cancer', 'Peritoneal Cancer']
NCT00892710;Trial of Poor Performance Status Patients (ToPPS);COMPLETED;['PHASE2'];INTERVENTIONAL;172.0;['Non Small Cell Lung Cancer']
NCT01722162;Levocetirizine + Capecitabine + Bevacizumab for Patients With Refractory Colorectal Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;47.0;['Colorectal Neoplasms']
NCT01403610;Safety and Efficacy Study of TH-302 CNS Penetration in Recurrent High Grade Astrocytoma Following Bevacizumab;COMPLETED;['PHASE2'];INTERVENTIONAL;28.0;['HIGH GRADE GLIOMA']
NCT00671372;A Study of Dulanermin Administered in Combination With CamptosarÂ®/ErbituxÂ® Chemotherapy or FOLFIRI (With or Without Bevacizumab) in Subjects With Previously Treated Metastatic Colorectal Cancer;COMPLETED;['PHASE1'];INTERVENTIONAL;42.0;['Colorectal Cancer']
NCT00803062;Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer;COMPLETED;['PHASE3'];INTERVENTIONAL;452.0;['Cervical Adenocarcinoma', 'Cervical Adenosquamous Carcinoma', 'Cervical Squamous Cell Carcinoma', 'Recurrent Cervical Carcinoma', 'Stage IVB Cervical Cancer']
NCT01081262;Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer;ACTIVE_NOT_RECRUITING;['PHASE3'];INTERVENTIONAL;50.0;['Borderline Ovarian Mucinous Tumor', 'Ovarian Mucinous Cystadenocarcinoma', 'Recurrent Fallopian Tube Carcinoma', 'Recurrent Ovarian Carcinoma', 'Stage IA Fallopian Tube Cancer AJCC v6 and v7', 'Stage IA Ovarian Cancer AJCC v6 and v7', 'Stage IB Fallopian Tube Cancer AJCC v6 and v7', 'Stage IB Ovarian Cancer AJCC v6 and v7', 'Stage IC Fallopian Tube Cancer AJCC v6 and v7', 'Stage IC Ovarian Cancer AJCC v6 and v7', 'Stage IIA Fallopian Tube Cancer AJCC v6 and v7', 'Stage IIA Ovarian Cancer AJCC V6 and v7', 'Stage IIB Fallopian Tube Cancer AJCC v6 and v7', 'Stage IIB Ovarian Cancer AJCC v6 and v7', 'Stage IIC Fallopian Tube Cancer AJCC v6 and v7', 'Stage IIC Ovarian Cancer AJCC v6 and v7', 'Stage IIIA Fallopian Tube Cancer AJCC v7', 'Stage IIIA Ovarian Cancer AJCC v6 and v7', 'Stage IIIB Fallopian Tube Cancer AJCC v7', 'Stage IIIB Ovarian Cancer AJCC v6 and v7', 'Stage IIIC Fallopian Tube Cancer AJCC v7', 'Stage IIIC Ovarian Cancer AJCC v6 and v7', 'Stage IV Fallopian Tube Cancer AJCC v6 and v7', 'Stage IV Ovarian Cancer AJCC v6 and v7']
NCT06011772;EGF-Depleting Therapy CIMAvax-EGF in Combination With Standard Therapy for RAS- and BRAF Wild-Type Metastatic Colorectal Cancer;RECRUITING;['EARLY_PHASE1'];INTERVENTIONAL;42.0;['Colo-rectal Cancer']
NCT04406272;VB-111 in Surgically Accessible Recurrent/Progressive GBM;ACTIVE_NOT_RECRUITING;['PHASE2'];INTERVENTIONAL;15.0;['Glioblastoma', 'Recurrent Glioblastoma']
NCT04068610;COLUMBIA-1: Novel Oncology Therapies in Combination With Chemotherapy and Bevacizumab as First- Line Therapy in MSS-CRC;TERMINATED;['PHASE1', 'PHASE2'];INTERVENTIONAL;61.0;['Metastatic Microsatellite-stable Colorectal Cancer']
NCT00405938;Bevacizumab Given With Either Anastrozole or Fulvestrant With Trastuzumab for Postmenopausal Metastatic Breast Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;79.0;['Breast Cancer', 'Breast Neoplasms']
NCT01270438;Combination Chemotherapy and Bevacizumab With or Without RO4929097 in Treating Patients With Metastatic Colorectal Cancer;WITHDRAWN;['PHASE2'];INTERVENTIONAL;0.0;['Adenocarcinoma of the Colon', 'Adenocarcinoma of the Rectum', 'Recurrent Colon Cancer', 'Recurrent Rectal Cancer', 'Stage IVA Colon Cancer', 'Stage IVA Rectal Cancer', 'Stage IVB Colon Cancer', 'Stage IVB Rectal Cancer']
NCT00047762;Safety, Efficacy, and Pharmacokinetics Study of Tarceva to Treat Advanced Colorectal Cancer;COMPLETED;['PHASE1'];INTERVENTIONAL;;['Colorectal Cancer']
NCT03694262;The EndoBARR Trial (Endometrial Bevacizumab, Atezolizumab, Rucaparib);COMPLETED;['PHASE2'];INTERVENTIONAL;30.0;['Endometrial Cancer', 'Uterine Carcinosarcoma']
NCT00290810;Bevacizumab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia;COMPLETED;['PHASE2'];INTERVENTIONAL;12.0;['B-cell Chronic Lymphocytic Leukemia', 'Refractory Chronic Lymphocytic Leukemia']
NCT06109272;A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solution in Combination With Budigalimab as an IV Solution in Adult Participants With Hepatocellular Carcinoma (HCC);RECRUITING;['PHASE2', 'PHASE3'];INTERVENTIONAL;660.0;['Hepatocellular Carcinoma']
NCT01256762;Imetelstat in Combination With Paclitaxel (With or Without Bevacizumab) in Patients With Locally Recurrent or Metastatic Breast Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;166.0;['Locally Recurrent or Metastatic Breast Cancer']
NCT03439462;Nab-Sirolimus in Combination With FOLFOX & BEV as 1st Line Therapy in Patients With Advanced or Metastatic Colorectal Cancer;COMPLETED;['PHASE1', 'PHASE2'];INTERVENTIONAL;60.0;['Colorectal Cancer Metastatic']
NCT01967810;ANG1005 in Patients With Recurrent High-Grade Glioma;COMPLETED;['PHASE2'];INTERVENTIONAL;73.0;['Glioma', 'Glioblastoma', 'Brain Tumor, Recurrent']
NCT01738646;Ph II SAHA and Bevacizumab for Recurrent Malignant Glioma Patients;COMPLETED;['PHASE2'];INTERVENTIONAL;48.0;['Recurrent Glioblastoma Multiforme', 'Malignant Glioma', 'Adult Brain Tumor']
NCT00321646;Neoadjuvant Bevacizumab Plus Docetaxel in High Risk Patients With Prostate Cancer Undergoing Radical Prostatectomy;COMPLETED;['PHASE2'];INTERVENTIONAL;42.0;['Prostate Cancer', 'Adenocarcinoma of the Prostate']
NCT01097746;First-Line Treatment of Bevacizumab, Carboplatin, and Paclitaxel in Treating Participants With Stage III-IV Ovarian, Primary Peritoneal, and Fallopian Tube Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;33.0;['Fallopian Tube Carcinoma', 'Fallopian Tube Clear Cell Adenocarcinoma', 'Fallopian Tube Endometrioid Adenocarcinoma', 'Fallopian Tube Mucinous Adenocarcinoma', 'Fallopian Tube Serous Adenocarcinoma', 'Fallopian Tube Transitional Cell Carcinoma', 'Fallopian Tube Undifferentiated Carcinoma', 'FIGO Stage III Ovarian Cancer', 'FIGO Stage IIIA Ovarian Cancer', 'FIGO Stage IIIA1 Ovarian Cancer', 'FIGO Stage IIIA1(i) Ovarian Cancer', 'FIGO Stage IIIA1(ii) Ovarian Cancer', 'FIGO Stage IIIA2 Ovarian Cancer', 'FIGO Stage IIIB Ovarian Cancer', 'FIGO Stage IIIC Ovarian Cancer', 'FIGO Stage IVA Ovarian Cancer', 'FIGO Stage IVB Ovarian Cancer', 'Malignant Ovarian Brenner Tumor', 'Ovarian Clear Cell Adenocarcinoma', 'Ovarian Endometrioid Adenocarcinoma', 'Ovarian Mucinous Adenocarcinoma', 'Ovarian Seromucinous Carcinoma', 'Ovarian Serous Adenocarcinoma', 'Ovarian Transitional Cell Carcinoma', 'Ovarian Undifferentiated Carcinoma', 'Primary Peritoneal Carcinoma', 'Primary Peritoneal Serous Adenocarcinoma']
NCT00378573;Multicenter Evaluation of Docetaxel, Gemcitabine, and Bevacizumab Combination Followed by Bevacizumab Alone in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer;TERMINATED;['PHASE2'];INTERVENTIONAL;17.0;['Non-small Cell Lung Cancer']
NCT00440973;Safety Study of Specific Tumor Target Drug Plus Immune System Therapy in Patients With Kidney Cancer;TERMINATED;['PHASE2'];INTERVENTIONAL;6.0;['Carcinoma, Renal Cell']
NCT00719264;Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab for the First-line Treatment in Adult Patients With Kidney Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;365.0;['Carcinoma', 'Adenocarcinoma', 'Renal Cell', 'Nephroid Carcinoma', 'Hypernephroid']
NCT00853073;Does Adding Bevacizumab Therapy in Glaucoma Surgery Improve the Success of Needle Bleb Revisions?;COMPLETED;['PHASE2', 'PHASE3'];INTERVENTIONAL;63.0;['Glaucoma']
NCT01125046;Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas;COMPLETED;['PHASE2'];INTERVENTIONAL;50.0;['Acoustic Schwannoma', 'Adult Anaplastic Meningioma', 'Adult Ependymoma', 'Adult Grade I Meningioma', 'Adult Grade II Meningioma', 'Adult Meningeal Hemangiopericytoma', 'Adult Papillary Meningioma', 'Neurofibromatosis Type 1', 'Neurofibromatosis Type 2', 'Recurrent Adult Brain Tumor']
NCT00537173;Predicting Response and Toxicity in Patients Receiving Paclitaxel and Avastin for Breast Cancer;TERMINATED;;OBSERVATIONAL;11.0;['Breast Cancer']
NCT01075464;A Study of the Safety and Pharmacology of MEGF0444A in Combination With Bevacizumab With or Without Paclitaxel in Patients With Locally Advanced or Metastatic Solid Tumors;COMPLETED;['PHASE1'];INTERVENTIONAL;64.0;['Solid Cancers']
NCT00393861;Study of Oxaliplatin Plus Bevacizumab in Germ Cell Tumor Patients;COMPLETED;['PHASE2'];INTERVENTIONAL;29.0;['Neoplasms, Germ Cell and Embryonal']
NCT02540161;Phase 2 Study of Sym004 for Adult Patients With Recurrent Glioblastoma;COMPLETED;['PHASE2'];INTERVENTIONAL;43.0;['Malignant Glioma']
NCT01213238;Hepatic Arterial Infusion Oxaliplatin, Capecitabine With or Without Bevacizumab;COMPLETED;['PHASE1'];INTERVENTIONAL;116.0;['Advanced Cancers']
NCT01428388;Bevacizumab Versus Ranibizumab in Treatment of Macular Edema From Vein Occlusion;COMPLETED;['NA'];INTERVENTIONAL;150.0;['Retinal Vein Occlusion', 'Macular Edema']
NCT03063762;Study to Evaluate Safety, Pharmacokinetics and Therapeutic Activity of RO6874281 as a Combination Therapy in Participants With Unresectable Advanced and/or Metastatic Renal Cell Carcinoma (RCC);COMPLETED;['PHASE1'];INTERVENTIONAL;69.0;['Renal Cell Carcinoma']
NCT00296062;Dose Dense Therapy and Bevacizumab in Solid Tumors and Colorectal Cancer;TERMINATED;['PHASE1'];INTERVENTIONAL;12.0;['Colorectal Cancer', 'Unspecified Adult Solid Tumor, Protocol Specific']
NCT00790010;Bevacizumab Plus Ipilimumab in Patients With Unresectable Stage III or IV Melanoma;COMPLETED;['PHASE1'];INTERVENTIONAL;46.0;['Melanoma']
NCT01837862;A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas;RECRUITING;['PHASE1', 'PHASE2'];INTERVENTIONAL;36.0;['Pilomyxoid Astrocytoma', 'Pilocytic Astrocytoma', 'Glioma, Astrocytic', 'Optic Nerve Glioma', 'Pleomorphic Xanthoastrocytoma', 'Glioblastoma Multiforme', 'Anaplastic Astrocytoma', 'Gliosarcoma', 'Diffuse Intrinsic Pontine Glioma', 'DIPG', 'Low-grade Glioma', 'Brainstem Glioma']
NCT01004172;Carboplatin and Bevacizumab for Progressive Breast Cancer Brain Metastases;COMPLETED;['PHASE2'];INTERVENTIONAL;38.0;['Metastatic Breast Cancer', 'Breast Cancer', 'Progressive Breast Cancer']
NCT02873962;A Phase II Study Of Nivolumab/ Bevacizumab/Rucaparib;ACTIVE_NOT_RECRUITING;['PHASE2'];INTERVENTIONAL;73.0;['Peritoneal Cancer', 'Ovarian Cancer', 'Fallopian Tube Cancer']
NCT05999812;Clinical Trial of All-trans-retinoic Acid, Bevacizumab and Atezolizumab in Colorectal Cancer;RECRUITING;['PHASE2'];INTERVENTIONAL;21.0;['Colorectal Cancer']
NCT01663012;Phase II NKTR-102 In Bevacizumab-Resistant High Grade Glioma;COMPLETED;['PHASE2'];INTERVENTIONAL;20.0;['Anaplastic Astrocytomas', 'Anaplastic Oligodendrogliomas', 'Glioblastomas (GBM)']
NCT04660812;An Open Label Study Evaluating the Efficacy and Safety of Etrumadenant (AB928) Based Treatment Combinations in Participants With Metastatic Colorectal Cancer.;ACTIVE_NOT_RECRUITING;['PHASE1', 'PHASE2'];INTERVENTIONAL;227.0;['Metastatic Colorectal Cancer']
NCT00506155;Neoadjuvant Chemotherapy With Methotrexate, Vinblastine, Adriamycin and Cisplatin (M-VAC) Plus Avastin in Patients With Urothelial Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;60.0;['Bladder Cancer']
NCT00723255;Bevacizumab and Temsirolimus in Treating Patients With Recurrent or Persistent Endometrial Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;53.0;['Recurrent Endometrial Carcinoma']
NCT00491855;Oxaliplatin and Paclitaxel Plus Bevacizumab in Advanced Peritoneal Carcinomatosis;COMPLETED;['PHASE1'];INTERVENTIONAL;3.0;['Peritoneal Cancer']
NCT00611325;Phase II Avastin + Bortezomib for Patients With Recurrent Malignant Glioma;COMPLETED;['PHASE2'];INTERVENTIONAL;56.0;['Glioblastoma', 'Gliosarcoma']
NCT03203525;Combination Chemotherapy and Bevacizumab With the NovoTTF-100L(P) System in Treating Participants With Advanced, Recurrent, or Refractory Hepatic Metastatic Cancer;RECRUITING;['PHASE1'];INTERVENTIONAL;52.0;['Advanced Malignant Neoplasm', 'Colorectal Carcinoma Metastatic in the Liver', 'Metastatic Malignant Neoplasm in the Liver', 'Refractory Malignant Neoplasm']
NCT00365365;Safety & Efficacy of Three Docetaxel-Based Chemotherapy Regimens Plus Bevacizumab With or Without Trastuzumab for Adjuvant Treatment of Patients With Breast Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;214.0;['Breast Cancer']
NCT00543842;Bevacizumab, Erlotinib, and Capecitabine for Locally Advanced Rectal Cancer;COMPLETED;['PHASE1'];INTERVENTIONAL;19.0;['Rectal Cancer']
NCT01496742;A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab (Avastin) Plus Platinum And Paclitaxel or With Pemetrexed Plus Platinum in Patients With Non-Squamous Non-Small Cell Lung Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;259.0;['Non-Squamous Non-Small Cell Lung Cancer']
NCT01270542;Avastin for PDR (Proliferative Diabetic Retinopathy);COMPLETED;['NA'];INTERVENTIONAL;20.0;['Retinal Detachment', 'Diabetic Retinopathy']
NCT00403442;Bevacizumab in Combination With Verteporfin Reduced and Standard Fluence in the Treatment of Hemorrhaged Lesions in Neovascular AMD;TERMINATED;['PHASE1'];INTERVENTIONAL;10.0;['Macular Degeneration']
NCT03463265;Nab-sirolimus in Recurrent High Grade Glioma and Newly Diagnosed Glioblastoma;COMPLETED;['PHASE2'];INTERVENTIONAL;62.0;['High Grade Recurrent Glioma and Newly Diagnosed Glioblastoma']
NCT01209442;Hypofractionated Intensity-Modulated Radiation Therapy With Temozolomide and Bevacizumab for Glioblastoma Multiforme;COMPLETED;['PHASE2'];INTERVENTIONAL;30.0;['Glioblastoma Multiforme']
NCT02357342;Sirolimus Versus Anti-Vascular Endothelial Growth Factor (antiVEGF) for Wet AMD;COMPLETED;['PHASE2'];INTERVENTIONAL;40.0;['Age-Related Macular Degeneration']
NCT00667342;A Study of Bevacizumab in Combination With Chemotherapy for Treatment of Osteosarcoma;COMPLETED;['PHASE2'];INTERVENTIONAL;43.0;['Osteosarcoma', 'Malignant Fibrous Histiocytoma (MFH) of Bone']
NCT01767792;Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas;COMPLETED;['PHASE2'];INTERVENTIONAL;22.0;['Neurofibromatosis Type 2', 'Progressive Vestibular Schwannomas']
NCT05158621;A Screening Study Targeting Tumor-specific Antigens;COMPLETED;;OBSERVATIONAL;22.0;['Metastatic Colorectal Cancer', 'Stage II/III Colon Cancer']
NCT00942331;Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer;COMPLETED;['PHASE3'];INTERVENTIONAL;506.0;['Advanced Urothelial Carcinoma', 'Metastatic Bladder Urothelial Carcinoma', 'Metastatic Prostate Carcinoma', 'Metastatic Renal Pelvis Urothelial Carcinoma', 'Metastatic Ureter Urothelial Carcinoma', 'Metastatic Urethral Urothelial Carcinoma', 'Metastatic Urothelial Carcinoma', 'Stage IV Bladder Urothelial Carcinoma AJCC v7', 'Stage IV Prostate Cancer AJCC v7', 'Stage IV Renal Pelvis Cancer AJCC v7', 'Stage IV Ureter Cancer AJCC v7', 'Stage IV Urethral Cancer AJCC v7', 'Unresectable Urothelial Carcinoma']
NCT02354612;Open Label Continuation Study of TRC105 for Patients Who Have Completed a Prior TRC105 Trial;NO_LONGER_AVAILABLE;;EXPANDED_ACCESS;;['Solid Tumors']
NCT02348255;NovoTTF-100A With Bevacizumab and Carmustine in Treating Patients With Glioblastoma Multiforme in First Relapse;WITHDRAWN;['PHASE2'];INTERVENTIONAL;0.0;['Adult Brain Glioblastoma', 'Recurrent Adult Brain Neoplasm']
NCT00096148;Idarubicin and Cytarabine With or Without Bevacizumab in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia;TERMINATED;['PHASE2'];INTERVENTIONAL;120.0;['Adult Acute Basophilic Leukemia', 'Adult Acute Eosinophilic Leukemia', 'Adult Acute Megakaryoblastic Leukemia (M7)', 'Adult Acute Minimally Differentiated Myeloid Leukemia (M0)', 'Adult Acute Monoblastic Leukemia (M5a)', 'Adult Acute Monocytic Leukemia (M5b)', 'Adult Acute Myeloblastic Leukemia With Maturation (M2)', 'Adult Acute Myeloblastic Leukemia Without Maturation (M1)', 'Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities', 'Adult Acute Myelomonocytic Leukemia (M4)', 'Adult Erythroleukemia (M6a)', 'Adult Pure Erythroid Leukemia (M6b)', 'Childhood Acute Basophilic Leukemia', 'Childhood Acute Eosinophilic Leukemia', 'Childhood Acute Erythroleukemia (M6)', 'Childhood Acute Megakaryocytic Leukemia (M7)', 'Childhood Acute Monoblastic Leukemia (M5a)', 'Childhood Acute Monocytic Leukemia (M5b)', 'Childhood Acute Myeloblastic Leukemia With Maturation (M2)', 'Childhood Acute Myeloblastic Leukemia Without Maturation (M1)', 'Childhood Acute Myelomonocytic Leukemia (M4)', 'Secondary Acute Myeloid Leukemia', 'Untreated Adult Acute Myeloid Leukemia', 'Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies']
NCT00322725;Bevacizumab (Avastin) Induced Hypertension and Correlation With Tumor Response, a Chart Review;TERMINATED;;OBSERVATIONAL;25.0;['Cancer']
NCT03786692;Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLC;RECRUITING;['PHASE2'];INTERVENTIONAL;117.0;['Non-Small Cell Carcinoma of Lung, TNM Stage 4']
NCT01903330;ERC1671/GM-CSF/Cyclophosphamide for the Treatment of Glioblastoma Multiforme;ACTIVE_NOT_RECRUITING;['PHASE2'];INTERVENTIONAL;84.0;['Glioblastoma', 'Gliosarcoma']
NCT00113230;Neoadjuvant Chemoradiation With RHUMAB VEGF (Avastin) for Rectal Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;25.0;['Rectal Cancer']
NCT01408030;North American Study of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT);COMPLETED;['PHASE2'];INTERVENTIONAL;123.0;['Telangiectasia, Hereditary Hemorrhagic', 'Epistaxis']
NCT00923130;Bevacizumab Plus Ixabepilone to Treat Patients With Advanced Kidney Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;30.0;['Renal Cell Carcinoma']
NCT03093155;Evaluation of Weekly Ixabepilone With or Without Biweekly Bevacizumab;COMPLETED;['PHASE2'];INTERVENTIONAL;78.0;['Epithelial Ovarian Cancer', 'Fallopian Tube Cancer', 'Primary Peritoneal Cancer']
NCT05001880;Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma;RECRUITING;['PHASE2'];INTERVENTIONAL;66.0;['Peritoneal Malignant Mesothelioma']
NCT00523640;A Phase II Trial of Gemcitabine, Capecitabine, and Bevacizumab in Metastatic Renal Cell Carcinoma;TERMINATED;['PHASE2'];INTERVENTIONAL;30.0;['Carcinoma, Renal Cell']
NCT00130780;Multimodality Treatment for Patients With Resectable Non-Small Cell Lung Cancer (NSCLC) - BEACON Study: Bevacizumab and Chemotherapy for Operable NSCLC;COMPLETED;['PHASE2'];INTERVENTIONAL;71.0;['Carcinoma, Non-Small-Cell Lung']
NCT00856180;Sequential Angiogenic Blockade for the Treatment of Recurrent Mullerian Malignancies;COMPLETED;['PHASE2'];INTERVENTIONAL;20.0;['Ovarian Cancer', 'Peritoneal Cancer', 'Fallopian Tube Cancer']
NCT01274624;Study of REOLYSINÂ® in Combination With FOLFIRI and Bevacizumab in FOLFIRI Naive Patients With KRAS Mutant Metastatic Colorectal Cancer;COMPLETED;['PHASE1'];INTERVENTIONAL;36.0;['KRAS Mutant Metastatic Colorectal Cancer']
NCT03127124;QUILT-2.022 NANT-008 in Combination w/ 5-fluorouracil, Bevacizumab, Leucovorin & Oxaliplatin in Subjects With Pancreatic Cancer;SUSPENDED;['PHASE1', 'PHASE2'];INTERVENTIONAL;64.0;['Pancreatic Adenocarcinoma Metastatic']
NCT00142480;Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Patients With Biliary Tract and Gallbladder Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;8.0;['Biliary Tract Cancer', 'Gallbladder Adenocarcinoma']
NCT01295944;Carboplatin and Bevacizumab for Recurrent Ependymoma;COMPLETED;['PHASE2'];INTERVENTIONAL;35.0;['Ependymoma', 'Anaplastic Ependymoma']
NCT00705874;Study of CGC-11047 When Used in Individual Combinations With 1) Gemcitabine or 2) Docetaxel or 3) Bevacizumab or 4) Erlotinib or 5) Cisplatin or 6) 5-Flurouracil or 7) Sunitinib in Patients With Advanced Solid Tumors or Lymphoma;COMPLETED;['PHASE1'];INTERVENTIONAL;172.0;['Cancer']
NCT04404881;Bevacizumab In Hereditary Hemorrhagic Telangiectasia;RECRUITING;['PHASE2'];INTERVENTIONAL;33.0;['Hereditary Hemorrhagic Telangiectasia']
NCT03597581;A Study of RGX-202-01 (Ompenaclid) as Combination Therapy in 2nd Line RAS Mutant Advanced Colorectal Cancer;RECRUITING;['PHASE1'];INTERVENTIONAL;60.0;['Gastrointestinal Cancer', 'Gastrointestinal Neoplasms', 'Colorectal Cancer', 'Colorectal Neoplasms', 'Colorectal Carcinoma', 'Gastric Cancer', 'Gastric Neoplasm', 'KRAS Mutation-Related Tumors', 'CRC', 'Colorectal Cancer Metastatic']
NCT01031381;Study of RAD001 and Bevacizumab in Recurrent Ovarian, Peritoneal, and Fallopian Tube Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;50.0;['Ovarian Cancer', 'Fallopian Tube Cancer', 'Primary Peritoneal Carcinoma']
NCT01954576;NovoTTF Therapy in Treating Patients With Recurrent Glioblastoma Multiforme;TERMINATED;['NA'];INTERVENTIONAL;21.0;['Glioblastoma', 'Brain Neoplasms']
NCT00482495;Bevacizumab in Treating Patients With Relapsed or Refractory Multiple Myeloma;COMPLETED;['PHASE2'];INTERVENTIONAL;42.0;['Multiple Myeloma and Plasma Cell Neoplasm']
NCT00069095;A Study of Capecitabine (Xeloda) and Bevacizumab as a First-line Therapy in Patients With Metastatic Colorectal Cancer;COMPLETED;['PHASE3'];INTERVENTIONAL;2035.0;['Colorectal Cancer']
NCT00684996;Bevacizumab With or Without MEDI-522 in Treating Patients With Unresectable or Metastatic Kidney Cancer;TERMINATED;['PHASE1', 'PHASE2'];INTERVENTIONAL;5.0;['Recurrent Renal Cell Cancer', 'Renal Cell Carcinoma', 'Stage III Renal Cell Cancer', 'Stage IV Renal Cell Cancer']
NCT03532295;Retifanlimab and Epacadostat in Combination With Radiation and Bevacizumab in Patients With Recurrent Gliomas;ACTIVE_NOT_RECRUITING;['PHASE2'];INTERVENTIONAL;51.0;['Glioma', 'Glioblastoma']
NCT00951496;Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II-III Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer;COMPLETED;['PHASE3'];INTERVENTIONAL;1560.0;['Fallopian Tube Clear Cell Adenocarcinoma', 'Fallopian Tube Endometrioid Adenocarcinoma', 'Fallopian Tube Mucinous Adenocarcinoma', 'Fallopian Tube Serous Adenocarcinoma', 'Fallopian Tube Transitional Cell Carcinoma', 'Fallopian Tube Undifferentiated Carcinoma', 'Malignant Ovarian Brenner Tumor', 'Ovarian Clear Cell Adenocarcinoma', 'Ovarian Endometrioid Adenocarcinoma', 'Ovarian Mucinous Adenocarcinoma', 'Ovarian Seromucinous Carcinoma', 'Ovarian Serous Adenocarcinoma', 'Ovarian Transitional Cell Carcinoma', 'Ovarian Undifferentiated Carcinoma', 'Primary Peritoneal Clear Cell Adenocarcinoma', 'Primary Peritoneal Endometrioid Adenocarcinoma', 'Primary Peritoneal Serous Adenocarcinoma', 'Primary Peritoneal Transitional Cell Carcinoma', 'Primary Peritoneal Undifferentiated Carcinoma', 'Stage II Fallopian Tube Cancer AJCC v6 and v7', 'Stage II Ovarian Cancer AJCC v6 and v7', 'Stage IIA Fallopian Tube Cancer AJCC v6 and v7', 'Stage IIA Ovarian Cancer AJCC V6 and v7', 'Stage IIB Fallopian Tube Cancer AJCC v6 and v7', 'Stage IIB Ovarian Cancer AJCC v6 and v7', 'Stage IIC Fallopian Tube Cancer AJCC v6 and v7', 'Stage IIC Ovarian Cancer AJCC v6 and v7', 'Stage III Ovarian Cancer AJCC v6 and v7', 'Stage III Primary Peritoneal Cancer AJCC v7', 'Stage IIIA Ovarian Cancer AJCC v6 and v7', 'Stage IIIA Primary Peritoneal Cancer AJCC v7', 'Stage IIIB Ovarian Cancer AJCC v6 and v7', 'Stage IIIB Primary Peritoneal Cancer AJCC v7', 'Stage IIIC Ovarian Cancer AJCC v6 and v7', 'Stage IIIC Primary Peritoneal Cancer AJCC v7', 'Stage IV Fallopian Tube Cancer AJCC v6 and v7', 'Stage IV Ovarian Cancer AJCC v6 and v7', 'Stage IV Primary Peritoneal Cancer AJCC v7']
NCT05636111;Phase 1b of Lurbinectedin in Combination With Weekly Paclitaxel and Bevacizumab in Platinum-resistant Ovarian Cancer;RECRUITING;['PHASE1'];INTERVENTIONAL;34.0;['Ovarian Cancer']
NCT00203411;Bevacizumab Plus Capecitabine (Xeloda) in Patients With Untreated Metastatic Colorectal Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;45.0;['Colorectal Cancer']
NCT01305213;Bevacizumab With or Without Fosbretabulin Tromethamine in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;107.0;['Recurrent Fallopian Tube Carcinoma', 'Recurrent Ovarian Carcinoma', 'Recurrent Primary Peritoneal Carcinoma']
NCT02141295;A Study Comparing the Efficacy and Safety of Vanucizumab and FOLFOX With Bevacizumab and FOLFOX in Participants With Untreated Metastatic Colorectal Cancer;TERMINATED;['PHASE2'];INTERVENTIONAL;197.0;['Colorectal Cancer']
NCT00517595;Phase II Study Alimta and Gemzar + Avastin as First Line Chemotherapy for Elderly Patients With Stage IIIB/IV NSCLC;COMPLETED;['PHASE2'];INTERVENTIONAL;48.0;['Non-Small Cell Lung Cancer']
NCT00516295;Vincristine Sulfate, Topotecan Hydrochloride, and Cyclophosphamide With or Without Bevacizumab in Treating Young Patients With Refractory or First Recurrent Extracranial Ewing Sarcoma;COMPLETED;['PHASE2'];INTERVENTIONAL;7.0;['Ewing Sarcoma of Bone', 'Extraosseous Ewing Sarcoma', 'Peripheral Primitive Neuroectodermal Tumor', 'Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor']
NCT05640895;Intravitreal Injection Site and Perceived Pain;RECRUITING;;OBSERVATIONAL;60.0;['Pain']
NCT01055795;Safety Study of Bevacizumab, Everolimus and LBH589 (BEL) for Advanced Solid Tumors;COMPLETED;['PHASE1'];INTERVENTIONAL;14.0;['Advanced Solid Tumors']
NCT02086695;Early Detection of Broken Hearts in Cancer Patients;COMPLETED;;OBSERVATIONAL;43.0;['Cardiotoxicity']
NCT01146795;Neoadjuvant Therapy for Ovarian Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;32.0;['Epithelial Ovarian Cancer', 'Primary Peritoneal Cancer', 'Fallopian Tube Cancer']
NCT00671970;Phase (Ph) II Bevacizumab + Erlotinib for Patients (Pts) With Recurrent Malignant Glioma (MG);COMPLETED;['PHASE2'];INTERVENTIONAL;57.0;['Glioblastoma', 'Gliosarcoma']
NCT00129870;CONCEPT: Comparison of Oxaliplatin vs Conventional Methods With Calcium/Magnesium in First-Line Metastatic Colorectal Cancer;TERMINATED;['PHASE4'];INTERVENTIONAL;180.0;['Colorectal Cancer']
NCT00941499;Hepatic Arterial Infusion Oxaliplatin + 5FU, Leucovorin, and Bevacizumab +/- Cetuximab;COMPLETED;['PHASE1'];INTERVENTIONAL;140.0;['Advanced Cancers']
NCT00512876;Effectiveness and Safety of Topical Bevacizumab (Avastin) for Treatment of Corneal Neovascularization;COMPLETED;['NA'];INTERVENTIONAL;24.0;['Corneal Neovascularization']
NCT00408070;Bevacizumab Study With Carboplatin & Paclitaxel in Ovarian, Fallopian Tube or Primary Peritoneal Cancer;TERMINATED;['PHASE2'];INTERVENTIONAL;5.0;['Ovarian Cancer', 'Peritoneal Cancer', 'Fallopian Tube Cancer', 'Stage 3 Cancer', 'Stage 4 Cancer']
NCT01183780;A Study in Second Line Metastatic Colorectal Cancer;COMPLETED;['PHASE3'];INTERVENTIONAL;1072.0;['Colorectal Cancer']
NCT03878524;Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial;ACTIVE_NOT_RECRUITING;['PHASE1'];INTERVENTIONAL;2.0;['Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive', 'Anatomic Stage IV Breast Cancer AJCC v8', 'Anemia', 'Ann Arbor Stage III Hodgkin Lymphoma', 'Ann Arbor Stage III Non-Hodgkin Lymphoma', 'Ann Arbor Stage IV Hodgkin Lymphoma', 'Ann Arbor Stage IV Non-Hodgkin Lymphoma', 'Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative', 'Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive', 'Castration-Resistant Prostate Carcinoma', 'Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive', 'Hematopoietic and Lymphoid System Neoplasm', 'Locally Advanced Pancreatic Adenocarcinoma', 'Metastatic Breast Carcinoma', 'Metastatic Malignant Solid Neoplasm', 'Metastatic Pancreatic Adenocarcinoma', 'Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis', 'Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable', 'Primary Myelofibrosis', 'Recurrent Acute Lymphoblastic Leukemia', 'Recurrent Acute Myeloid Leukemia', 'Recurrent Chronic Lymphocytic Leukemia', 'Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive', 'Recurrent Hematologic Malignancy', 'Recurrent Hodgkin Lymphoma', 'Recurrent Myelodysplastic Syndrome', 'Recurrent Myelodysplastic/Myeloproliferative Neoplasm', 'Recurrent Myeloproliferative Neoplasm', 'Recurrent Non-Hodgkin Lymphoma', 'Recurrent Plasma Cell Myeloma', 'Recurrent Small Lymphocytic Lymphoma', 'Refractory Acute Lymphoblastic Leukemia', 'Refractory Acute Myeloid Leukemia', 'Refractory Chronic Lymphocytic Leukemia', 'Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive', 'Refractory Chronic Myelomonocytic Leukemia', 'Refractory Hematologic Malignancy', 'Refractory Hodgkin Lymphoma', 'Refractory Malignant Solid Neoplasm', 'Refractory Myelodysplastic Syndrome', 'Refractory Myelodysplastic/Myeloproliferative Neoplasm', 'Refractory Non-Hodgkin Lymphoma', 'Refractory Plasma Cell Myeloma', 'Refractory Primary Myelofibrosis', 'Refractory Small Lymphocytic Lymphoma', 'Stage II Pancreatic Cancer AJCC v8', 'Stage III Pancreatic Cancer AJCC v8', 'Stage IV Pancreatic Cancer AJCC v8', 'Stage IV Prostate Cancer AJCC v8', 'Unresectable Pancreatic Adenocarcinoma']
NCT05271240;Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM;RECRUITING;['PHASE3'];INTERVENTIONAL;432.0;['Glioblastoma', 'Glioblastoma Multiforme', 'Glioma, Malignant', 'GBM', 'Brain Cancer', 'Glioblastoma, IDH-wildtype', 'Glioblastoma Multiforme, Adult']
NCT01076140;Blood Pressure Effects of Nebivolol Versus Lisinopril in New Onset or Worsening Hypertension Induced by Bevacizumab;WITHDRAWN;['NA'];INTERVENTIONAL;0.0;['Hypertension']
NCT01814501;Panitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With Bevacizumab;UNKNOWN;['PHASE2'];INTERVENTIONAL;16.0;['Mucinous Adenocarcinoma of the Colon', 'Mucinous Adenocarcinoma of the Rectum', 'Recurrent Colon Cancer', 'Recurrent Rectal Cancer', 'Signet Ring Adenocarcinoma of the Colon', 'Signet Ring Adenocarcinoma of the Rectum', 'Stage IV Colon Cancer', 'Stage IV Rectal Cancer']
NCT01884740;Intraarterial Infusion Of Erbitux and Bevacizumab For Relapsed/Refractory Intracranial Glioma In Patients Under 22;TERMINATED;['PHASE1', 'PHASE2'];INTERVENTIONAL;13.0;['Glioblastoma Multiforme', 'Fibrillary Astrocytoma of Brain', 'Glioma of Brainstem', 'Anaplastic Astrocytoma', 'Pilomyxoid Astrocytoma', 'Mixed Oligodendroglioma-Astrocytoma', 'Brain Stem Glioma', 'Diffuse Intrinsic Pontine Glioma']
NCT00367601;Erlotinib + Bevacizumab for PS 2 Chemotherapy NaÃ¯ve Non-Small Cell Lung Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;25.0;['Lung Cancer']
NCT01079780;Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing Chemotherapy;COMPLETED;['PHASE2'];INTERVENTIONAL;136.0;['Colorectal Cancer']
NCT00826540;Sorafenib and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;83.0;['Recurrent Colon Cancer', 'Recurrent Rectal Cancer', 'Stage IV Colon Cancer', 'Stage IV Rectal Cancer']
NCT00079040;Cisplatin, Etoposide, and Bevacizumab in Treating Patients With Previously Untreated Extensive Stage Small Cell Lung Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;65.0;['Extensive Stage Small Cell Lung Cancer']
NCT00349557;Bevacizumab With Hormonal and Radiotherapy for High-Risk Prostate Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;18.0;['Prostate Cancer']
NCT01743157;Biochemotherapy and Bevacizumab Followed by Consolidation Therapy With Ipilimumab for Metastatic Melanoma;COMPLETED;['PHASE1', 'PHASE2'];INTERVENTIONAL;24.0;['Metastatic Melanoma']
NCT00887536;A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer;COMPLETED;['PHASE3'];INTERVENTIONAL;1613.0;['Breast Cancer']
NCT00923936;Pilot Study of Liposomal Doxorubicin Combined With Bevacizumab Followed by Bevacizumab Monotherapy in Adults With Advanced Kaposi s Sarcoma;COMPLETED;['PHASE2'];INTERVENTIONAL;16.0;['Sarcoma, Kaposi']
NCT00127036;Trial for Microarray Analysis of Colon Cancer Outcome-A (MACCO-A);TERMINATED;['PHASE2'];INTERVENTIONAL;65.0;['Adenocarcinoma', 'Colon Cancer']
NCT00307736;Bevacizumab, Erlotinib and 5-Fluorouracil With External Beam Radiation Therapy in Locally Advanced Rectal Cancer;COMPLETED;['PHASE1', 'PHASE2'];INTERVENTIONAL;32.0;['Rectal Cancer', 'Adenocarcinoma of the Rectum']
NCT02833701;Bevacizumab and Ascorbic Acid in Patients Treating With Recurrent High Grade Glioma;TERMINATED;['PHASE1'];INTERVENTIONAL;9.0;['Glioblastoma', 'Glioma']
NCT04099836;Atezolizumab and Bevacizumab in EGFR Mutant NSCLC in Patients With Progressive Disease After Receiving Osimertinib;TERMINATED;['PHASE2'];INTERVENTIONAL;7.0;['Non Small Cell Lung Cancer']
NCT00559936;Topical Avastin for Treatment of Corneal Neovascularization;COMPLETED;['PHASE1'];INTERVENTIONAL;24.0;['Corneal Neovascularization']
NCT03746041;A Phase I Pilot Study of Abaloparatide + Bevacizumab in Myelodysplastic Syndromes;COMPLETED;['PHASE1'];INTERVENTIONAL;20.0;['Myelodysplastic Syndromes', 'Chronic Myelomonocytic Leukemia']
NCT01625936;CRLX101 Plus Bevacizumab in Advanced RCC;COMPLETED;['PHASE1'];INTERVENTIONAL;22.0;['Renal Cell Carcinoma']
NCT01051934;A Phase I Trial of SS1 (dsFv) PE38 With Paclitaxel, Carboplatin, and Bevacizumab in Subjects With Unresectable Non-Small Cell Lung Adenocarcinoma;COMPLETED;['PHASE1'];INTERVENTIONAL;2.0;['Non-Small Cell Lung Cancer', 'Adenocarcinoma']
NCT01085734;Single Site, Masked, Randomized, Controlled Study to Assess Efficacy of Osurdex as Adjunct to Avastin Compared With Avastin Alone in the Treatment of Patients With Macular Edema Due to Central or Branch Retinal Vein Occlusion;COMPLETED;['PHASE4'];INTERVENTIONAL;30.0;['Retinal Vein Occlusions']
NCT01552434;Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease;ACTIVE_NOT_RECRUITING;['PHASE1'];INTERVENTIONAL;155.0;['Advanced Malignant Neoplasm', 'Castleman Disease', 'Digestive System Carcinoma', 'Erdheim-Chester Disease', 'Lip and Oral Cavity Carcinoma', 'Lymphangioleiomyomatosis', 'Malignant Endocrine Neoplasm', 'Malignant Female Reproductive System Neoplasm', 'Malignant Male Reproductive System Neoplasm', 'Malignant Neoplasm', 'Malignant Respiratory Tract Neoplasm', 'Malignant Thoracic Neoplasm', 'Malignant Urinary System Neoplasm', 'Mesothelial Neoplasm', 'Metastatic Malignant Neoplasm', 'Metastatic Urothelial Carcinoma', 'Neurofibromatosis Type 2', 'Recurrent Adult Soft Tissue Sarcoma', 'Recurrent Breast Carcinoma', 'Recurrent Childhood Soft Tissue Sarcoma', 'Recurrent Digestive System Carcinoma', 'Recurrent Female Reproductive System Carcinoma', 'Recurrent Male Reproductive System Carcinoma', 'Recurrent Malignant Neoplasm', 'Recurrent Pharyngeal Carcinoma', 'Recurrent Thyroid Gland Carcinoma', 'Refractory Malignant Neoplasm', 'Soft Tissue Neoplasm', 'Stage III Breast Cancer AJCC v7', 'Stage III Pharyngeal Cancer', 'Stage IIIA Breast Cancer AJCC v7', 'Stage IIIB Breast Cancer AJCC v7', 'Stage IIIC Breast Cancer AJCC v7', 'Stage IV Breast Cancer AJCC v6 and v7', 'Stage IV Pharyngeal Cancer', 'Stage IVA Pharyngeal Cancer', 'Stage IVB Pharyngeal Cancer', 'Stage IVC Pharyngeal Cancer', 'Thyroid Gland Neoplasm']
NCT02387957;A 24 Month Phase 2a Open Label, Randomized Study of AvastinÂ®, LucentisÂ®, or EyleaÂ® (Anti-VEGF Therapy) Administered in Combination With FovistaÂ® (Anti-PDGF BB Pegylated Aptamer);TERMINATED;['PHASE2'];INTERVENTIONAL;63.0;['Age-Related Macular Degeneration']
NCT01113398;AMG 102 and Avastin for Recurrent Malignant Glioma;COMPLETED;['PHASE2'];INTERVENTIONAL;36.0;['Glioblastoma Multiforme', 'Gliosarcoma']
NCT01811498;Repeated Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Newly Diagnosed GBM;COMPLETED;['PHASE1', 'PHASE2'];INTERVENTIONAL;31.0;['Glioblastoma Multiforme', 'Brain Tumor']
NCT00883298;Bi-weekly Temozolomide Plus Bevacizumab for Adult Patients With Recurrent Glioblastoma Multiforme;COMPLETED;['PHASE2'];INTERVENTIONAL;30.0;['Recurrent Glioblastoma Multiforme', 'Recurrent Gliosarcoma']
NCT05112861;A 3-month Study to Compare the Safety of ONS-5010 in Vials Versus Pre-filled Syringe in Subjects With Visual Impairment Due to Retinal Disorders;ACTIVE_NOT_RECRUITING;['PHASE3'];INTERVENTIONAL;120.0;['Age-Related Macular Degeneration', 'Neovascular Age-related Macular Degeneration', 'Wet Macular Degeneration', 'BRVO - Branch Retinal Vein Occlusion', 'Diabetic Macular Edema']
NCT01894061;NovoTTF-100A With Bevacizumab (Avastin) in Patients With Recurrent Glioblastoma;COMPLETED;['PHASE2'];INTERVENTIONAL;25.0;['Adult Giant Cell Glioblastoma', 'Adult Glioblastoma', 'Adult Gliosarcoma', 'Recurrent Adult Brain Tumor']
NCT04743661;131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma;ACTIVE_NOT_RECRUITING;['PHASE2'];INTERVENTIONAL;62.0;['Recurrent Medulloblastoma', 'Recurrent Ependymoma']
NCT00301964;Bevacizumab in Treating Patients With Recurrent or Persistent Endometrial Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;56.0;['Recurrent Endometrial Carcinoma']
NCT00337389;Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer.;UNKNOWN;['PHASE3'];INTERVENTIONAL;1200.0;['Metastatic Colorectal Cancer', 'Colon Cancer', 'Rectal Cancer']
NCT02768389;Feasibility Trial of the Modified Atkins Diet and Bevacizumab for Recurrent Glioblastoma;COMPLETED;['EARLY_PHASE1'];INTERVENTIONAL;18.0;['Glioblastoma', 'Brain Tumor']
NCT05588388;Study of Bevacizumab in Combination With Chemoimmunotherapy and Atezolizumab in Patients With Extensive Stage Small Cell Lung Cancer and Liver Metastases;NOT_YET_RECRUITING;['PHASE2'];INTERVENTIONAL;39.0;['Extensive-stage Small-cell Lung Cancer', 'Liver Metastases']
NCT01995188;A Study to Evaluate the Safety and Pharmacology of DNIB0600A in Participants With Platinum-Sensitive Ovarian Cancer or Non-Squamous Non-small Cell Lung Cancer;COMPLETED;['PHASE1'];INTERVENTIONAL;41.0;['Non-Squamous Non-Small Cell Lung Cancer']
NCT00756340;A Trial of Everolimus and Bevacizumab in Children With Recurrent Solid Tumors;COMPLETED;['PHASE1'];INTERVENTIONAL;16.0;['Recurrent or Refractory Solid Tumors', 'CNS Malignancies']
NCT00366457;Gemcitabine, Bevacizumab and Erlotinib in Pancreatic Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;32.0;['Pancreatic Cancer', 'Adenocarcinoma of the Pancreas']
NCT01936974;(PGA) for Platinum-resistant/Refractory, Paclitaxel-Pretreated Recurrent Ovarian and Peritoneal Carcinoma;TERMINATED;['PHASE2'];INTERVENTIONAL;7.0;['Ovarian Carcinoma', 'Fallopian Tube Carcinoma', 'Peritoneal Carcinoma']
NCT00410774;Gemcitabine and Bevacizumab in Treating Patients With Pancreatic Cancer That Has Been Completely Removed By Surgery;TERMINATED;['PHASE1', 'PHASE2'];INTERVENTIONAL;20.0;['Pancreatic Cancer']
NCT00433381;Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma;COMPLETED;['PHASE2'];INTERVENTIONAL;123.0;['Adult Glioblastoma', 'Adult Gliosarcoma', 'Recurrent Adult Brain Neoplasm']
NCT00217581;Bevacizumab, Oxaliplatin, and Docetaxel in Treating Patients With Locally Advanced Unresectable or Metastatic Stomach or Gastroesophageal Junction Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;39.0;['Esophageal Cancer', 'Gastric Cancer']
NCT00460174;Gemcitabine, Bevacizumab, and Abdominal Radiation Therapy in Treating Patients With Localized Pancreatic Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;31.0;['Pancreatic Cancer']
NCT01096381;Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor;TERMINATED;;OBSERVATIONAL;8.0;['Breast Cancer', 'Cardiovascular Complications', 'Colorectal Cancer', 'Fallopian Tube Cancer', 'Head and Neck Cancer', 'Lung Cancer', 'Ovarian Cancer', 'Peritoneal Cavity Cancer', 'Unspecified Adult Solid Tumor, Protocol Specific']
NCT01845844;Ranibizumab For Persistent Diabetic Macular Edema After Bevacizumab;UNKNOWN;['PHASE1', 'PHASE2'];INTERVENTIONAL;30.0;['Diabetic Macular Edema']
NCT05739981;Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer;RECRUITING;['PHASE1', 'PHASE2'];INTERVENTIONAL;50.0;['Ovarian Cancer', 'Fallopian Tube Cancer', 'Primary Peritoneal Cancer']
NCT03786081;Safety and Efficacy of Tisotumab Vedotin Monotherapy & in Combination With Other Cancer Agents in Subjects With Cervical Cancer;ACTIVE_NOT_RECRUITING;['PHASE1', 'PHASE2'];INTERVENTIONAL;214.0;['Cervical Cancer']
NCT01468844;Minocycline to Treat Central Retinal Vein Occlusion;COMPLETED;['PHASE1', 'PHASE2'];INTERVENTIONAL;6.0;['Retinal Vein Occlusion']
NCT00343044;Ph II Study of Wkly Topotecan + Bevacizumab in Plat. Resistant/Recurrent Gyn Cancers;COMPLETED;['PHASE2'];INTERVENTIONAL;40.0;['Ovarian Cancer', 'Fallopian Tube Cancer', 'Peritoneal Cancer']
NCT00137774;Bevacizumab in Combination With Temozolomide in Patients With Neuroendocrine Tumors;COMPLETED;['PHASE2'];INTERVENTIONAL;34.0;['Neuroendocrine Tumors']
NCT00479674;Phase II Study With Abraxane, Bevacizumab and Carboplatin in Triple Negative Metastatic Breast Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;41.0;['Breast Cancer']
NCT00590681;Bevacizumab and Temozolomide Following Radiation and Chemotherapy for Newly Diagnosed Glioblastoma Multiforme;COMPLETED;['PHASE2'];INTERVENTIONAL;62.0;['Glioblastoma Multiforme']
NCT06083844;Phase II Investigation of Pembrolizumab in Combination With Bevacizumab and Oral Cyclophosphamide in Patients With High Grade Ovarian Cancer and Surgically Documented Minimal Residual Disease After Frontline Therapy;RECRUITING;['PHASE2'];INTERVENTIONAL;20.0;['Ovarian Cancer']
NCT04449874;A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-6036 Alone or in Combination in Participants With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation;RECRUITING;['PHASE1'];INTERVENTIONAL;498.0;['Non-Small Cell Lung Cancer', 'Colorectal Cancer', 'Advanced Solid Tumors']
NCT00424840;Phase I/II Study to Evaluate the Efficacy and Safety of a Combination Chemotherapy;TERMINATED;['PHASE1'];INTERVENTIONAL;12.0;['Lung Cancer']
NCT00281840;Bevacizumab, Docetaxel, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;30.0;['Head and Neck Cancer']
NCT05523440;Bevacizumab and/or Niraparib in Patients With Recurrent Endometrial and/or Ovarian Cancer With ARID1A Mutation;RECRUITING;['PHASE2'];INTERVENTIONAL;92.0;['Recurrent Endometrial Carcinoma', 'Recurrent Ovarian Carcinoma', 'ARID1A Gene Mutation']
NCT05678257;A Study of NUC-3373 in Combination With Other Agents in Patients With Colorectal Cancer;RECRUITING;['PHASE2'];INTERVENTIONAL;171.0;['Colorectal Cancer', 'Colorectal Neoplasms', 'Colorectal Adenocarcinoma', 'Colorectal Cancer Metastatic', 'Neoplasm, Colorectal']
NCT02456857;"Liposomal Doxorubicin, Bevacizumab, and Everolimus in Patients With Locally Advanced TNBC With Tumors Predicted Insensitive to Standard Chemotherapy; A Moonshot Initiative";COMPLETED;['PHASE2'];INTERVENTIONAL;17.0;['Invasive Breast Carcinoma', 'Triple-Negative Breast Carcinoma']
NCT04102098;A Study of Atezolizumab Plus Bevacizumab Versus Active Surveillance as Adjuvant Therapy in Patients With Hepatocellular Carcinoma at High Risk of Recurrence After Surgical Resection or Ablation;ACTIVE_NOT_RECRUITING;['PHASE3'];INTERVENTIONAL;668.0;['Carcinoma, Hepatocellular']
NCT03836157;Mirvetuximab Soravtansine (IMGN853) and Bevacizumab in Patients With Endometrial Cancer;WITHDRAWN;['PHASE2'];INTERVENTIONAL;0.0;['Endometrial Cancer', 'Endometrial Adenocarcinoma', 'Endometrial Serous Adenocarcinoma', 'Endometrial Clear Cell Adenocarcinoma']
NCT05854498;Liposomal Irinotecan With TAS102 and Bevacizumab for Patients With Metastatic Colorectal Cancer;RECRUITING;['PHASE2'];INTERVENTIONAL;25.0;['Metastatic Colorectal Cancer']
NCT00934440;A Study to Evaluate the Effectiveness of 5-Azacitidine and Bevacizumab in Advanced Renal Cell Carcinoma;TERMINATED;['PHASE1', 'PHASE2'];INTERVENTIONAL;11.0;['Renal Cell Carcinoma']
NCT01189240;RO4929097and Bevacizumab in Treating Patients With Progressive or Recurrent Malignant Glioma;TERMINATED;['PHASE1', 'PHASE2'];INTERVENTIONAL;13.0;['Adult Anaplastic Astrocytoma', 'Adult Anaplastic Oligodendroglioma', 'Adult Giant Cell Glioblastoma', 'Adult Glioblastoma', 'Adult Gliosarcoma', 'Recurrent Adult Brain Tumor']
NCT00968240;Super-Selective Intraarterial Intracranial Infusion of Avastin (Bevacizumab);COMPLETED;['PHASE1'];INTERVENTIONAL;30.0;['Glioblastoma Multiforme', 'Anaplastic Astrocytoma']
NCT01610557;Ranibizumab and Bevacizumab for Diabetic Macular Edema;COMPLETED;['PHASE2'];INTERVENTIONAL;56.0;['Diabetic Macular Edema']
NCT04109924;TAS-102, Irinotecan, and Bevacizumab for the Treatment of Pre-treated Metastatic or Unresectable Colorectal Cancer, the TABAsCO Study;ACTIVE_NOT_RECRUITING;['PHASE2'];INTERVENTIONAL;42.0;['Advanced Colorectal Carcinoma', 'Metastatic Colon Adenocarcinoma', 'Metastatic Rectal Adenocarcinoma', 'Recurrent Colon Adenocarcinoma', 'Recurrent Colorectal Adenocarcinoma', 'Recurrent Rectal Adenocarcinoma', 'Stage III Colon Cancer AJCC v8', 'Stage III Colorectal Cancer AJCC v8', 'Stage III Rectal Cancer AJCC v8', 'Stage IIIA Colon Cancer AJCC v8', 'Stage IIIA Colorectal Cancer AJCC v8', 'Stage IIIB Colorectal Cancer AJCC v8', 'Stage IIIB Rectal Cancer AJCC v8', 'Stage IIIC Colon Cancer AJCC v8', 'Stage IIIC Colorectal Cancer AJCC v8', 'Stage IV Colon Cancer AJCC v8', 'Stage IVA Colorectal Cancer AJCC v8', 'Stage IVA Rectal Cancer AJCC v8', 'Stage IVB Colon Cancer AJCC v8', 'Stage IVB Colorectal Cancer AJCC v8', 'Stage IVB Rectal Cancer AJCC v8', 'Stage IVC Colon Cancer AJCC v8', 'Stage IVC Colorectal Cancer AJCC v8', 'Stage IVC Rectal Cancer AJCC v8', 'Unresectable Colon Adenocarcinoma', 'Unresectable Colorectal Carcinoma', 'Unresectable Rectal Adenocarcinoma']
NCT00504257;Avastin in Combination With Docetaxel in Ovarian/Fallopian Tube/Peritoneum Carcinoma;COMPLETED;['PHASE2'];INTERVENTIONAL;45.0;['Fallopian Tube Cancer', 'Ovarian Cancer', 'Malignant Tumor of Peritoneum']
NCT01344824;Carboplatin, Pemetrexed Disodium, and Bevacizumab for Patients With Stage III or IV Non-Small Cell Lung Cancer Who Are Light/Never Smokers;COMPLETED;['PHASE2'];INTERVENTIONAL;38.0;['Lung Cancer']
NCT02036424;Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Alone Versus Ozurdex Given Every 3 Months for Treatment of Persistent Diabetic Macular Edema;COMPLETED;['PHASE4'];INTERVENTIONAL;45.0;['Diabetic Macular Edema']
NCT03778957;A Global Study to Evaluate Transarterial Chemoembolization (TACE) in Combination With Durvalumab and Bevacizumab Therapy in Patients With Locoregional Hepatocellular Carcinoma;ACTIVE_NOT_RECRUITING;['PHASE3'];INTERVENTIONAL;724.0;['Hepatocellular Carcinoma']
NCT00819780;PEAK: Panitumumab Plus mFOLFOX6 vs. Bevacizumab Plus mFOLFOX6 for First Line Treatment of Metastatic Colorectal Cancer (mCRC) Patients With Wild-Type Kirsten Rat Sarcoma-2 Virus (KRAS) Tumors;COMPLETED;['PHASE2'];INTERVENTIONAL;285.0;['Colon Cancer', 'Colorectal Cancer', 'Rectal Cancer', 'Metastatic Colorectal Cancer']
NCT03882424;A Study to Compare Pharmacokinetic and Safety of TRS003 to China-approved Bevacizumab and US-licensed AvastinÂ®;COMPLETED;['PHASE1'];INTERVENTIONAL;114.0;['Healthy']
NCT00112840;CCI-779 and Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney Cancer;COMPLETED;['PHASE1', 'PHASE2'];INTERVENTIONAL;60.0;['Clear Cell Renal Cell Carcinoma', 'Recurrent Renal Cell Cancer', 'Stage IV Renal Cell Cancer']
NCT01072357;Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival;COMPLETED;['PHASE1', 'PHASE2'];INTERVENTIONAL;30.0;['Corneal Neovascularization', 'Corneal Graft Failure']
NCT00618657;Carboplatin+Nab-paclitaxel, Plus Trastuzumab (HER2+) or Bevacizumab (HER2-) in the Neoadjuvant Setting;COMPLETED;['PHASE2'];INTERVENTIONAL;127.0;['Breast Cancer', 'HER2-negative Breast Cancer', 'HER2-positive Breast Cancer', 'Recurrent Breast Cancer', 'Stage IA Breast Cancer', 'Stage IB Breast Cancer', 'Stage II Breast Cancer', 'Stage IIIA Breast Cancer', 'Stage IIIB Breast Cancer', 'Stage IIIC Breast Cancer']
NCT03632798;Avastin Plus Chemotherapy vs. Avastin Plus Chemotherapy Guided by Cancer Stem Cell Test in Recurrent Ovarian Cancer;SUSPENDED;['PHASE3'];INTERVENTIONAL;300.0;['Recurrent Ovarian Cancer']
NCT00748657;Bevacizumab in Treating Patients With Recurrent Sex Cord-Stromal Tumors of the Ovary;COMPLETED;['PHASE2'];INTERVENTIONAL;36.0;['Malignant Ovarian Epithelial Tumor', 'Ovarian Granulosa Cell Tumor', 'Ovarian Gynandroblastoma', 'Ovarian Sertoli-Leydig Cell Tumor', 'Ovarian Sex Cord Tumor With Annular Tubules', 'Ovarian Sex Cord-Stromal Tumor', 'Ovarian Sex Cord-Stromal Tumor of Mixed or Unclassified Cell Types', 'Ovarian Steroid Cell Tumor']
NCT02810457;Evaluation of FKB238 and Avastin in Patients With Advanced/Recurrent Non-squamous Non-small Cell Lung Cancer;COMPLETED;['PHASE3'];INTERVENTIONAL;731.0;['Carcinoma, Non-Small-Cell Lung']
NCT00309998;Vinorelbine and Bevacizumab in Treating Older Patients With Stage III or Stage IV Non-Small Cell Lung Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;50.0;['Lung Cancer']
NCT00591734;RAD001 Plus Bevacizumab in Metastatic Melanoma;COMPLETED;['PHASE2'];INTERVENTIONAL;57.0;['Metastatic Melanoma']
NCT00478634;A Phase 1 Study Investigating the Combination of RAD001, Cetuximab and Irinotecan as Second-line Therapy After FOLFOX (or XELOX) Plus Bevacizumab in Patients With Metastatic Colorectal Cancer;COMPLETED;['PHASE1'];INTERVENTIONAL;19.0;['Colorectal Cancer', 'Colorectal Carcinoma', 'Colorectal Tumors', 'Neoplasms, Colorectal']
NCT02287298;Triple Combination Therapy of Choroidal Neovascularization in AMD, a Cost Effect and Efficient Therapeutic Treatment;COMPLETED;;OBSERVATIONAL;400.0;['Exudative Macular Degeneration']
NCT03713944;Carboplatin Plus Pemetrexed Plus Atezolizumab Plus Bevacizumab in Chemotherapy and Immunotherapy-naÃ¯ve Patients With Stage IV Non-squamous Non-small Cell Lung Cancer;TERMINATED;['PHASE2'];INTERVENTIONAL;30.0;['NSCLC Stage IV', 'NSCLC, Recurrent']
NCT00977574;Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer;ACTIVE_NOT_RECRUITING;['PHASE2'];INTERVENTIONAL;349.0;['Endometrial Adenocarcinoma', 'Endometrial Adenosquamous Carcinoma', 'Endometrial Clear Cell Adenocarcinoma', 'Endometrial Serous Adenocarcinoma', 'Recurrent Uterine Corpus Cancer', 'Stage IIIA Uterine Corpus Cancer AJCC v7', 'Stage IIIB Uterine Corpus Cancer AJCC v7', 'Stage IIIC Uterine Corpus Cancer AJCC v7', 'Stage IVA Uterine Corpus Cancer AJCC v7', 'Stage IVB Uterine Corpus Cancer AJCC v7']
NCT00426998;Combination Bevacizumab and Verteporfin (Two Different Sequences of Treatment)in Neovascular AMD;COMPLETED;['PHASE2'];INTERVENTIONAL;30.0;['Choroidal Neovascularization', 'Macular Degeneration']
NCT00365144;Bevacizumab and Erlotinib in Treating Patients With Metastatic Pancreatic Cancer That Did Not Respond to Previous Treatment With Gemcitabine;COMPLETED;['PHASE2'];INTERVENTIONAL;36.0;['Pancreatic Cancer']
NCT03337698;A Study Of Multiple Immunotherapy-Based Treatment Combinations In Participants With Metastatic Non-Small Cell Lung Cancer (Morpheus- Non-Small Cell Lung Cancer);RECRUITING;['PHASE1', 'PHASE2'];INTERVENTIONAL;675.0;['Carcinoma, Non-Small-Cell Lung']
NCT01292798;Ranibizumab 0.5mg and 2.0mg to Treat Diabetic Macular Edema in Patients With Poor Response to Bevacizumab;COMPLETED;['PHASE1', 'PHASE2'];INTERVENTIONAL;43.0;['Diabetic Macular Edema']
NCT00986674;Carboplatin and Paclitaxel Combined With Cetuximab and/or IMC-A12 in Patients With Advanced Non-Small Cell Lung Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;140.0;['Recurrent Non-small Cell Lung Cancer', 'Stage IIIB Non-small Cell Lung Cancer', 'Stage IV Non-small Cell Lung Cancer']
NCT05733598;RP3 in Combination With 1L or 2L Therapy in Patients With Locally Advanced Unresectable or Metastatic HCC;NOT_YET_RECRUITING;['PHASE2'];INTERVENTIONAL;60.0;['Locally Advanced Hepatocellular Carcinoma', 'Recurrent Hepatocellular Carcinoma', 'Metastatic Hepatocellular Carcinoma']
NCT03563144;QUILT-3.088: NANT Pancreatic Cancer Vaccine;WITHDRAWN;['PHASE2'];INTERVENTIONAL;0.0;['Metastatic Pancreatic Cancer']
NCT00761644;Doxil, Bevacizumab and Temsirolimus Trial;COMPLETED;['PHASE1'];INTERVENTIONAL;200.0;['Advanced Cancer']
NCT01004874;Avastin/Radiation (XRT)/Temozolomide (Temodar) Followed by Avastin/Temodar/Topotecan for Glioblastoma;COMPLETED;['PHASE2'];INTERVENTIONAL;80.0;['Malignant Glioma', 'Glioblastoma', 'Gliosarcoma']
NCT04456699;Efficacy and Safety of Olaparib (MK-7339) With or Without Bevacizumab Compared to Bevacizumab With a Fluoropyrimidine in Unresectable or Metastatic Colorectal Cancer (CRC) (MK-7339-003/LYNK-003);COMPLETED;['PHASE3'];INTERVENTIONAL;335.0;['Metastatic Colorectal Cancer']
NCT00911170;PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study;COMPLETED;['PHASE3'];INTERVENTIONAL;847.0;['Cancer', 'Colon Cancer', 'Colorectal Cancer', 'Fever', 'Locally Advanced', 'Metastatic Colorectal Cancer', 'Neutropenia', 'Rectal Cancer']
NCT02192970;Bevacizumab Against Recurrent Retinal Detachment;COMPLETED;['PHASE2'];INTERVENTIONAL;101.0;['Retinal Detachment', 'Proliferative Vitreoretinopathy']
NCT01312376;Autologous T-Cells Combined With Autologous OC-DC Vaccine in Ovarian Cancer;TERMINATED;['PHASE1'];INTERVENTIONAL;18.0;['Ovarian Carcinoma', 'Fallopian Tube Cancer', 'Primary Peritoneal Cancer']
NCT00703976;Radiation, Cetuximab and Pemetrexed With or Without Bevacizumab in Locally Advanced Head and Neck Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;80.0;['Cancer']
NCT00324870;Vorinostat and Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney Cancer;COMPLETED;['PHASE1', 'PHASE2'];INTERVENTIONAL;37.0;['Clear Cell Renal Cell Carcinoma', 'Recurrent Renal Cell Cancer', 'Stage III Renal Cell Cancer', 'Stage IV Renal Cell Cancer']
NCT00619424;A Phase I Study Of Pazopanib With Either Erlotinib Or Pemetrexed In Patients With Advanced Solid Tumors;COMPLETED;['PHASE1'];INTERVENTIONAL;58.0;['Lung Cancer, Non-Small Cell']
NCT00251524;A Phase II Study of Eloxatin and Alimta in Combination With Bevacizumab in Advanced Non-Squamous NSCLC;COMPLETED;['PHASE2'];INTERVENTIONAL;69.0;['Non-Small Cell Lung Cancer']
NCT04299880;Rollover Study to Provide Continued Access to Napabucasin for Patients Enrolled in Boston Biomedical-sponsored Protocols;COMPLETED;['PHASE1'];INTERVENTIONAL;7.0;['Oncology']
NCT00203424;Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib;COMPLETED;['PHASE2'];INTERVENTIONAL;23.0;['Prostate Cancer']
NCT01459380;Pegylated Liposomal Doxorubicin Hydrochloride, Carboplatin, Veliparib, and Bevacizumab in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer;COMPLETED;['PHASE1'];INTERVENTIONAL;41.0;['Ovarian Clear Cell Cystadenocarcinoma', 'Ovarian Endometrioid Adenocarcinoma', 'Ovarian Seromucinous Carcinoma', 'Ovarian Serous Cystadenocarcinoma', 'Recurrent Fallopian Tube Carcinoma', 'Recurrent Ovarian Carcinoma', 'Recurrent Primary Peritoneal Carcinoma', 'Undifferentiated Ovarian Carcinoma']
NCT01788280;Preliminary Assessment of [18F] Fluciclatide (GE [18F]AH111585) in Glioblastoma Multiforme Treated With Bevacizumab;WITHDRAWN;['PHASE2'];INTERVENTIONAL;0.0;['Glioblastoma Multiforme (GBM)']
NCT02559180;Treatment of Diabetic Macular Edema With Aflibercept in Subjects Previously Treated With Ranibizumab or Bevacizumab;COMPLETED;['PHASE4'];INTERVENTIONAL;20.0;['Diabetic Retinopathy', 'Macular Edema']
NCT02876224;Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors;COMPLETED;['PHASE1'];INTERVENTIONAL;51.0;['Colorectal Cancer']
NCT00348998;Bevacizumab, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer;UNKNOWN;['PHASE2'];INTERVENTIONAL;18.0;['Prostate Cancer']
NCT00993044;A Study of Vincristine, Escalating Doses of Irinotecan, Temozolomide and Bevacizumab (Vit-b) in Pediatric and Adolescent Patients With Recurrent or Refractory Solid Tumors of Non-hematopoietic Origin;COMPLETED;['PHASE1'];INTERVENTIONAL;13.0;['Refractory Solid Tumors in Children']
NCT01229644;Study of Crenolanib, a Selective and Potent Inhibitor of PDGFR, for the Treatment of Adult Gliomas;TERMINATED;['PHASE2'];INTERVENTIONAL;10.0;['Glioma']
NCT00973557;The Effect of Monoclonal Vascular Endothelial Growth Factor (VEGF) Antibody (Bevacizumab) on Pituitary Function;COMPLETED;;OBSERVATIONAL;6.0;['Colorectal Cancer', 'Lung Cancer', 'Breast Cancer', 'Glioblastoma']
NCT00832598;[18F] FACBC and [18F] FLT PET Imaging in Central Nervous System Tumors;COMPLETED;['NA'];INTERVENTIONAL;13.0;['Brain Cancer', 'Gliomas']
NCT00077298;Bevacizumab and Cetuximab With or Without Irinotecan in Treating Patients With Irinotecan-Refractory Metastatic Colorectal Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;70.0;['Recurrent Colon Cancer', 'Recurrent Rectal Cancer', 'Stage IVA Colon Cancer', 'Stage IVA Rectal Cancer', 'Stage IVB Colon Cancer', 'Stage IVB Rectal Cancer']
NCT01814813;Vaccine Therapy With Bevacizumab Versus Bevacizumab Alone in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery;TERMINATED;['PHASE2'];INTERVENTIONAL;90.0;['Recurrent Glioblastoma', 'Recurrent Adult Brain Tumor', 'Gliosarcoma']
NCT01067469;Standard Dose Bevacizumab Versus Low Dose Bevacizumab Plus Lomustine (CCNU) for Recurrent Glioblastoma Multiforme (GBM);COMPLETED;['PHASE2'];INTERVENTIONAL;83.0;['Brain Cancer', 'Glioblastoma']
NCT03586869;QUILT-3.080: NANT Pancreatic Cancer Vaccine;UNKNOWN;['PHASE1', 'PHASE2'];INTERVENTIONAL;173.0;['Pancreatic Cancer']
NCT02873195;Capecitabine and Bevacizumab With or Without Atezolizumab in Treating Patients With Refractory Metastatic Colorectal Cancer;ACTIVE_NOT_RECRUITING;['PHASE2'];INTERVENTIONAL;133.0;['Metastatic Colorectal Carcinoma', 'Recurrent Colorectal Carcinoma', 'Refractory Colorectal Carcinoma', 'Stage IV Colorectal Cancer AJCC v7', 'Stage IVA Colorectal Cancer AJCC v7', 'Stage IVB Colorectal Cancer AJCC v7']
NCT00541099;Bevacizumab and Docetaxel in Treating Older Patients With Stage III or Stage IV Non-Small Cell Lung Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;11.0;['Lung Cancer']
NCT03856099;TTAC-0001 Phase II Trial With Recurrent Glioblastoma Progressed on Bevacizumab;TERMINATED;['PHASE2'];INTERVENTIONAL;19.0;['Recurrent Glioblastoma']
NCT01931098;Oral Pazopanib Plus Oral Topotecan Metronomic Antiangiogenic Therapy for Recurrent Glioblastoma Multiforme (A) Without Prior Bevacizumab Exposure and (B) After Failing Prior Bevacizumab;COMPLETED;['PHASE2'];INTERVENTIONAL;35.0;['Glioblastoma', 'Glioblastoma Multiforme', 'Gliosarcoma', 'Brain Neoplasms', 'Central Nervous System Neoplasms']
NCT01669798;BIBF 1120 in Bevacizumab Resistant, Persistent, or Recurrent Epithelial Ovarian Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;32.0;['Ovarian Cancer', 'Fallopian Tube Cancer', 'Peritoneal Cancer']
NCT03961698;Evaluation of IPI-549 Combined With Front-line Treatments in Pts. With Triple-Negative Breast Cancer or Renal Cell Carcinoma;ACTIVE_NOT_RECRUITING;['PHASE2'];INTERVENTIONAL;91.0;['Breast Cancer', 'Renal Cell Carcinoma']
NCT03321513;DRCR.Net Aflibercept vs. Bevacizumab + Deferred Aflibercept for the Treatment of CI-DME;COMPLETED;['PHASE3'];INTERVENTIONAL;270.0;['Diabetic Macular Edema']
NCT03587311;Bevacizumab and Anetumab Ravtansine or Paclitaxel in Treating Patients With Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer;ACTIVE_NOT_RECRUITING;['PHASE2'];INTERVENTIONAL;96.0;['Fallopian Tube Endometrioid Adenocarcinoma', 'Fallopian Tube High Grade Serous Adenocarcinoma', 'Ovarian Endometrioid Adenocarcinoma', 'Ovarian High Grade Serous Adenocarcinoma', 'Platinum-Resistant Fallopian Tube Carcinoma', 'Platinum-Resistant Ovarian Carcinoma', 'Platinum-Resistant Primary Peritoneal Carcinoma', 'Primary Peritoneal High Grade Serous Adenocarcinoma']
NCT00323011;FOLFIRI + Bevacizumab With or Without Dalteparin in First Line Treatment of Advanced Colorectal Cancer;TERMINATED;['PHASE2'];INTERVENTIONAL;5.0;['Colorectal Cancer']
NCT00027599;APC8015 and Bevacizumab in Treating Patients With Prostate Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;25.0;['Prostate Cancer']
NCT05446870;Pembrolizumab With Chemotherapy and MK-4830 for Treating Participants With Ovarian Cancer (MK-4830-002);ACTIVE_NOT_RECRUITING;['PHASE2'];INTERVENTIONAL;160.0;['High-grade Serous Ovarian Carcinoma', 'Ovarian Carcinoma']
NCT00433511;Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer;ACTIVE_NOT_RECRUITING;['PHASE3'];INTERVENTIONAL;4994.0;['Breast Adenocarcinoma']
NCT05609370;A Study Investigating the Efficacy and Safety of LBL-007 Plus Tislelizumab in Combination With Bevacizumab Plus Fluoropyrimidine Versus Bevacizumab Plus Fluoropyrimidine in Participants With Unresectable or Metastatic Colorectal Cancer;RECRUITING;['PHASE1', 'PHASE2'];INTERVENTIONAL;226.0;['Unresectable or Metastatic Microsatellite Stable/Mismatch Repair Proficient Colorectal Cancer']
NCT01197170;Hormone Receptor Positive Disease Across Solid Tumor Types: A Phase I Study of Single-Agent Hormone Blockade and Combination Approaches With Targeted Agents to Provide Synergy and Overcome Resistance;COMPLETED;['PHASE1'];INTERVENTIONAL;277.0;['Solid Tumors', 'Advanced Cancer']
NCT04958811;Tiragolumab With Atezolizumab Plus Bevacizumab in Previously-Treated Advanced Non-squamous NSCLC;RECRUITING;['PHASE2'];INTERVENTIONAL;42.0;['Non-squamous Non-small-cell Lung Cancer']
NCT02364999;A Comparative Study Of PF-06439535 Plus Paclitaxel-Carboplatin And Bevacizumab Plus Paclitaxel-Carboplatin Patients With Advanced Non-Squamous NSCLC;COMPLETED;['PHASE3'];INTERVENTIONAL;719.0;['Non-Small Cell Lung Cancer']
NCT00607113;Avastin (Bevacizumab) and RAD001 (Everolimus) in Advanced Low or Intermediate Grade Neuroendocrine Carcinoma;COMPLETED;['PHASE2'];INTERVENTIONAL;41.0;['Neuroendocrine Carcinoma']
NCT00326911;Cetuximab and Bevacizumab With or Without Gemcitabine to Treat Metastatic Pancreatic Cancer;TERMINATED;['PHASE2'];INTERVENTIONAL;61.0;['Metastatic Pancreatic Cancer']
NCT00786669;A Pilot Study of the Addition of Bevacizumab to VOIT Regimen for Relapsed/Refractory Pediatric Solid Tumors;COMPLETED;['PHASE1'];INTERVENTIONAL;13.0;['Solid Tumor']
NCT02272413;Phase III Trial BI 695502 Plus Chemotherapy vs. AvastinÂ® Plus Chemotherapy in Patients With Lung Cancer;COMPLETED;['PHASE3'];INTERVENTIONAL;671.0;['Carcinoma, Non-Small-Cell Lung']
NCT00318513;Safety Study of Bevacizumab to Treat Women With a History of Breast Cancer and Suffering From Upper Extremity Lymphedema;UNKNOWN;['PHASE1'];INTERVENTIONAL;35.0;['Lymphedema']
NCT02364713;MV-NIS or Investigator's Choice Chemotherapy in Treating Patients With Ovarian, Fallopian, or Peritoneal Cancer;ACTIVE_NOT_RECRUITING;['PHASE2'];INTERVENTIONAL;66.0;['Fallopian Tube Carcinosarcoma', 'Fallopian Tube Clear Cell Adenocarcinoma', 'Fallopian Tube Endometrioid Adenocarcinoma', 'Fallopian Tube Mucinous Adenocarcinoma', 'Fallopian Tube Serous Adenocarcinoma', 'Fallopian Tube Transitional Cell Carcinoma', 'Fallopian Tube Undifferentiated Carcinoma', 'Ovarian Carcinosarcoma', 'Ovarian Clear Cell Adenocarcinoma', 'Ovarian Endometrioid Adenocarcinoma', 'Ovarian Mucinous Adenocarcinoma', 'Ovarian Seromucinous Carcinoma', 'Ovarian Serous Adenocarcinoma', 'Ovarian Transitional Cell Carcinoma', 'Ovarian Undifferentiated Carcinoma', 'Platinum-Resistant Fallopian Tube Carcinoma', 'Platinum-Resistant Ovarian Carcinoma', 'Platinum-Resistant Primary Peritoneal Carcinoma', 'Primary Peritoneal Carcinosarcoma', 'Primary Peritoneal Clear Cell Adenocarcinoma', 'Primary Peritoneal Endometrioid Adenocarcinoma', 'Primary Peritoneal Serous Adenocarcinoma', 'Primary Peritoneal Transitional Cell Carcinoma', 'Primary Peritoneal Undifferentiated Carcinoma', 'Recurrent Fallopian Tube Carcinoma', 'Recurrent Ovarian Carcinoma', 'Recurrent Primary Peritoneal Carcinoma']
NCT00323869;Phase II Bevacizumab, Gemcitabine and Carboplatin in Newly Diagnosed Non-Small Cell Lung Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;48.0;['Lung Cancer', 'Non-small Cell Lung Cancer (NSCLC)']
NCT01187199;Phase I Trial of Bevacizumab and Temsirolimus in Combination With 1) Carboplatin, 2) Paclitaxel, 3) Sorafenib for the Treatment of Advanced Cancer;ACTIVE_NOT_RECRUITING;['PHASE1'];INTERVENTIONAL;278.0;['Advanced Cancer']
NCT01633970;A Study of Atezolizumab Administered in Combination With Bevacizumab and/or With Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors;COMPLETED;['PHASE1'];INTERVENTIONAL;240.0;['Cancer']
NCT05489211;Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03);RECRUITING;['PHASE2'];INTERVENTIONAL;670.0;['Endometrial Cancer', 'Gastric Cancer', 'Metastatic Castration-resistant Prostate Cancer', 'Ovarian Cancer', 'Colorectal Cancer', 'Urothelial Cancer', 'Biliary Tract Cancer']
NCT00137813;Avastin and Taxotere for Esophagogastric Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;42.0;['Esophageal Cancer', 'Gastric Cancer']
NCT00674011;Hypertension in Breast Cancer Patients Receiving Bevacizumab;TERMINATED;;OBSERVATIONAL;10.0;['Breast Cancer']
NCT00121199;Combination Chemo, Rituximab, and Bevacizumab in Older Patients With Stage II-IV Diffuse Large B-Cell Lymphoma;COMPLETED;['PHASE2'];INTERVENTIONAL;73.0;['Contiguous Stage II Adult Diffuse Large Cell Lymphoma', 'Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma', 'Stage III Adult Diffuse Large Cell Lymphoma', 'Stage IV Adult Diffuse Large Cell Lymphoma']
NCT01999270;Evaluation of FDOPA-PET/MRI in Pediatric Patients With CNS Tumors;COMPLETED;['PHASE1'];INTERVENTIONAL;6.0;['Astrocytoma, Oligoastrocytoma, Mixed', 'Ganglioneuroma', 'Glioma', 'Ganglioglioma', 'Glioblastoma Multiforme Glioma']
NCT05733611;RP2/RP3 in Combination With Atezolizumab and Bevacizumab for the Treatment of Patients With CRC;ACTIVE_NOT_RECRUITING;['PHASE2'];INTERVENTIONAL;60.0;['Refractory Metastatic Colorectal Cancer', 'pMMR', 'MSS']
NCT01644513;Evaluation of the Association Between Genetic Load and Response to Anti-VEGF Therapy in AMD Patients;COMPLETED;;OBSERVATIONAL;196.0;['Age Related Macular Degeneration']
NCT01580969;Repeat Radiation, Minocycline and Bevacizumab in Patients With Recurrent Glioma;COMPLETED;['PHASE1', 'PHASE2'];INTERVENTIONAL;22.0;['Recurrent Glioma']
NCT02610413;Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Hypertension Receiving Bevacizumab for Breast Cancer;RECRUITING;;OBSERVATIONAL;354.0;['Breast Carcinoma']
NCT00364611;Pilot Study of Docetaxel & Bevacizumab +/- Trastuzumab in First-Line Treatment of Patients With Metastatic Breast Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;73.0;['Breast Cancer']
NCT00779311;A Phase I Trial Evaluating mFOLFOX6 and Avastin With Nexavar as First-Line Treatment for Metastatic Colorectal Cancer;TERMINATED;['PHASE1'];INTERVENTIONAL;8.0;['Metastatic Colorectal Cancer']
NCT03387111;QUILT-3.090: NANT Squamous Cell Carcinoma (SCC) Vaccine: Subjects With SCC Who Have Progressed;UNKNOWN;['PHASE1', 'PHASE2'];INTERVENTIONAL;65.0;['Squamous Cell Carcinoma']
NCT04164069;Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab;ACTIVE_NOT_RECRUITING;['PHASE1'];INTERVENTIONAL;9.0;['Advanced Colorectal Carcinoma', 'Metastatic Colorectal Carcinoma', 'Stage IV Colorectal Cancer AJCC v8', 'Stage IVA Colorectal Cancer AJCC v8', 'Stage IVB Colorectal Cancer AJCC v8', 'Stage IVC Colorectal Cancer AJCC v8', 'Stage II Colon Cancer', 'Stage II Rectal Cancer', 'Stage III Colon Cancer', 'Stage III Rectal Cancer', 'Esophageal Cancer', 'Pancreatic Cancer', 'Bile Duct Cancer', 'Gastric Cancer', 'Gall Bladder Cancer', 'Small Bowel Adenocarcinoma']
NCT02648711;Alternative Dosing for CRLX101(NLG207) Alone, With Avastin and With mFOLFOX6 in Advanced Solid Tumors;TERMINATED;['PHASE1'];INTERVENTIONAL;41.0;['Solid Tumors']
NCT00913913;Bevacizumab, Autologous Tumor/DC Vaccine, IL-2 and IFNÎ±-2b in Metastatic Renal Cell Carcinoma (RCC) Patients;TERMINATED;['PHASE2'];INTERVENTIONAL;8.0;['Metastatic Renal Cell Carcinoma']
NCT02921269;Atezolizumab and Bevacizumab in Treating Patients With Recurrent, Persistent, or Metastatic Cervical Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;11.0;['Cervical Adenocarcinoma', 'Cervical Adenosquamous Carcinoma', 'Cervical Squamous Cell Carcinoma, Not Otherwise Specified', 'Recurrent Cervical Carcinoma', 'Stage IV Cervical Cancer AJCC v6 and v7', 'Stage IVA Cervical Cancer AJCC v6 and v7', 'Stage IVB Cervical Cancer AJCC v6 and v7']
NCT02671435;A Study of Durvalumab (MEDI4736) and Monalizumab in Solid Tumors;ACTIVE_NOT_RECRUITING;['PHASE1', 'PHASE2'];INTERVENTIONAL;383.0;['Advanced Solid Tumors']
NCT00972335;Trial of the Combination of Bevacizumab and Everolimus in Patients With Refractory, Progressive Intracranial Meningioma;TERMINATED;['PHASE2'];INTERVENTIONAL;18.0;['Intracranial Meningioma']
NCT00968435;Bevacizumab, Cetuximab, and Cisplatin With IMRT (Intensity-Modulated Radiation Therapy) for Patients With Stage III/IV Head and Neck Squamous Cell Carcinoma;COMPLETED;['PHASE2'];INTERVENTIONAL;30.0;['Head and Neck Cancer']
NCT01982435;Safety and Efficacy of Ranibizumab for Diabetic Macular Edema;COMPLETED;['PHASE1', 'PHASE2'];INTERVENTIONAL;27.0;['Diabetic Macular Edema']
NCT00499369;Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy;TERMINATED;['PHASE3'];INTERVENTIONAL;72.0;['Recurrent Colon Cancer', 'Recurrent Rectal Cancer', 'Stage IVA Colon Cancer', 'Stage IVA Rectal Cancer', 'Stage IVB Colon Cancer', 'Stage IVB Rectal Cancer']
NCT00520013;Avastin +/- Erlotinib Consolidation Chemotherapy After Carboplatin, Paclitaxel, and Avastin (CTA) Induction Therapy for Advanced Ovarian, Fallopian Tube, Primary Peritoneal Cancer & Papillary Serous or Clear Cell Mullerian Tumors;COMPLETED;['PHASE2'];INTERVENTIONAL;60.0;['Ovarian Cancer', 'Fallopian Tube Cancer', 'Primary Peritoneal Cancer', 'Papillary Serous Mullerian Tumor', 'Clear Cell Mullerian Tumor']
NCT00444535;Lapatinib and Bevacizumab for Metastatic Breast Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;52.0;['Neoplasms, Breast']
NCT06107413;Study to Assess Adverse Events and Change in Disease Activity in Previously Treated Adult Participants Receiving Intravenous (IV) ABBV-400 With Unresectable Metastatic Colorectal Cancer in Combination With IV Fluorouracil, Folinic Acid, and Bevacizumab;RECRUITING;['PHASE2'];INTERVENTIONAL;206.0;['Unresectable Metastatic Colorectal Cancer']
NCT03074513;Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors;ACTIVE_NOT_RECRUITING;['PHASE2'];INTERVENTIONAL;133.0;['Appendix Adenocarcinoma', 'Human Papillomavirus-Related Anal Squamous Cell Carcinoma', 'Human Papillomavirus-Related Cervical Squamous Cell Carcinoma', 'Human Papillomavirus-Related Squamous Cell Carcinoma of the Penis', 'Human Papillomavirus-Related Vulvar Squamous Cell Carcinoma', 'Neuroendocrine Carcinoma', 'Pancreatic Neuroendocrine Tumor', 'Recurrent Merkel Cell Carcinoma', 'Recurrent Nasopharynx Carcinoma', 'Recurrent Peritoneal Malignant Mesothelioma', 'Recurrent Pleural Malignant Mesothelioma', 'Stage III Merkel Cell Carcinoma AJCC v7', 'Stage III Nasopharyngeal Carcinoma AJCC v7', 'Stage III Pleural Malignant Mesothelioma AJCC v7', 'Stage IV Merkel Cell Carcinoma AJCC v7', 'Stage IV Nasopharyngeal Carcinoma AJCC v7', 'Stage IV Pleural Malignant Mesothelioma AJCC v7', 'Stage IVA Nasopharyngeal Carcinoma AJCC v7', 'Stage IVB Nasopharyngeal Carcinoma AJCC v7', 'Stage IVC Nasopharyngeal Carcinoma AJCC v7', 'Vaginal Squamous Cell Carcinoma, Not Otherwise Specified']
NCT00731211;Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma;COMPLETED;['PHASE2'];INTERVENTIONAL;57.0;['Renal Cell Carcinoma']
NCT03875313;Study of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid Tumors;TERMINATED;['PHASE1', 'PHASE2'];INTERVENTIONAL;33.0;['Solid Tumor', 'Clear Cell Renal Cell Carcinoma', 'TNBC - Triple-Negative Breast Cancer', 'Colorectal Cancer', 'CRC', 'RCC', 'ccRCC']
NCT05627635;FOLFOX and Bevacizumab in Combination With Botensilimab and Balstilimab (3B-FOLFOX) for the Treatment of Microsatellite Stable (MSS) Metastatic Colorectal Cancer;RECRUITING;['PHASE1', 'PHASE2'];INTERVENTIONAL;86.0;['Metastatic Colon Adenocarcinoma', 'Metastatic Colorectal Adenocarcinoma', 'Metastatic Microsatellite Stable Colorectal Carcinoma', 'Metastatic Rectal Adenocarcinoma', 'Stage IV Colon Cancer AJCC v8', 'Stage IV Colorectal Cancer AJCC v8', 'Stage IV Rectal Cancer AJCC v8']
NCT00118235;Cisplatin, Irinotecan, and Bevacizumab, in Treating Patients With Small Cell Lung Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;72.0;['Extensive Stage Small Cell Lung Cancer']
NCT00222469;Combination Chemotherapy for 1st Line Treatment of Advanced or Metastatic Pancreatic Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;50.0;['Metastatic Pancreatic Cancer']
NCT00469469;Treatment Study Using Bevacizumab for Patients With Adrenocortical Carcinoma;WITHDRAWN;['PHASE2'];INTERVENTIONAL;0.0;['Adrenocortical Carcinoma']
NCT00574769;Safety Study & Effectiveness of Docetaxel With RAD001 and Bevacizumab in Men With Advanced Prostate Cancer;COMPLETED;['PHASE1', 'PHASE2'];INTERVENTIONAL;27.0;['Prostate Cancer']
NCT01006369;Hydroxychloroquine, Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer;COMPLETED;['PHASE2'];INTERVENTIONAL;38.0;['Colorectal Cancer']
NCT00085111;Bevacizumab in Treating Young Patients With Refractory Solid Tumors;COMPLETED;['PHASE1'];INTERVENTIONAL;24.0;['Unspecified Childhood Solid Tumor, Protocol Specific']
